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“Das entspricht vollkommen meinen an Daphnien gewonnenen Angaben und lässt sich einfach 
dahin formuliren, dass Riesenzellen Bacillen auffressen und sie dann ertödten. Dass daraus 
noch nicht der definitive Sieg der Phagocyten unbedingt folgt, leuchtet von selbst ein.” 
 
Elias Metschnikoff, 1883,  
Archiv für pathologische Anatomie und Physiologie und für klinische Medicin 
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  Summary
Summary 1 
Phagocytosis, the cellular uptake of large particles, such as pathogens or apoptotic cells, 
usually starts with the recognition of specific ligands on the particle surface. The receptors 
engaged during phagocytic particle uptake determine the signalling events that occur during 
phagosome formation and maturation. However, pathogens generally have multiple ligands, 
making it difficult to dissect the roles of individual receptors in these processes. 
 In this study, I used latex beads coupled to single ligands, focusing on IgG, mannan, 
LPS, avidin and gelatin, as a model system of receptor mediated phagocytosis in mouse 
macrophages. The major aim of this thesis was to analyse whether initial receptor ligand 
interactions are able to influence not only the phagocytic uptake but also later events in 
phagocytosis, such as phagosome maturation. After the addition of coated latex beads to 
J774 macrophages, different phagocytic functions, such as phagocytic uptake rates and 
fusion of phagosomes with lysosomes, as well as macrophage gene expression were 
investigated. Additionally, phagosomes containing coated latex beads were isolated and their 
proteomic composition as well as their capability to bind to actin filaments in vitro were 
analysed. The following results could be obtained:  
1. The model system of latex beads coupled to single or multiple ligands allows the 
investigation of several aspects of receptor mediated phagocytosis in more detail. 
2. Particles coupled to mannan were internalised at higher rates and their phagosomes 
fused with lysosomes earlier after uptake than the ones formed by the other ligands. 
3. The pattern of gene expression showed that each bead ligand upregulated a distinct 
pattern of genes, arguing against a common set of genes influenced during 
phagocytosis in general.  
4. The analysis of phagosomal proteomes exhibited similar results, because the protein 
composition of isolated phagosomes was predominantly unique to the bead ligand.  
5. Furthermore, isolated phagosomes also displayed differences in their capability to 
bind to actin filaments in vitro influenced by their ligand recognition during receptor
specific phagocytosis. 
 These results demonstrate that interactions between receptor and ligand specifically 
modulate gene expression and protein composition of forming phagosomes that, collectively, 
contribute to cellular signalling and inflammatory processes as well as later stages of 
phagosome maturation and the association of phagosomes with actin filaments. The 
conclusion can be drawn that the activation of each receptor initiates a specific ‘signature’ 
that lasts many hours and influences several phagosome functions. 
  Introduction
Introduction 2 
1.1 Phagocytosis  
Phagocytosis is one type of endocytosis, which generally describes the uptake of 
extracellular material. Phagocytosis is a process by which cells engulf large particles of a 
diameter >0.5 μm. Other endocytic routes exist, such as pinocytosis, which involves the 
ingestion of fluids and solutes and receptor mediated endocytosis, which can be subdivided 
into those dependent on clathrin and other, less well understood mechanisms, like pathways 
initiated by caveolae and lipid rafts (reviewed in Mousavi et al. 2004, Mayor & Pagano 2007). 
 The Ukrainian zoologist and microbiologist Ilya Mechnikov, also known as Elias 
Metschnikoff, first described phagocytosis nearly 125 years ago in the small fresh water 
crustacean Daphnia (Metschnikoff 1883). In protozoans, phagocytosis is mainly dedicated to 
nutrition, whereas in metazoans this activity is predominantly restricted to specialized cells, 
called professional phagocytes. Phagocytosis is essential for host defense against invading 
pathogens and the clearance of apoptotic cells, thereby playing a central role in tissue 
homeostasis. In addition, internalization and degradation of pathogenic microbes by 
professional phagocytes trigger activation of the innate and adaptative immune response 
after antigen presentation at the surface of the phagocytic cell. The phagocytic process is 
initiated by the recognition of specific ligands present on the surface of the phagocytosed 
particle. These interactions between receptor and ligand trigger a specific signalling pathway 
that activates actin cytoskeleton and membrane remodeling, leading to particle uptake. The 
organelle with the enclosed particle, termed phagosome, then fuses transiently and 
sequentially with the endosomal and lysosomal machinery to eventually degrade the 
phagosome content (Aderem & Underhill 1999).  
 Professional phagocytes are equipped for rapid and efficient uptake of invading 
microorganisms at sites of inflammation. In addition, these cells are crucial for antigen 
presentation and release of cytokines and chemokines to induce inflammation and the 
recruitment of components of the adaptive immune system (Aderem 2003). In mammals this 
task is mainly accomplished by two types of cells, members of the mononuclear phagocytic 
system like monocytes, macrophages and dendritic cells or by polymorphonuclear 
neutrophils. Members of the last group are short living cells (1 2 days) that are abundantly 
found in the blood of infected individuals but rarely in tissues. In contrast, macrophages are 
long living cells (several months) that can be located in different tissues, such as the 
connective tissue, the submucosa of the gastro intestinal tract, the lungs, the liver (Kupffer 
cells), the central nervous system (microglia), the bones (osteoclasts) and throughout the 
spleen, where they remove senescent blood cells (Janeway et al. 2004). All those cell types 
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originate from pluripotent stem cells present in the bone marrow that differentiate in response 
to hematopoietic factors. After differentiation, mononuclear phagocytes are released in the 
blood and remain circulating as monocytes, unless they are recruited to sites of inflammation 
by chemotactic signals and become macrophages which enter tissues (Janeway et al. 2004).  
 Macrophages have three major functions: phagocytosis, antigen presentation and the 
modulation of immune responses through production of various cytokines and growth factors. 
Macrophages thus represent a major defense against invasion of the host by a wide variety 
of microorganisms, including bacteria, viruses, fungi and protozoa. They play a critical role in 
the initiation, maintenance, and resolution of inflammation and are activated and deactivated 
during the inflammatory process. In response to cytokines and microbial products, 
macrophages become activated and express specialized and polarized functional properties. 
Macrophage activation is divided in the classical and the alternative pathway dependent on 
the involved cytokines released from T helper cells (Gordon 2003; Ma et al. 2003). Activation 
signals include cytokines like interferon gamma (IFN ), granulocyte monocyte colony 
stimulating factor (GM CSF), and tumor necrosis factor alpha (TNF ), but also bacterial 
lipopolysaccharides, extracellular matrix proteins and other chemical mediators. Inhibition of 
inflammation by removal or deactivation of mediators and inflammatory effector cells is 
crucial to repair damaged tissues. Activated macrophages can be deactivated by anti
inflammatory cytokines like interleukin 10 (IL 10) or transforming growth factor beta as well 
as by antagonist cytokines that are mainly produced by the macrophage itself. 
 In addition to professional phagocytes several other cell types, like epithelial cells and 
fibroblasts have been shown to be capable of phagocytosis and are referred as non
professional phagocytes. These cells differ by their low efficiency of uptake and the limited 
range of particles that they internalise (Rabinovitch 1995). Often, such phagocytes can be 
induced by pathogens, e.g. by the interaction of Shigella species with epithelial cells (Clerc & 
Sansonetti 1987). 
 The phagocytic process is very complex, and one single model cannot be applied to 
describe the diverse cellular structures and signalling pathways associated with particle 
internalisation. However, this process can be divided into four major steps: 1.) binding of the 
particle to specific receptors present on the surface of the phagocytic cell triggering signalling 
events beneath the plasma membrane; 2.) internalisation through actin myosin cytoskeleton 
activation and plasma membrane deformation leading to an intracellular vesicle, termed the 
phagosome, enclosing the phagocytosed partice; 3.) a change of the intraphagosomal 
environment to antimicrobial conditions by fusion events with endosomal/lysosomal 
compartments and the acquisition of various hydrolases, the production of large quantities of 
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superoxide radicals from molecular oxygen and nitric oxide radicals from arginine as well as 
the acidification of the phagosome lumen by a membrane embedded proton pumping 
ATPase complex, all together termed as phagosome maturation; and 4.) degradation of the 
phagolysosomal content which can be accompanied by antigen cross presentation (Houde et 
al. 2003). Degradable substances may be used by the cell, are secreted from the cell via 
exocytic routes or in the case of non degradable material stay in phagolysosomes or 
lysosomes as residual bodies. Subsequently, these different steps of phagocytosis are 
described in more detail. 
1.1.1 Phagocytic receptors  
The phagocytic uptake is initiated by the recognition of ligands present on the surface of 
particles, especially microbes, by one or multiple selective receptor types that trigger specific 
signalling pathways activating particle internalisation. The ability of phagocytes to 
discriminate between different particles, cell debris and potential pathogens depends on 
those cell surface receptors. Two general mechanisms of receptor particle interaction have 
been identified in macrophages and neutrophils. Receptors can either interact directly with 
structural determinants on the particle surface (non opsonic phagocytosis) or bind indirectly 
to the particle via host supplied opsonins located on the surface of potential pathogens 
(opsonin dependent phagocytosis). Opsonins are mainly complement compounds and 
immunoglobulins delivered by the adaptive immunity response. 
 Professional phagocytes have evolved to express a broad array of membrane 
receptors that allow them to recognize a wide range of specific molecular determinants on 
phagocytic targets, which makes them a powerful tool of the immune system (Taylor et al. 
2005). The signalling pathways triggered by the different phagocytic receptors are diverse 
and complex (Figure 1). This complexity can be also increased by the capacity of a variety of 
microbes to influence their fate as they are internalized. The fact that most particles are 
recognized by more than one receptor, and that these receptors are capable of signalling 
crosstalk and synergy, further complicates our understanding. In addition, many phagocytic 
receptors have a dual function, often mediating both adhesion and particle internalisation, 
and a complex relationship exists between these two related processes (Aderem & Underhill 
1999). A primary challenge to the innate immune system is the discrimination of a large 
number of potential pathogens from self, utilizing a restricted number of phagocytic 
receptors. This challenge has been solved by the evolution of a variety of receptors that 
recognize conserved motifs on pathogens that are not found in higher eukaryotes (Kabelitz & 
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Medzhitov 2007). These motifs have essential roles in the biology of the invading agents, and 
they are therefore not subjected to high mutation rates. Janeway has proposed to call the 
phagocytic receptors, “pattern recognition receptors” and the targets of those receptors 
“pathogen associated molecular patterns” (Janeway 1992). Pathogen associated motifs 
include mannans in the yeast cell wall, formylated peptides, lipopolysaccharides and 
lipoteichoic acids on the surface of Gram negative and Gram positive bacteria. While direct 
pathogen recognition is a fundamental aspect of innate immunity, opsonisation allows 
diversification of the phagocyte recognition repertoire (Stuart & Ezekowitz 2005).  
 In macrophages, their involved receptors (Figure 1) can be classified in non opsonic 
phagocytic receptors, such as lectins (mannose receptor, DC SIGN,  glucan receptor), 
integrins and scavenger receptors (SR) or opsonic phagocytic receptors, like members of the 
Fc receptor (FcR) family, complement receptors (CR) and collectin receptors. A third group 
contains toll like receptors (TLR) which often function as co receptors in phagocytosis by 
their detection of a broad range of microbial products including lipopolysaccharide, 
peptidoglycan and bacterial lipopeptides (Underhill & Ozinsky 2002). Some of macrophage 
receptors that are essential for this study are characterized in more detail below. 
 
Figure 1. Receptor and signalling interactions during phagocytosis of microbes. Multiple receptors 
simultaneously recognise microbes both through direct binding and by binding to opsonins on their 
surface. Receptor engagement induces many intracellular signals by different enzymes that activate or 
inhibit further phagocytosis and microbe-induced responses (adapted from Underhill & Ozinsky 2002). 
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Mannose receptor (MR) 
The mannose receptor (CD206) on macrophages has been identified as a 175 kDa 
membrane glycoprotein (Wileman et al. 1986) that recognizes mannose and fucose on the 
surfaces of pathogens and requires calcium and neutral pH for optimal ligand binding 
(reviewed in Stahl & Ezekowitz 1998). The MR is a single chain receptor with a short 
cytoplasmic tail and an extracellular domain including eight lectin like carbohydrate binding 
domains that share homology with other C type lectins including the mannose binding protein 
and the phospholipase A2 receptor (Ezekowitz et al. 1990). The cytoplasmic tail is crucial to 
both the endocytic and phagocytic functions of the receptor, but little is known about the 
signals that lead to phagocytosis.  
 Several studies suggested that exclusive activation of the mannose receptor cannot 
induce phagocytosis and other co receptors are usually needed (Kang et al. 2005; Taylor et 
al. 2005). The high affinity of this receptor for branched mannose and fucose 
oligosaccharides makes the MR a phagocytic receptor with broad pathogen specificity. 
Importantly, the mannose receptor is able to recognize a prominent lipoglycan of the cell wall 
of Mycobacterium tuberculosis, the terminal mannose capped lipoarabinomannan (ManLAM) 
which contributes together with complement receptors to the internalisation of these 
pathogens (Fenton et al. 2005). In contrast, phosphatidylmyoinositol capped 
lipoarabinomannan (PILAM) from avirulent Mycobacterium smegmatis does not engage the 
MR (Schlesinger et al. 1994), but rather toll like receptor 2 (TLR2), and thereby activating a 
proinflammatory response (Means et al. 1999). Thus, the terminal components of ManLAM 
are very important in host cell recognition and response and induce an anti inflammatory 
program (Nigou et al. 2001). However, in addition to this and dependent on the recognized 
ligands, also proinflammatory signals can be also generated upon MR ligation, like 
production of TNF  and IL 12 (Garner et al. 1994; Shibata et al. 1997). 
 The signalling events during mannose receptor mediated phagocytosis modulate 
cytoskeletal rearrangements as well as changes in phagosomal trafficking. As an example, 
MR dependent phagocytosis of zymosan mobilizes the actin cytoskeleton around nascent 
phagosomes, and proteins such as F actin, talin, PKC and myosin I are recruited (Allen & 
Aderem 1996). However, in contrast to FcR  and CR mediated phagocytosis, vinculin and 
paxillin are not recruited to MR phagosomes, reinforcing the notion that different phagocytic 
receptors send different signals to the actin cytoskeleton and initiate different mechanisms of 
internalisation (Allen & Aderem 1996). The MR has also been implicated in antigen uptake 
and processing (Prigozy et al. 1997). 
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Scavenger receptors (SR) 
Scavenger receptors are a family of structurally diverse receptors having broad ligand 
specificity that includes low density lipoproteins, phosphatidylserine and polyanionic 
compounds (Krieger & Herz 1994). Based on primary sequence information, SRs have been 
divided into at least six groups, and receptors from several of these groups are expressed on 
macrophages. One member, SR A, is a homotrimeric glycoprotein with an extracellular 
ligand binding domain and represents an important nonopsonic receptor involved in foam cell 
formation as well as host defense (Krieger 1997). Direct evidence for involvement of SR A in 
macrophage phagoctosis of apoptotic cells comes from studies on the phagocytosis of 
apoptotic thymocytes by thymus derived macrophages in vitro (Platt et al. 1996). Several 
studies with wild type and knockout mice have implicated SR A in microbial susceptibility to 
bacterial infection in vivo including Listeria monocytogenes and Staphylococcus aureus (Platt 
et al. 2002). However, scavenger receptors are also believed to recognise but not 
significantly cause internalisation of different particles and could participate in the more non
specific uptake of ligands like avidin and gelatin. 
Fc family of receptors (FcR) 
Most of our understanding of the signalling pathways leading to phagocytosis in 
macrophages comes from studies of receptors binding to the Fc region of immunoglobulin 
(Ig), the so called Fc receptors (FcR). Receptors for IgG (FcR), IgE (FcR) and IgA (FcR) 
have been described (Janeway et al. 2004). Interaction of FcRs with their immunoglobulin 
ligands triggers a wide series of leukocyte responses including phagocytosis, respiratory 
burst, antibody dependent cell mediated cytotoxity, release of pro inflammatory mediators 
and production of cytokines (Sanchez Mejorada & Rosales 1998). Among FcRs, only FcR 
und FcR are capable of mediating phagocytosis. FcR is expressed in neutrophils, 
monocytes and macrophages. The three classes of FcRs (FcRI, FcRII, FcRIII) are 
expressed differentially in many cell types of the immune system.  
 In all mammalian species studied to date, four different classes of Fc receptors have 
been defined: FcRI (CD64), FcRII (CD32), FcRIII (CD16), and FcRIV (Nimmerjahn & 
Ravetch 2006). Whereas FcRI displays high affinity for the antibody constant region and 
restricted isotype specificity, FcRII and FcRIII have low affinity for the Fc region of IgG but 
a broader isotype binding pattern (Hulett & Hogarth, 1994). FcRIV is a recently identified 
receptor, conserved in all mammalian species with intermediate affinity and restricted 
subclass specificity (Nimmerjahn et al., 2005). Functionally, there are two different classes of 
Fc receptors: the activation and the inhibitory receptors, which transmit their signals via 
Introduction 8 
 
immunoreceptor tyrosine based activation (ITAM) or inhibitory motifs (ITIM), respectively 
(Ravetch & Lanier, 2000). The paired expression of activating and inhibitory molecules on the 
same cell is the key for the generation of a balanced immune response. When an opsonized 
particle binds to Fc receptors, the receptors cluster, a process initiating the assembly of a 
signalling complex on the cytoplasmatic side of the membrane. After its phosphorylation, the 
ITAM motif acts as a docking site for members of the Syk family of tyrosine kinases which 
cause their phosphorylation and subsequent activation. Syk has been reported to be involved 
in activating F actin rearrangement that sustains phagocytic cup formation (Greenberg 1999).  
Toll-like receptors (TLR) 
Toll like receptors recognize specific patterns of microbial components, especially those from 
pathogens, and regulate the activation of both innate and adaptive immunity. First 
characterised in Drosophila, the TLR family in mammals consists of more than 10 members 
and is characterized structurally by the presence of a leucine rich repeat (LRR) domain 
(Takeda et al. 2003). While TLR2 recognizes a variety of microbial components from Gram
negative and Gram positive bacteria, including mycobacteria, Staphylococcus sp. (Underhill 
et al. 1999) as well as some atypical LPS (Werts et al. 2001), TLR4 is the central receptor for 
the recognition of lipopolysaccharide (LPS), a major cell wall component of Gram negative 
bacteria (Poltorak et al. 1998). Recognition of LPS requires other molecules in addition to 
TLR4, like CD14 and LPS binding protein, which interact to initiate signalling pathways (Jiang 
et al. 2000). In addition to LPS, TLR4 recognizes several other ligands present on murine 
retroviruses (Rassa et al. 2002) and some heat shock proteins (Asea et al. 2002), being likely 
the receptor responsible for the inflammatory responses elicited by those proteins. Thus, 
TLR4 is presumably involved in several aspects of the inflammatory response by recognizing 
endogenous ligands produced during inflammation, even in the absence of infection. 
However, it should be noted that all endogenous TLR4 ligands activate immune cells only at 
very high concentration, which is in sharp contrast to the much lower concentrations required 
for LPS.  
CD14 
In addition to membrane spanning hydrophobic residues for the association with plasma 
membrane, cell surface receptors can also use a phosphatidylinositol based glycolipid (GPI) 
to anchor in cell membranes. One example that is highly expressed in macrophages is CD14 
which was identified as a receptor for LPS (Wright et al. 1990). Because CD14 does not 
contain a transmembrane domain, accessory molecules are needed for signal transduction. 
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The N terminal portion of CD14 is important for LPS binding and the interaction with 
accessory receptors (Juan et al. 1995). In recent years, TLR4 and TLR2 were identified as 
co receptors with CD14 for specific microbial ligands (Triantafilou & Triantafilou 2002). In 
addition to this, CD14 has also been implicated in recognition and internalisation of apoptotic 
cells. Interestingly, although apoptotic cells bind to CD14 at a site close to the LPS binding 
site, they do not elicit inflammatory responses, such as TNF  production, that are induced in 
macrophages by LPS (Devitt et al. 1998). 
 
It is important to mention that during phagocytosis, ligands on the surface of a particle 
orchestrate a set of signalling events that are necessary to engulf the particle and enclose it 
in the phagosome. Although a single ligand on the particle can efficiently induce phagocytic 
uptake, most pathogens have many different ligands on their surface. The more complex 
process of phagocytic uptake of pathogens occurs via multi ligand interactions, which also 
offer the opportunity of more specific immune responses. In this case many receptors are 
engaged, as it occurs during uptake via the zipper mechanism (see below). The different 
ligand receptor interactions undoubtedly contribute into the overall process of phagocytosis, 
even in the later stage of phagosome maturation. How these interactions influence the final 
steady state identity of the phagosome is less well understood. At present, it is unclear for 
example whether multiple receptors signal in synergy and in the same extent in response to 
ligand binding or whether a single receptor will dominate the different induced signalling 
pathways. 
1.1.2 Phagocytic internalisation and signalling  
After the recognition of ligands on the surface of a particle by phagocytic receptors, signalling 
events occur leading to phagocytic cup formation and uptake of the particle (Garcia Garcia & 
Rosales 2002). Phagosome formation is a complex sequence of events requiring not only 
signalling, but also transduction of information and engagement of the cytoskeleton and of 
membrane fusion and fission machinery. Two models have been proposed to describe the 
uptake process. First, the “zipper” mechanism that was mentioned before, proposed that the 
particle internalisation occurs by sequential recruitment of cell surface receptors to ligands on 
the particle surface, closing tightly and progressively the plasma membrane around it (Griffin 
& Silverstein 1974; Griffin et al. 1975). Studies on FcR mediated phagocytosis support this 
hypothesis (Show & Griffin 1981; Montesano et al. 1983). The “zipper” mechanism is 
characterized by the extension of long and thin membrane pseudopods around the particle. 
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In contrast, pathogens bound to CR3 do not cause major membrane deformation, but rather 
seem to sink into the cell (Underhill & Ozinsky 2002). The second model is called the “trigger” 
mechanism, where upon particle binding an all or none phagocytic response is initiated. In 
this case, large membrane protrusions will extend and enclose rapidly the particle in one 
step. This type of uptake has been described for bacterial entry into epithelial cells and 
macrophages (Swanson & Baer 1995). 
 The remodeling of the plasma membrane during phagocytic cup formation, in 
particular the initial extension of pseudopodia that grow and enclose the particle, requires the 
localized and rapid assembly of actin filaments (F actin) at the site of ingestion (Allison et al. 
1971). Studies on the regulation of F actin reorganization have identified several proteins and 
lipids playing a direct role in this process. Key regulators of cytoskeleton dynamics during 
phagocytosis include guanine nucleotide exchange factors (GEFs), adaptor molecules with 
associated GEF activity, Rho family GTPases, actin nucleation promoting factors, such as 
the Arp2/3 complex and contractile activity provided by several myosin isoforms (Castellano 
et al. 2001; Brandt et al. 2007). In dependence of the involved receptors different enzymes 
can be involved in the early signalling pathways (Garcia Garcia & Rosales 2002). 
Phagocytosis by FcR is initiated by the clustering of these receptors followed by 
phosphorylation of specific tyrosine residues within special amino acid motifs (Isakov 1997). 
It is caused by enzymes of the Src tyrosine kinase family. At least six members of the Src 
family have been identified in phagocytes: Fgr, Fyn, Hck, Lyn, Yes, and Src, which have 
been found associated to specific receptors (Korade Mirnics & Corey 2000). After 
phosphorylation, the tyrosine kinase Syk is recruited and activated to phagocytic sites (Darby 
et al. 1994), which is essential for actin remodeling by forming a molecular complex 
containing several proteins that contribute to the regulation of actin reorganization (Coppolino 
et al. 2001). The downstream pathways stimulated by active Syk are not completely 
understood, but include many signalling molecules, such as calcium, protein kinase C, 
phospholipase A2, C and D as well as phosphatidylinositol 3 kinase and the extracellular 
signal regulated kinase ERK (Garcia Garcia & Rosales 2002).  
 These enzymes modulate several classes of lipids, which are involved in 
phagosome formation including 1) glycerophospholipids, 2) cholesterol, 3) sphingolipids and 
4) phosphoinositides (Yeung & Grinstein 2007). 1) The group of glycerophospholipids 
contains phosphatidylcholine (PC), which is hydrolyzed by phospholipase D to generate the 
metabolically active phosphatidic acid (PA), as well as phosphatidylserine (PS), 
lysophosphatidic acid (LPA) and arachidonic acid (AA). After exposure to immunoglobulin G
opsonized targets, macrophages produce PA, which is involved in particle engulfment and 
Introduction 11 
 
promotes membrane fission (Kusner et al. 1999). External PS serves as a major recognition 
signal for phagocytosis of apoptotic cells (Marguet et al. 1999). LPA activates G protein
coupled receptors and binds to cognate cell surface receptors that are coupled to 
heterotrimeric G proteins that signal through the MAPK pathway (Fueller et al. 2003). 
Arachidonic acid is a key lipid in cellular signalling with multiple functions and is generated on 
engagement of phagocytic receptors by phospholipase A2 (Fernandez et al. 2003). It 
activates subunits of the NADPH oxidase (Li & Catheart 1997) and is important in various 
physiological and pathological processes, including inflammation, because it is metabolized 
to leukotrienes and prostaglandins, which are potent proinflammatory mediators (Diaz & Arm 
2003). 2) Cholesterol is taken up by cells through the receptor mediated internalization of 
lipoprotein complexes and is delivered to the endocytic pathway (Ikonen 2006). It is present 
in phagosomes and modulates targeting and retention of Rab family GTPases (Holtta Vuori 
& Ikonen 2006). 3) The third group of signalling lipids contains sphingolipids like ceramides, 
sphingomyelin (SM) and sphingosine, which form cellular lipid rafts including Src family 
kinases (Kwiatkowska et al. 2003), as well as sphingosine 1 phosphate (S1P), which is 
involved in phagosome formation (Treede et al. 2007) and maturation (Spiegel & Milstien 
2007). 4) Phosphoinositides, which exist as mono , bi  or triphosphoinositides in the cell, 
possess multiple functions in phagocytosis (Yeung & Grinstein 2007). Phosphatidylinositol 
4,5 bisphosphate [PI(4,5)P2], which is important for this study, is well known for its role in 
actin remodeling and was identified at the forming phagosome (Botelho et al. 2000). 
PI(4,5)P2 can be hydrolyzed to generate the second messengers inositol 1,4,5 triphosphate 
(IP3) and diacylglycerol (DAG), which mobilize calcium stores and activate protein kinase C. 
 Several studies have shown that different enzymes and lipids are involved in 
signalling cascades, which induce the initial steps of phagocytosis, like the extension of 
pseudopods. Essentially, de novo polymerized actin filaments provide the structural network 
that supports myosin driven contractile activity to tightly enclose the particle (Swanson et al. 
1999). Several myosin isoforms from myosin classes I, II, V, VII, IX and X have been found 
located around nascent phagosomes, suggesting that they are required transiently for 
phagosome internalization and closure (Figure 2). Myosin IC, IXb and X seem to be key 
players in the extension of phagocytic cup pseudopods (Swanson et al. 1999; Diakonova et 
al. 2002; Cox et al. 2002), whereas myosin II promotes closure of the cup (Olazabal et al. 
2002). Myosin VII has been implicated in phagocytic uptake both in D. discoideum and 
mammalian cells (Titus 1999). Following internalization, myosin V regulates the early stage 
of phagosome maturation. This motor protein rapidly associates with the phagosome after 
phagocytic cup closure and modulates the transitional step of phagosomal binding to cortical 
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actin filaments followed by switching to the microtubule network (Al Haddad et al. 2001). 
Microtubule association of phagosomes is crucial for their centripetal movement towards the 
center of the cell and their fusion with endo lysosomal compartments (Blocker et al. 1998; 
Araki 2006), which is essential for the degradation of the phagosomal content (described 
below). 
 After phagocytic cup closure, F actin is rapidly depolymerised and the newly formed 
phagosome becomes accessible for fusion events with compartments of the endocytic 
pathway (Swanson & Baer 1995). The following steps, referred to as phagosome maturation, 
are defined as the process by which phagosomes change their functional capacity as they 
age within cells. The main inducer of these alterations in phagosome behaviour is thought to 
be the sequential process of fusion, which takes place first with early endosomes and then 
with the late endosomes and lysosomes (Pitt et al. 1992a; Griffiths 2004). 
 
Figure 2. Overview of the motors that are involved in endocytic and recycling traffic (adapted from 
Soldati & Schliwa 2006). Cargoes are transported within cells along actin filaments or microtubules by 
the help of different classes of myosin (myo), kinesin (kin) or dynein (dyn). Shown are different 
pathways that are implicated in endocytic traffic, like phagocytosis, macropinocytosis, the clathrin-
dependent pathway and the caveolae pathway. The different cargoes are destined for degradation or 
are recycled either to the plasma membrane (directly or through recycling endosomes) or to the Golgi 
apparatus. 
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1.1.3 Phagosome maturation  
After the enclosure of particles at the cell surface the newly formed phagosomes are 
interacting with compartment of the endocytic pathway. The membrane that is needed to 
form nascent phagocytic vacuoles is composed largely of the plasmalemma, as it derives 
from its extension or inward deformation. However, it was shown that supplementary 
membrane from intracellular pools is delivered to forming phagosomes (Aderem 2002). For 
example, recycling endosomes fuse with phagosomes during their formation, a process 
known as focal exocytosis (Bajno et al. 2000). Many proteins, mostly identified for their role in 
membrane traffic, are required for the fusion of vesicles with the forming phagosome. These 
include SNAREs, proteins known to promote vectorial docking and fusion of membranes; 
Rab 11, a GTPase that promotes the trafficking of recycling endosomes to the plasma 
membrane and amphiphysin and dynamin 2, two interacting proteins involved in regulating 
endocytosis (Aderem & Underhill 1999; Greenberg & Grinstein 2002). More recently, studies 
presented a significant body of evidence indicating that the endoplasmic reticulum is also 
directly involved in the formation of nascent phagosomes (Müller Taubenberger et al. 2001; 
Gagnon et al. 2002). ER mediated phagocytosis is believed enabling phagosomes to play a 
direct role in the processing and presentation of exogenous peptides on major 
histocompatibility complex class I molecules, a process referred to as cross presentation 
(Houde et al. 2003; Desjardins 2003). Although the extent of contribution of the ER to forming 
phagosomes is still a matter of debate, there are compelling recent results that support this 
hypothesis (Hatsuzawa et al. 2006; Stuart et al. 2007). 
 Phagosomes undergo changes in their composition due to a progressive maturation 
process that ultimately leads to a hybrid organelle, the phagolysosome (Mayorga et al. 1991; 
Desjardins et al. 1994). The primary function of the phagolysosome is to degrade the 
phagocytosed particle. To fulfil this function, phagolysosomes possess a variety of 
complementary degradative properties, including a very low pH, hydrolytic enzymes for 
particle digestion, defensins and other bactericidal peptides and the ability to generate toxic 
oxidative compounds (Tapper 1996; Tjelle et al. 2000). The maturation process that 
equipped the phagosome with lytic activity depends critically on the interaction of the nascent 
vacuole with the endocytic pathway, which is organized as a continuum of organelles ranging 
from early endosomes to lysosomes.  
 During endocytosis, solutes, membrane bound ligands and transmembrane proteins 
are trapped in small vesicles derived from the plasma membrane. Following formation, 
endocytic vesicles are first targeted to early (or sorting) endosomes. These organelles are 
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often tubulovesicular and can be typically recognized by the presence of the small GTPase 
Rab5 or early endosome antigen 1 (EEA1). The lumen of early endosomes is relatively poor 
in proteases and is mildly acidic with a pH of ~6.0 (Barbieri et al. 1996). From these 
organelles cargo can be directed towards recycling endosomes, which are morphologically 
and biochemically distinct and less acidic (pH ~6.5) or to late endosomes which are 
comparatively enriched in hydrolytic enzymes with a pH ~5.5 (Vieira et al. 2002). Recycling 
endosomes can be identifed by the presence of Rab11 (Ullrich et al. 1996), whereas the 
multivesicular late endosomes are characterized by the presence of Rab7, Rab9, mannose
6 phosphate receptor and lysosomal associated membrane proteins (LAMP; Somsel 
Rodman & Wandinger Ness 2000). It is agreed that lysosomes are the final step during 
endosomal trafficking, that they contain the bulk of active proteases and lipases and are 
extremely acidic (pH ~4.5 5.5). They characteristically contain LAMPs and hydrolytic 
enzymes such as cathepsin D, but, while these proteins were thought to be unique to 
lysosomes, it is now apparent that they are also found in late endosomes. Therefore the best 
method for lysosome identification is their labelling by pulse/chase loading with fluid phase 
markers, such as fluorochrome conjugated dextran (Kielian et al. 1982), or labelled 
nanometer sized gold particles that accumulate in these organelles (Deng et al. 1991).  
 Interactions between phagosomes and endosomes occur soon after phagosome 
sealing, in a fashion that recapitulates the endocytic sequence (Figure 3): nascent 
phagosomes fuse initially with early endosomes, followed by late endosomes and ultimately 
lysosomes (Desjardins et al. 1994; 1997). There are several lines of evidence that early 
phagosomes interact preferentially with early endocytic vesicles and display markers such as 
transferrin receptor (TfR), EEA1 and Rab5 but are devoid of late endosomal/lysosomal 
markers (Pitt et al. 1992a; Scianimanico et al. 1999; Duclos et al. 2000). Afterwards integral 
and peripheral proteins such as TfR and EEA1 are eliminated from phagosomes during 
maturation and some phagosomal proteins, including Fc  and mannose receptors, were 
shown to traffic retrogradely to the plasma membrane, suggesting that recycling from 
phagosomes occurs (Muller et al. 1983; Pitt et al. 1992b). Phagosomes rapidly lose the 
characteristics of early endosomes while recruiting those of late endosomes, best 
exemplified by the presence of Rab7, the mannose 6 phosphate receptor and 
lysobisphosphatidic acid (Via et al. 1997). The existence of late endosome components on 
phagosomes is followed by a transition into phagolysosomes by association with lysosomal 
compartments identified by the presence of hydrolytic proteases, such as different 
cathepsins, and by the acquisition of an extremely acidic pH, reported to be as low as 4.5 
(Clemens & Horwitz 1995). 
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Figure 3. Phagosomal maturation pathway in macrophages (adapted from Koul et al. 2004). Nascent 
phagosomes acquire the GTPase Rab5 either from the plasma membrane or by fusion with early 
endosomes. Ca2+ activates the calmodulin-dependent protein kinase (CaMKII), which, together with 
Rab5, is necessary for recruitment of phosphatidylinositol-3-kinase (PI3K). PI3K generates 
phosphatidylinositol-3-phosphate (PI3P) followed by subsequent recruitment of early endosomal 
antigen (EEA1) from endosomes. EEA1 is a Rab5 effector that triggers fusion of phagosomes with late 
endosomes. During the course of phagosomal maturation, the early endosomal markers Rab5 and 
EEA1 are lost from the intermediate phagosome, which then fuses with late endosomes and thereby 
acquires Rab7. Late phagosomes fuse with lysosomes to form phagolysosomes, which are 
characterized by the presence of hydrolytic proteases, such as cathepsin D, the proton-ATPase pump 
(V-ATPase) and lysosome-associated membrane glycoprotein 1 (LAMP1). During maturation, fusion 
events change the pH of phagosomes from neutral to acidic conditions. F-actin dynamics are 
important for engulfment and formation of phagosomes, whereas subsequent phagosomal/endosomal 
trafficking rely predominantly on microtubules. Although there are hints for the involvement of F-actin 
and associated proteins at later stages of phagosome maturation, their contribution is not clear. 
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 Subsequent to phagocytosis in macrophage, there is an abrupt increase of 
superoxide formation known as the oxidative burst, which is catalyzed by an NADPH oxidase 
enzyme complex. The NADPH oxidase is a membrane associated enzyme complex that 
generates superoxide (O2 ) by the one electron reduction of oxygen, using NADPH as the 
electron donor (Babior, 1999). The NADPH oxidase is activated on phagosomes and 
generates superoxide to aid in the killing of phagocytosed microorganisms. It is important 
that superoxide is primarily released into phagosomes to prevent damage to surrounding 
cells (Ridley, 2001). The subsequent superoxide formation mainly occurs through FcR 
activation. However, the stimulation of CR3 by anti CR3 antibody coated particles (Serrander 
et al., 1999), by Staphylococcus particles coated with anti CD18 antibodies (Lofgren et al., 
1999) induces superoxide production. The pathway linking generation of ROS to 
downregulation of Rho involves inhibition of the low molecular weight protein tyrosine 
phosphatase and then an increase in the tyrosine phosphorylation and activation of its target, 
p190Rho GAP (Nimnual et al., 2003). Despite the multiple events associated with superoxide 
formation, it remains to be studied in detail how NADPH oxidase complex is activated. As for 
the cell death and apoptosis of phagocytes including macrophages and neutrophils, studies 
have mainly been focused on conditions that lead to endogenous production of ROS or nitric 
oxide (NO). Earlier studies showed that phagocytotic apoptosis was induced through CR and 
FcR ligation (Coxon et al., 1996; Gamberale et al., 1998) and Rho GTPases regulates the 
phagocytosis mediated through FcR and CR3 (Caron and Hall, 1998; Massol et al., 1998), 
which may be implicated to the superoxide formation. On the other hand, overexpression of 
src homology 2 domain containing inositol 5' phosphatase (SHIP) in macrophages leads to 
an inhibition of phagocytosis mediated by FcR and CR3 (Cox et al., 2001).  
 The active role of phagosomes in directing their own maturation is supported by in 
vitro experiments showing that phagosomes isolated 1 h after formation fuse preferentially 
with lysosomes, but not with earlier endocytic organelles (Desjardins et al. 1997; Jahraus et 
al. 1998; Kjeken et al. 2004). The fusion processes that occur between phagosomes and 
endocytic organelles can be completely or only partially. The latter case is known as “kiss
and run” hypothesis (Desjardins 1995) that describes transient fusion events between these 
organelles, which allows the transfer of selected membrane and luminal contents between 
phagosomes and endosomes. This is promptly followed by a fission event preventing the 
complete intermixing of the two compartments. 
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The dynamic role of the cytoskeleton in phagosome maturation 
The intracellular localization as well as the trafficking of many organelles of the endocytic 
pathway is strongly dependent on their association with cytoskeleton components (Figure 2). 
There are several lines of evidence that endocytic organelles including phagosomes interact 
with microtubules and actin filaments as well as their associated motor proteins during 
different maturation stages (Araki 2006; Soldati & Schliwa 2006). Newly formed phagosomes 
that have lost their F actin coat after internalisation, rapidly engage in centripetal motion that 
is arrested by microtubule disruption (Blocker et al. 1998). Interestingly, phagosomes were 
shown to possess bidirectional movement along microtubules both in vitro and in vivo, 
although displacement towards the minus ends predominated (Blocker et al. 1997). It is 
widely accepted that microtubule based motility is essential for correct phagosomal 
maturation (Blocker et al. 1996; Funato et al. 1997) which is supported by the observations of 
Desjardins and co workers, who found that phagosomes acquired 5 fold less LAMP 2, when 
microtubules were disrupted by nocodazole (Desjardins et al. 1994).  
 As mentioned before, actin filaments together with different classes of associated 
motor proteins are responsible for particle engulfment and phagosome formation. Actin 
filaments do not only play an essential role during phagocytic particle ingestion. There are 
many hints suggesting that organelle motility and distribution not only depend on 
microtubules, but also involve the actin cytoskeleton (Kelleher & Titus 1998; DePina & 
Langford 1999). A role for actin in phagosome maturation appears to be contrary to the 
notion that, once severed from the plasma membrane, phagosomes are devoid of actin. This 
simplistic view has been changed by several observations. First, in cells mature phagosomes 
were reported to be often surrounded by an actin rich coat (Toyohara & Inaba 1989). 
Secondly, actin was identified by western blotting and proteomic analysis on isolated late 
phagosomes from macrophages (Desjardins et al. 1994; Garin et al. 2001). Lastly, it was 
shown that actin filaments can assemble de novo on the surface of isolated late phagosomes 
without any additional cytoplasmic components (Defacque et al. 2000; Kjeken et al. 2004). 
These observations correlate with the fact that numerous actin binding proteins, including 
myosins, annexins,  actinin and coronin are found associated with phagosomes (Al Haddad 
et al. 2001; Morrissette et al. 1999) and can be found in proteomic analyses of phagosomes 
(Garin et al. 2001; Gotthardt et al. 2002; Stuart et al. 2007). Like microtubules, actin filaments 
are highly dynamic and polarized polymers and can associate with endosomes and 
lysosomes (vanDeurs et al. 1995; Taunton 2001). It has been observed that endosomes and 
lysosomes can be propelled in the cell by the formation of actin comet tails in a manner 
dependent on N WASP, Cdc42 and protein kinase C (Taunton et al. 2000).  
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 What is the relationship between actin and the phagosome after its detachment from 
the surface membrane? One explanation proposed by Griffiths and co workers is 
summarized in the so called actin track model (Kjeken et al. 2004). This group has shown 
that the actin filaments assembled at the phagosomal membrane display their fast growing 
barbed end at the membrane and the minus end growing away from it, meaning that the 
monomers are inserted at the membrane. In addition, they demonstrated that this process is 
modulated by ezrin and moesin (Defacque et al. 2000). Because the majority of myosins 
move unidirectionally along actin filaments toward the barbed end (Hasson & Cheney 2001), 
the actin filaments could provide tracks that guide vectorially the myosin bound cargo, e.g. 
lysosomes, toward the actin nucleating phagosome. Therefore, an actin assembly of 
maturing phagosomes could help to facilitate lysosomes clustering around phagosomes and 
subsequent fusion events between the two organelles. 
1.1.4 Degradation and antigen presentation  
The last step of the phagocytic process is marked by the degradation of the phagosomal 
content, which can be accompanied by antigen presentation on the surface of the 
macrophage (Niedergang & Chavrier 2004). Hydrolases delivered to the phagosomal lumen 
contribute to the degradation of the ingested material. Interestingly, evidence indicates that 
hydrolases are not acquired by phagosomes through a simple one step fusion event with 
lysosomes all at once, as implied in the term ‘phagolysosomes’. Instead, as indicated by the 
protein profile of phagosomes obtained by two dimensional gel electrophoresis, the subsets 
of hydrolases acquired by phagosomes vary throughout the maturation process whereby 
newly formed phagosomes become phagolysosomes (Garin et al. 2001). The kinetics of 
protease acquisition may also vary between phagocytes, for instance, it is faster in 
macrophages than in dendritic cells (Lennon Duménil et al. 2002). The proteins present on 
engulfed particles encounter an array of degrading proteases in phagosomes. Peptides 
derived from processing are then loaded onto major histocompatibility complex (MHC) class 
II molecules, originating mostly from newly synthetized pools stored in endocytic 
compartments, such as late endosomes or multivesicular bodies, as well as lysosomes and 
lamellar bodies (Hiltbold & Roche 2002). Phagosomes containing latex beads have been 
shown to acquire MHC class II molecules both from a recycling pool on the plasma 
membrane and from a newly synthesized pool (Ramachandra & Harding 2000). Although 
several cysteine proteases can be involved, the step of processing is mainly dependent on 
cathepsin S (Watts 2004). MHC class II molecules are then expressed on the surface of the 
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phagocytic cell to activate CD4+ T lymphocytes (reviewed in Ramachandra et al. 1999; 
Jutras & Desjardins 2005).  
 The common view has long been that exogenous proteins, internalized by 
endocytosis or phagocytosis, are presented by the MHC class II pathway. A large body of 
evidence indicates that antigens from pathogens, including mycobacteria, Salmonella and 
Leishmania, can elicit an MHC class I dependent response (Kaufmann & Schaible 2005). 
These peptides presented by MHC class I molecules can activate cytotoxic CD8+ T 
lymphocytes in a process called ‘cross presentation’ (reviewed in Lehner & Cresswell 2004; 
Jutras & Desjardins 2005). Peptide loading on MHC class I molecules normally occurs in the 
endoplasmic reticulum (ER) after translocation of the peptides processed via the cytosolic 
degradative proteasome complex. Further insights into the molecular mechanisms linked to 
cross presentation came from proteomics analysis of latex bead containing phagosomes 
indicating that several ER proteins known to play a role in MHC class I mediated antigen 
presentation, but no Golgi resident protein, were present on phagosomes (Garin et al. 2001). 
On the basis of these observations, it was shown that the ER is recruited to phagocytic cups 
to provide some of the membrane required for the formation of phagosomes (Gagnon et al. 
2002). Fusion of phagosomes with the ER provides this organelle with components of the 
class I presentation machinery: Sec61 transporters, chaperones, the ubiquitination 
machinery, proteasome subunits and TAP (transporter associated with antigen presentation) 
proteins have been found associated with the phagosome (Houde et al. 2003; Guermonprez 
et al. 2003; Ackerman et al. 2003).  
 The described mechanisms link both, innate and adaptive immunity. Additional to 
immune responses, phagocytes are also able to ultimately recycle the phagosomal content 
out of the cell. This property, long considered a peculiarity of Dictyostelium discoideum, has 
also been observed in macrophages (Di et al. 2002). The fact that several proteins involved 
in membrane trafficking, including annexins, synaptobrevin and syntaxins, are found on 
phagosomal membranes suggested that mature phagosomes potentially fuse with 
membraneous structures including the plasma membrane. Furthermore, it was demonstrated 
that microtubules participate in the egestion process, whereas cortical actin prevents it 
(Damiani & Colombo 2003).  
1.1.5 Alteration of phagosome functions by pathogens  
The above described events of phagocytic uptake and phagosome maturation are part of 
innate immunity and serve predominantly to destroy invading pathogens. However, 
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numerous microorganisms have evolved strategies to prevent killing by phagocytes and 
moreover, have developed mechanisms to live intracellularly into phagocytic vacuoles and 
replicate within their host (reviewed in Knodler et al. 2001; Rosenberger & Finlay 2003; Haas 
2007). Intracellular pathogens can be classified into the following groups concerning their 
survival strategies in phagocytes: (1) Those, such as Listeria monocytogenes and Francisella 
tularensis that disrupt the membrane of the maturing phagosome to escape into the 
cytoplasm which protects them from encounter with lysosome agents (Goetz et al. 2001). (2) 
Pathogens (e.g. Mycobacterium tuberculosis and Rhodococcus equi) that are able to arrest 
phagosome maturation at an early stage before reaching phagolysosomal characteristics and 
therefore avoid contact with lysosomal contents (Russell 2001; Fernandez Mora et al. 2005). 
(3) Microbes that redirect phagosome maturation during or soon after uptake and remain in a 
vacuole without endocytic characteristics, as it is the case for Legionella pneumophila 
(Kagan & Roy 2002) and Afipia felis (Lührmann et al. 2001). (4) A last group represents 
pathogens, such as Leishmania donovani and Coxiella burnettii, which force the maturation 
machinery to slow down but not permanently inhibit phagolysosome formation and survive 
within these vacuoles (Scianimanico et al. 1999; Maurin et al. 1992). All these strategies 
demonstrate how pathogens are able to interfere with phagosome maturation processes and 
adapt the host as an environment to their own benefits. Pathogens that block 
phagolysosomal maturation, are often responsible for diseases which have a strong impact 
on humans. Around one third of mankind is infected with Mycobacterium tuberculosis, the 
agent that causes tuberculosis, and more than 1.6 million humans die because of it annually 
(http://www.who.int/tb/en/; Berrington & Hawn 2007). The capacity of this pathogen does not 
only prevent phagosome maturation, it also affects antigen processing and presentation. For 
instance, in phagosomes containing M. tuberculosis, the formation of bacterial antigen MHC 
class II complexes is decreased when live bacteria, rather than heat killed bacteria, are 
phagocytosed (Ramachandra et al. 2001). 
 The complex process of phagocytic uptake of pathogens occurs via multi ligand 
interactions and engages many receptors. Although a single ligand on the particle can 
efficiently induce phagocytic uptake, most pathogens have many different ligands on their 
surface. This makes it very difficult to dissect the contribution of different ligand receptor 
interactions into the overall process of phagocytosis, and, in the case of a pathogen that lives 
intracellularly in phagosomes, in influencing the final steady state identity of the phagosome. 
At present, it is unclear for example whether multiple receptors can signal in parallel in 
response to phagocytosis or whether a single receptor will dominate the signalling pathways. 
In this study, a system will be introduced that can eventually be adapted to answer such 
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questions. By the help of a well characterized phagocyte model system, the latex bead 
system, it is possible to investigate down stream cellular events induced by contact of 
phagocytic particles with J774 macrophages in more detail. Moreover, the coupling of 
specific ligands to latex beads allows analysis of receptor dependent mechanisms that 
influence not only the phagocytic uptake but also the maturation of phagosomes containing 
these particles.  
1.2 Latex beads as a phagosome model  
The method using inert latex beads as a model system to study phagocytosis was introduced 
by Wetzel and Korn more than 35 years ago (Wetzel & Korn 1969) and was re discovered 
and expanded by Griffiths and co workers in the early 1990’s (Desjardins et al. 1994a). The 
ability of latex bead phagosomes (LBP) to display most of the functions of phagosomes 
containing other particles, such as apoptotic cells or non pathogenic bacteria, qualified it as a 
system suitable to analyse the phagocytic process. LBP display fission and fusion events 
with endosomes and lysosomes over long time periods (Desjardins et al. 1994a; Jahraus et 
al. 1998; Kjeken et al. 2004), bind and move along microtubules (Blocker et al. 1997), 
promote the assembly of actin filaments (Jahraus et al. 2001) and bind to them (Al Haddad et 
al. 2001) and become acidified (Defacque et al. 2002). Phagosomes containing non
pathogenic Mycobacterium smegmatis, but not those containing the pathogens M. 
tuberculosis and M. avium, have also been shown to assemble actin (Anes et al. 2003), 
confirming that LBPs are a good model for providing insights into the behavior of 
phagosomes containing non pathogenic bacteria. Moreover, the use of LBP provides other 
unique advantages for the study of receptor dependent phagocytosis, which are of high 
importance for this study. In contrast to pathogens, which are internalised after multiple 
ligand interactions, latex beads can be coupled to single ligands and offers the opportunity 
for the analysis of single receptor recognition pathways that influence not only uptake and 
signalling but also phagosomal maturation events (Desjardins & Griffiths 2003). In previous 
studies the use of latex beads coated with proteins from Shigella flexneri or Listeria 
monocytogenes provided important insights into the functions of pathogens interacting with 
host cells (Menard et al. 1996; Lecuit et al. 1997). Additionally, LBP are easily detectable by 
electron microscopy and can readily be labelled with fluorochromes, allowing studies by 
fluorescence microscopy.  
 However, one of their biggest advantages is the fact that latex bead phagosomes can 
be isolated simply and cleanly in a one step procedure by flotation in a discontinous sucrose 
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gradient (Korn 1974; Gotthardt et al. 2006b), whereas other membrane bound organelles 
require multiple steps of purification. Isolated LBP are organelles with the highest degree of 
purity (>95 %), and only very few contaminant proteins are present in enriched phagosome 
fractions (Stuart et al. 2007). Therefore, beside the option of studies on phagosomal 
behaviour in vitro, they provide an opportunity for the analysis and identification of 
phagosomal lipids and proteins. One of the first proteomic studies using LBP determined a 
partial proteome of these organelles in the mouse J774 macrophage cell line and identified 
171 phagosomal proteins (Garin et al. 2001). A continuation of this analysis has since 
identified more than 800 of the estimated 1000 proteins in mouse macrophage phagosomes 
(M. Desjardins, personal communication). Burlak and co workers identified about 200 
proteins in a proteomic analysis of LBP from human neutrophils (Burlak et al. 2005). In 
addition to mammalian studies, LBP have also been applied to analyse phagocytosis in other 
organisms. A proteomic analysis on magnetic bead phagosomes isolated from the human 
protozoan pathogen Entamoeba histolytica identified around 150 proteins including myosins 
and other actin binding proteins (Marion et al. 2005). LBP have also been used in extensive 
proteomics analyses of phagosomes from Drosophila identifying more than 600 proteins 
(Stuart et al. 2007) and Dictyostelium discoideum, which revealed around 1380 proteins, 179 
being identified (Gotthardt et al. 2002; Gotthardt et al. 2006a). Many orthologs to mammalian 
proteins could be found in these organisms, indicating a high degree of conservation. 
Proteins of similar function are consistently detected in all the phagosomes studied. In 
mature phagosomes, major classes of luminal proteins include hydrolases and other 
bacteriocidal proteins. In the phagosome membrane are found the various subunits of the 
proton transporter H+ ATPase, other transporters and ion channels, heterotrimeric G 
proteins, monomeric GTPases of the Rab and Rho families, SNARE fusion machinery, actin
binding and microtubule binding proteins, clathrin and COP proteins of vesicle coats, and a 
spectrum of signalling proteins such as protein kinase C and phospholipase D. Collectively, 
these analyses leave no doubt that the phagosome, even when it contains only an inert 
bead, is a complex signalling machine. 
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1.3 Aims of the study  
The latex bead system provides many advantages to analyse phagocytosis in more detail. A 
former study of our lab investigated the capability of latex bead phagosomes to bind to actin 
filaments and established a light microscopy based assay that reconstitutes phagosomal 
binding to pre assembled F actin in vitro (Al Haddad et al. 2001).  
 In this study, we wanted to extend the analysis to phagosomes containing particles 
that were internalised via specific, receptor dependent pathways to analyse the influence of 
early events at the cell surface on subsequent phagosome functions. Additional to the 
investigation of phagosomes containing pathogenic and non pathogenic mycobacteria, which 
are recognised by more than one phagocytic receptor type, the latex bead system offers the 
possibility to conjugate beads to single ligands in order to trigger defined receptor mediated 
uptake. In this study, I focused on IgG, mannan, LPS, avidin and gelatin as coupling ligand to 
investigate non opsonic and opsonic internalisation routes.  
 In addition to the characterization of the capability of these phagosomes to bind to F
actin, other phagocytic functions and macrophage gene expression should be analysed to 
gain more insight in how receptor ligand interactions influence the phagocytic process. 
Therefore, the specific aims of this study were: 
 
1. To reconstitute the binding of maturing mycobacterial and coupled latex bead 
 phagosomes to F actin in vitro and to characterize the influence of cytosolic factors as 
 well as of signalling molecules, such as different phospholipids. 
 
2. To analyse early phagocytic events of ligand coupled latex beads, like their uptake 
 and protein tyrosine phosphorylation, as well as later phagocytic processes, such as 
 phagosome maturation.  
 
3. To investigate macrophage gene expression in response to the receptor mediated 
 uptake of latex beads coupled to IgG, mannan, LPS and avidin.   
 
4. To identify and compare phagosomal proteins after the internalisation of coated latex 
 beads to analyse whether receptor ligand interactions also modulate the proteome of 
 maturing phagosomes. 
 
  Material & Methods
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2.1 Cells and bacteria 
2.1.1 Used material, reagents and instruments 
o Phosphate-buffered saline (PBS): 80 g/l NaCl + 2 g/l KCl + 11.5 g/l Na2HPO4 * 
2H2O + 2 g/l KH2PO4 (Merck, Germany) 
o Fetal bovine serum (FBS), Lot. #55H (Biochrom KG, Germany) 
o Culture medium of J774 macrophages: DMEM (4500 mg/l glucose) + 1 % 10 000 
U/10 000 μg/ml Penicillin/Streptomycin + 1% 200 mM L-Glutamine + 1 % non-
essential amino acids (Invitrogen, Germany) 
o Culture medium of primary mouse bone-marrow macrophages (MBMM) and L929 
fibroblasts: RPMI 1640 + 1 % 100 U/10 000 μg/ml Penicillin/Streptomycin + 1% 200 
mM L-Glutamine + 1 % non-essential amino acids (Invitrogen, Germany) 
o Luria Broth (LB) medium, D-Glucose, Tween-80, Dimethylsulfoxide (DMSO), 2-
Mercaptoethanol (Sigma-Aldrich, USA) 
o Middlebrook 7H9 medium, ADC and OADC nutrient broth (Difco, BD Diagnostic 
Systems, Germany)  
o Trypsin-EDTA, Hygromycin B, Ampicillin (Invitrogen, Germany) 
o sterile cell culture material, like pipettes, dishes and flasks, cell scraper, centrifuge 
tubes etc. (TPP, Switzerland) 
o Cryotubes, LabTek cell culture chambers (Nalge, USA); sterile filters (Sarstedt, 
Germany); syringes, cannula (Braun, Germany) 
o Flow Hood (BDK, Germany); Centrifuge ZK 380 (Hermle, Germany); Incubator BB 
16 (Heraeus, Germany) adjusted to 37 °C, 5 % CO2  
2.1.2 Cultivation of cells 
Unless otherwise stated, all experiments were carried out using the mouse macrophage-like cell line 
J774A.1 (ACC170) obtained from the German Resource Center of Biological Material (DSMZ, 
Germany). J774 cells express a variety of phagocytic receptors and are frequently used for studies on 
phagocytosis. To avoid the influence of changes in the internalisation characteristics of this cell line, 
J774 macrophages were only used up to passage 25. New passages were obtained from stocks that 
were frozen in FBS supplemented with 10 % DMSO kept in liquid nitrogen. Confluent cell layers were 
split using Trypsin-EDTA. For some experiments, primary mouse macrophages were isolated from 
bone marrow (MBMM) as described in Al-Haddad et al. (2001). Bone marrow cells were obtained by 
rinsing tibia and femur of mice legs. MBMM from 3 weeks old Bmp5se wild type mice and myosin Va-
deficient mice (homozygous strain DLS/Le a/a Myo5ad-l; Jackson Laboratories, Bar Harbor, USA) 
were grown in MBMM medium (see 2.1.1) supplemented with supernatant obtained from confluent 
mouse L929 fibroblasts (CCL1; American Type Culture Collection, USA) at a ratio of 1:5. Addition of 
L929 supernatant to macrophage medium is essential because of the macrophage colony-stimulating 
factor (M-CSF) produced by L929 cells (Nolte et al. 1997). MBMM cells were viable for around three 
weeks, could be passaged two to three times by scraping and were used for experiments two weeks 
after initial plating usually in passage 2 or 3.  
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2.1.3 Cultivation of bacteria 
Non-pathogenic Mycobacterium smegmatis mc2 155 harbouring a p19-(long-lived) EGFP plasmid 
(Anes et al. 2003) was grown in medium containing Middlebrook's 7H9 broth and 10 % ADC nutrient 
broth, supplemented with 0.5 % D-glucose and 0.05 % Tween-80 at 37 °C on a shaker at 220 rpm 
until exponential phase. In order to stabilize GFP expression, medium was supplemented with 50 
μg/ml Hygromycin B and bacteria were subcultured every day in fresh medium for 7-10 days before 
used for experiments. Fresh cultures were made out of glycerol stocks (50 % glycerol, 50 % bacteria in 
7H9 medium) kept at -80 °C. The slow-growing, pathogenic strains M. bovis BCG Pasteur (ATCC 
35734) and M. avium (ATCC 25291) were grown in the same medium, but were supplemented with 10 
% OADC instead of ADC. Non-pathogenic Escherichia coli strain TG1 stably expressing GFP (Kunert 
et al. 2003) was kindly provided by PD Dr. M. Hagemann (University of Rostock). Bacteria were grown 
in LB medium supplemented with 70 μg/ml ampicillin at 37 °C on a shaker at 220 rpm until exponential 
phase. 
2.2 Preparation and coupling of latex beads to ligands 
2.2.1 Used material and reagents 
Latex beads  
o Blue-fluorescent carboxylate-modified microspheres containing 2 % solids of 
diameter 1 μm (Cat. F8815; Invitrogen, Germany) 
o Non-fluorescent Polybead® carboxylate-modified microspheres containing 2.68 % 
solids of diameter 1 μm (Cat. #08226; Polysciences, Inc., USA) 
Ligands  
o Fish skin gelatin (FSG; Cat. G7765; Sigma-Aldrich, USA) 
o Avidin (Cat. A2666; Invitrogen, Germany) 
o mouse IgG, whole molecule (Cat. I5381; Sigma-Aldrich, Germany) and Fc fragment 
of mouse IgG (Cat. 31205; Pierce Biotechnology, USA) 
o Complement purified from murine serum was kindly provided by the group of Dr. 
Gareth Griffiths, EMBL Heidelberg, Germany  
o Lipopolysaccharides from Klebsiella pneumoniae (LPS; Cat. L4268; Sigma-Aldrich, 
USA) 
o Mannan from Saccharomyces cerevisae (Man; Cat. M7504; Sigma-Aldrich, USA) 
Reagents 
o MES buffer (Cat. M8250; Sigma-Aldrich): 500 mM stock solution in Aqua dest.; 
diluted 100 mM and 50 mM solutions were adjusted to pH 6.7 
o Stop buffer: 1 % Triton X-100 in 10 mM Trizma base (Sigma-Aldrich, USA); 
adjusted to pH 9.4 
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o Bicarbonate buffer: 50 mM Na2CO3 + 50 mM NaHCO3 (both from Sigma-Aldrich, 
USA); adjusted to pH 9.6 
o modified Phosphate buffer (PBS): 50 mM Na3PO4 * 12 H2O + 0.9 % NaCl (both 
from Sigma-Aldrich, USA); adjusted to pH 7.4 
o Activator of surface carboxyl groups: N-(3-Dimethylaminopropyl)-N-
ethylcarbodiimide hydrochloride (EDAC; Cat. E1769; Sigma-Aldrich, USA); 10 
mg/ml stock solution in Aqua dest., prepared freshly 
o Cross-linker: Concanavalin A from Canavalia ensiformis (ConA; Cat. C2010; 
Sigma-Aldrich, USA) 
o Bovine serum albumin (BSA), IgM (M5909) and sodium azide (all from Sigma-
Aldrich, USA)   
2.2.2 Coupling of latex beads to fish skin gelatin (FSG) 
Blue-fluorescent latex beads were vortexed and sonicated in an ultrasonic waterbath for 2 min. 5 ml of 
bead suspension were mixed with 10 mg FSG diluted in 50 mM MES and filled to a final volume of 10 
ml with 50 mM MES. The suspension was mixed on a vertical tube rotator for 15 min. at RT. 
Subsequently, 0.4 ml EDAC stock solution was added to bead suspension, mixed by vortexing and 
adjusted to pH 6.5 using about 10-15 μl 0.8 N NaOH (checked with pH indicator sticks). The 
suspension was mixed on a vertical tube rotator for 2 hrs. at RT. To quench the reaction, glycine 
powder was added to give a final concentration of 100 mM. The suspension was incubated for another 
30 min. on the vertical tube rotator at RT. Coupled latex beads were transferred to conical Eppis and 
centrifuged with 6.000 g for 5 min. at 4 °C to separate particles from unreacted protein. Pellets were 
resuspended in PBS and wash was repeated twice. Pellets were resuspended and combined in PBS 
and suspension was adjusted to 1 % solids by measuring OD600nm using a photospectrometer. 
2.2.3 Coupling of latex beads to avidin 
Non-fluorescent latex beads were vortexed and sonicated in an ultrasonic waterbath for 2 min. 4 ml of 
bead suspension were mixed with 5 mg avidin diluted in 2 ml 50 mM MES. Suspension was filled to a 
final volume of 10 ml with 100 mM MES and mixed on a vertical tube rotator for 15 min. at RT. 
Subsequently, 0.14 ml EDAC stock solution was added to bead suspension and mixed on a vertical 
tube rotator for 1 hr. at RT. Another 0.14 ml EDAC were added and mixed for 1 hr. Afterwards, 2 ml 
stop buffer were added to the suspension, which was centrifuged in conical Eppis with 6.000 g for 5 
min. at 4 °C. Pellets were resuspended in stop buffer and centrifuged again followed by three washes 
in PBS. Coupled latex beads were resuspended and combined in PBS containing 0.03 % FSG and 
suspension was adjusted to 1 % solids by measuring OD600nm using a photospectrometer. 
2.2.4 Coupling of latex beads to IgG (whole molecule or Fc 
 fragment) 
Blue-fluorescent latex beads were vortexed and sonicated in an ultrasonic waterbath for 2 min. 5 ml of 
bead suspension were mixed with 0.5 mg mouse IgG (whole molecule or only the Fc fragment). The 
following steps were carried out identical to the protocol of coupling beads to avidin. Latex bead 
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suspensions coupled to the whole IgG molecule tend to aggregate easily and therefore caused 
problems during uptake of single beads. Alternatively, coupling to the Fc fragment was carried out, 
which did not cause much aggregation. 
2.2.5 Coupling of latex beads to mouse complement 
Non-fluorescent latex beads were vortexed and sonicated in an ultrasonic waterbath for 2 min. 4 ml of 
bead suspension were mixed with 1 mg IgM and filled to a final volume of 10 ml with 100 mM MES. 
Suspension was mixed on a vertical tube rotator for 15 min. at RT. Subsequently, 0.14 ml EDAC stock 
solution was added to bead suspension and mixed on a vertical tube rotator for 1 hr. at RT. Another 
0.14 ml EDAC were added and mixed for 1 hr. Afterwards, 2 ml stop buffer were added to the 
suspension, which was centrifuged in conical Eppis with 6.000 g for 5 min. at 4 °C. Pellets were 
resuspended in PBS and centrifuged again followed by another two washes in PBS. Pellets were 
resuspended in 9.5 ml PBS and 0.5 ml mouse serum. Suspension was mixed on a vertical tube rotator 
for 30 min. at RT. Afterwards, 2 ml stop buffer were added to the suspension, which was centrifuged in 
conical Eppis with 6.000 g for 5 min. at 4 °C. Pellets were resuspended in stop buffer and centrifuged 
again followed by three washes in PBS. Coupled latex beads were resuspended and combined in PBS 
containing 0.03 % FSG and suspension was adjusted to 1 % solids by measuring OD600nm using a 
photospectrometer. 
2.2.6 Coupling of latex beads to lipopolysaccharides (LPS) 
Blue-fluorescent latex beads were vortexed and sonicated in an ultrasonic waterbath for 2 min. 5 ml of 
bead suspension were washed in bicarbonate buffer twice. Latex beads were resuspended in 10 ml 
bicarbonate buffer containing 0.05 mg/ml LPS and mixed on a vertical tube rotator for 2 hrs. at RT. 
Suspension was transferred to conical Eppis and centrifuged with 6.000 g for 5 min. at 4 °C. Pellets 
were resuspended in bicarbonate buffer and centrifuged again followed by two washes in bicarbonate 
buffer. Latex beads were resuspended in 10 ml PBS containing 5 % BSA and mixed on a vertical tube 
rotator for 1 hr. at RT. Suspension was transferred again to conical Eppis, centrifuged and washed 
twice in PBS containing 5 % BSA. Coupled latex beads were resuspended in the same buffer and 
adjusted to 1 % solids by measuring OD600nm using a photospectrometer. 
2.2.7 Coupling of latex beads to mannan 
Blue-fluorescent latex beads were vortexed and sonicated in an ultrasonic waterbath for 2 min. 5 ml of 
bead suspension were mixed with 0.5 mg ConA and filled to a final volume of 10 ml with 100 mM 
MES. Suspension was mixed on a vertical tube rotator for 15 min. at RT. Subsequently, 0.14 ml EDAC 
stock solution was added to bead suspension and mixed on a vertical tube rotator for 1 hr. at RT. 
Another 0.14 ml EDAC were added and mixed for 1 hr. Afterwards, suspension was centrifuged in 
conical Eppis with 6.000 g for 5 min. at 4 °C, pellets were resuspended in PBS and centrifuged again 
followed by another two washes in PBS. Pellets were resuspended in 7.5 ml PBS and 2 mg mannan 
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were added. Suspension was mixed on a vertical tube rotator for 15 min. at RT. Afterwards, 2 ml stop 
buffer were added to the suspension, which was centrifuged in conical Eppis again. Pellets were 
resuspended in stop buffer and centrifuged again followed by another spin down in stop buffer. 
Coupled latex beads were washed three times in PBS, resuspended in PBS containing 0.03 % FSG 
and suspension was adjusted to 1 % solids by measuring OD600nm using a photospectrometer. 
 
All coupled 1 % latex bead suspensions were stored at 4 °C after adding 3 mM sodium azide.  
2.3 Isolation of phagosomes and cytosol 
2.3.1 Used material, reagents and instruments 
o Internalisation medium: DMEM (Invitrogen, Germany) + 1 % HEPES (Sigma-Aldrich, USA) 
o Protease inhibitor (PI) Cocktail Set III containing 100 mM AEBSF, 0.08 mM Aprotinin, 5 mM 
Bestatin, 1.5 mM E-64 protease inhibitor, 2 mM Leupeptin and 1 mM Pepstatin A 
(Calbiochem, Merck, Germany) 
o Homogenisation buffer (HB), adjusted to pH 7.4: Aqua dest. containing 250 mM (= 8.6 %) 
sucrose, 3 mM imidazole, 1 mM DTT, 1 mM PMSF (all from Sigma-Alrich, USA), 1:1000 PI 
o Solutions for discontinous sucrose gradient centrifugation: HB containing 62 %, 55 %, 37 % 
and 25 % sucrose, respectively  
o Salt-stripping buffer: Aqua dest. containing 2.6 M NaCl, 48 % sucrose, 3 mM imidazole, pH 
7.4, 1 mM DTT, 1 mM PMSF (all from Sigma-Alrich, USA), 1:1000 PI 
o HBKS buffer, adjusted to pH 7.4: Aqua dest. containing 0.1 mM EDTA, 2 mM EGTA, 2 mM 
MgCl2, 50 mM KCl, 25 mM HEPES, 10 % sucrose, 2 mM DTT, 1 mM PMSF (all from Sigma-
Aldrich, USA), 1:1000 PI 
o Syringes, needles (Braun, Germany) 
o Trypan blue, FITC-labelled biotin (Sigma-Aldrich, USA) 
o Cell culture centrifuge ZK 380 (Hermle, Germany) 
o Ultracentrifuge, UltraClear centrifuge tubes of different sizes, SW60Ti rotor, TLA 120.1 rotor 
(Beckman Coulter, USA) 
o Centrifuge tubes, Sorvall TH-641 rotor (Thermo Fisher Scientific, USA) 
2.3.2 Isolation of latex bead-containing phagosomes (LBP) 
Isolation of LBP was carried out as described previously (Kühnel et al. 2006) with slight modifications. 
J774 macrophages were grown in cell culture dishes until they reached around 80 % confluency. Latex 
bead suspensions adjusted to 1 % solids were vortexed, sonicated and washed three times in PBS to 
remove sodium azide. Stock solution of latex beads was added to prewarmed internalisation medium 
at a ratio of 1:25. Cells were washed with PBS and internalisation medium was added. Uptake of latex 
beads (‘pulse’ time) was allowed for 1 hr. at 37 °C under continuous wiping to increase internalisation 
efficiency. Non-internalised beads were removed by intensive washing of the cells with PBS followed 
by another hour of incubation in cell culture medium at 37 °C and 5 % CO2 (‘chase’ time). 
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Subsequently, the medium was removed, cells were washed with PBS and harvested by detaching 
them from the dish with a cell scraper in ice-cold PBS. Cells were collected in 50 ml tubes and 
centrifuged with 800 rpm for 7 min. at 4 °C. Pellets were resuspended in ice-cold PBS and centrifuged 
with 1500 rpm for 5 min. at 4 °C. Cell pellets were resuspended in ice-cold HB and centrifuged with 
2500 rpm for 5 min. at 4 °C. The final volume of the cell pellet was mixed with the same amount of ice-
cold HB and lysed with a 1 ml syringe fitted to a 22-gauge needle on ice using 15-20 strokes. 
Homogenisation success and cell breakage was monitored by phase contrast microscopy after adding 
trypan blue. After centrifugation at 800 g for 15 min. at 4 °C to remove nuclei and intact cells (Fig. 5A”), 
the post-nuclear supernatant (PNS, Fig. 5A’) containing phagosomes was collected and gently mixed 
with the same amount of HB containing 62 % sucrose. Isolation of LBP was accomplished in a 
sucrose gradient, which was prepared by overlaying 3-4 ml of the PNS / 62 % sucrose mix with 5 ml 
HB containing 25 % sucrose and 2 ml HB containing 8.6 % sucrose on top in ultracentrifugation tubes. 
Centrifugation was carried out in a Beckman ultracentrifuge and a Sorvall TH-641 rotor at 100.000 g 
for 60 min. at 4 °C. Afterwards enriched and purified LBP (Fig. 5B) formed a visible band between the 
8.6 % and the 25 % sucrose interphase, which was collected by penetrating the tube wall with a 22-
gauge needle. After determination of the concentration by measuring OD at 600 nm, isolated LBP 
were aliquoted, frozen in liquid nitrogen and stored at -80 °C. Integrity of the prepared phagosomes 
was checked by incubation with 5 nM FITC-biotin for 10 min. Broken phagosomes containing avidin-
coupled beads were detectable by fluorescence microscopy, while intact Avidin-LBP could not be 
stained by the label. Routinely around 80 % of the isolated phagosomes were found to be intact. 
 For some preparations, additional salt-stripping was applied to isolated LBP to remove 
membrane-bound proteins. Isolated LBP were mixed with the same amount of salt-stripping buffer and 
incubated on a vertical tube rotator for 40 min. at 4 °C. Salt-stripped LBP were adjusted to 40 % 
sucrose including 1.3 M NaCl and purified by discontinuous sucrose gradient centrifugation. 1 ml of the 
40 % sucrose suspension was overlaid with 1.5 ml HB containing 25 % sucrose and 0.5 ml HB 
containing 8.6 % sucrose. Centrifugation was carried out in a Beckman ultracentrifuge and SW60Ti 
rotor at 45.000 g for 60 min. at 4 °C. Afterwards, concentration of purified LBP was determined and 
suspension was aliquoted, snap-frozen in liquid nitrogen and stored at -80 °C. 
2.3.3 Isolation of bacteria-containing phagosomes 
Isolations of phagosomes containing mycobacteria or E. coli were carried out as described previously 
(Chakraborty et al. 1994; Kühnel et al. 2006) with slight modifications. Cultures were grown until 
exponential growth phase was reached (OD600nm= 0.2; corresponds to ~108 cells/ml). Bacteria were 
washed twice in PBS and resuspended in PBS to a final concentration of 5 x 109 cells/ml. The 
suspension was treated for 2 min. in a waterbath sonicator at RT using four times 30 sec. pulses to 
disperse clumps. Subsequently, bacteria were passed through a 23-gauge needle to disrupt remaining 
bacterial clumps. Before infection, residual bacterial aggregates were removed by low speed 
centrifugation at 120 g for 2 min. The absence of bacterial clumps was finally verified by phase 
contrast microscopy. For some experiments, bacteria were heat-inactivated for 15 min. at 80 °C.  
Material & Methods 30 
 
 J774 macrophages were grown in cell culture dishes until they reached around 80 % 
confluency and washed with PBS before infection. Mycobacteria suspensions were resuspended in 
prewarmed internalisation medium and macrophages were infected at an OD600nm= 0.2. Uptake of 
bacteria (‘pulse’ time) was allowed for 1 hr. at 37 °C under continuous wiping to increase 
internalisation efficiency. Non-internalised bacteria were removed by intensive washing of the cells 
with PBS followed by another hour of incubation (or different ‘chase’ times) in cell culture medium at 
37 °C and 5 % CO2. Subsequently, the medium was removed, cells were washed with PBS and 
harvested by detaching them from the dish with a cell scraper in ice-cold PBS. Cells were collected in 
50 ml tubes and centrifuged with 800 rpm for 7 min. at 4 °C. Pellets were resuspended in ice-cold PBS 
and centrifuged with 1500 rpm for 5 min. at 4 °C. Cell pellets were resuspended in ice-cold HB and 
centrifuged with 2500 rpm for 5 min. at 4 °C. The final volume of the cell pellet was mixed with ice-cold 
HB at a 2:1 ratio and lysed with a 5 ml syringe fitted to a 25-gauge needle on ice using 5-10 strokes. 
Homogenisation success and cell breakage was monitored by phase contrast microscopy after adding 
trypan blue. After another centrifugation step at 900 g for 15 min. at 4 °C to remove nuclei and intact 
cells, the post-nuclear supernatant (PNS) containing phagosomes was collected. Isolation of 
phagosomes was accomplished in a sucrose gradient, which was prepared by 2 ml HB containing 62 
% sucrose overlaid by 3 ml HB containing 55 % sucrose, 5 ml HB containing 37 % sucrose and 2 ml 
PNS on top. Centrifugation was carried out in a Beckman ultracentrifuge and a Sorvall TH-641 rotor at 
100.000 g for 30 min. at 4°C. After centrifugation, three different bands were visible. One laid on top of 
the 37 % gradient along with the majority of endocytic organelles, another in the interface between 55 
% and 37 % sucrose with the bacterial phagosomes and, in the case of more mature phagosomes, a 
third one was seen between the 55 % and the 62 % sucrose interphase. Material of the 37 % / 55 % 
sucrose interphase was collected by penetrating the tube wall with a 22-gauge needle. The isolated 
phagosomes were aliquoted, snap-frozen in liquid nitrogen and stored at -80 °C. 
2.3.4 Isolation of macrophage cytosol 
J774 and MBMM macrophages were grown in cell culture dishes until they reached around 80 % 
confluency. Culture medium was removed, cells were washed with PBS and harvested by detaching 
them from the dish with a cell scraper in ice-cold PBS. Cells were collected in 50 ml tubes and 
centrifuged with 800 rpm for 7 min. at 4 °C. Pellets were resuspended in ice-cold PBS and centrifuged 
with 1500 rpm for 5 min. at 4 °C. Cell pellets were resuspended in ice-cold HBKS and centrifuged with 
2500 rpm for 5 min. at 4 °C. The final volume of the cell pellet was mixed with ice-cold HBKS at a ratio 
of 3:1 and lysed on ice with a 5 ml syringe fitted to a 24-gauge needle using 15 strokes followed by a 
25-gauge needle using around 10 strokes. Homogenisation success and cell breakage was monitored 
by phase contrast microscopy after adding trypan blue. After a centrifugation step at 9.100 g for 15 
min. at 4 °C using a Beckman TLA 120.1 rotor, supernatant was collected, transferred to a new tube 
and centrifuged at 145.000 g for 60 min. at 4 °C. Protein concentration was determined according to 
Bradford (1976). Cytosol aliquots were snap-frozen in liquid nitrogen and stored at -80 °C.  
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2.4 Isolation of G-actin from rabbit muscle 
2.4.1 Used material, reagents and instruments 
o Rabbit muscle acetone powder (M0637; Sigma-Aldrich, USA) 
o Cheesecloth; Teflon-coated homogeniser; semi-permeable dialysis tubing, pore-size 
diameter: 5 nm, MW cut-off: 14 kDa (all from Roth, Germany) 
o G-buffer, adjusted to pH 8.0: Aqua dest. containing 5 mM Trizma base, 0.2 mM CaCl2, 0.2 
mM Na-ATP and 0.1 % 2-mercaptoethanol (all from Sigma-Aldrich, USA) 
o Ultracentrifuge, Ti50 rotor (Beckman Coulter, USA) 
o Sorvall T 647.5 rotor (Thermo Fisher Scientific, USA)  
2.4.2 Isolation of G-actin 
G-actin was isolated by the method of Spudich & Watt (1971) with slight modifications. 5 g of rabbit 
muscle acetone powder were washed in Aqua dest. twice for 5 min. at 4 °C to remove remaining an- 
and cations. Solutions were passed through several layers of sterile cheesecloth. Washed powder was 
incubated in 100 ml ice-cold G-buffer under continuous stirring (500 rpm) for 40 min. at 4 °C. Solution 
was again passed through several layers of sterile cheesecloth. Filtrate was centrifuged in a T 647.5 
rotor with 30.000 rpm for 15 min. at 4 °C and supernatant (S1 in Fig. 4) was transferred to a beaker. 
While stirring slowly at 4 °C, solution was brought to 50 mM KCl, 2 mM MgCl2 and 1 mM Na-ATP. The 
beaker was sealed with parafilm and incubated without stirring for 2 hrs. at 4 °C. The viscosity of the 
solution increased significantly during incubation. While gentle stirring, KCl concentration was 
increased to 0.6 M by adding crystalline KCl to remove tropomyosin complexes. Solution was gently 
stirred for 60 min. at 4 °C followed by centrifugation using the T 647.5 rotor with 40.000 rpm for 2 hrs. 
at 4 °C. The supernatant (S2 in Fig. 4) was discarded and pellet was resuspended in 7.5 ml G-buffer. 
The solution was homogenised using a Teflon-coated rod homogeniser and transferred to dialysis 
tubing. While gentle stirring, the actin solution was dialysed against 1 l G-buffer for 36 hrs. at 4 °C. 
During dialysis, G-buffer was replaced completely every 8 hrs. After first dialysis cycle, solution was 
centrifuged again using the Ti50 rotor with 40.000 rpm for 2 hrs. at 4 °C. Supernatant (S3 in Fig. 4) 
containing G-actin was partly aliquoted and frozen in liquid N2 while pellet (P2 in Fig. 4) was discarded. 
 6 ml of supernatant were transferred to a new tube and salt concentrations were increased 
again (50 mM KCl, 2 mM MgCl2, 1 mM Na-ATP). The tube was sealed and incubated without stirring 
for 48 hrs. at 4 °C. The solution was centrifuged again using the Ti50 rotor with 40.000 rpm for 2 hrs. 
at 4 °C. The supernatant (S2b in Fig. 4) was discarded and pellet was resuspended in 4 ml G-buffer. 
The solution was homogenised again and transferred to dialysis tubing. While gentle stirring, the actin 
solution was dialysed against 1 l G-buffer for 36 hrs. at 4 °C. During dialysis, G-buffer was replaced 
completely every 8 hrs. After second dialysis cycle, solution was centrifuged again using the Ti50 rotor 
with 40.000 rpm for 2 hrs. at 4 °C. Pellet and supernatant (P3 and S4 in Fig. 4) containing purified G-
actin were aliquoted, frozen in liquid nitrogen and stored at -80 °C. 
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Figure 4. SDS-PAGE (10 % gel) of supernatant (S) and pellet (P) fractions during isolation of G-actin 
from rabbit muscle. Proteins were stained with Coomassie Blue. Lane designations are described in 
the text. Final fractions after dialysis (S3, P3, S4) contained purified G-actin (42 kDa). 
2.5 In vitro actin-binding assay 
Isolated G-actin from rabbit muscle (0.05 mM) was polymerised on ice in the presence of 2 mM MgCl2 
overnight. After overnight polymerisation, F-actin was stabilised and labelled on ice with the same 
concentration (ratio: 1:1) of rhodamine-conjugated phalloidin (Sigma-Aldrich, USA) for 2 hrs. Prepared 
and stabilised F-actin fractions were kept on ice and were used for experiments within two weeks. 
 Microscopy chambers were built from glass microscopy slides and 11 mm glass coverslips 
(Menzel GmbH, Germany) sealed onto two pieces of double-sided tape (3M Scotch, USA) forming a 
reaction chamber of around 3 μl volume. Before sealing, coverslips were coated with 0.1 mg/ml poly-L-
lysine (PLL; P1274; Sigma-Aldrich, Germany) diluted in Aqua dest. for 15 min. at RT to maintain 
homogenous F-actin network formation on the glass surface. Unbound PLL was removed by intensive 
rinsing with Aqua dest. All experiment incubations were carried out in a moist chamber at RT.  
 Stabilised and labelled filamentous actin was diluted in G-buffer (5 mM Trizma base, pH 8.0, 
0.2 mM CaCl2, 0.2 mM Na-ATP, 2 mM DTT) at a ratio of 1:200. Diluted F-actin was perfused into the 
chamber and incubated for 3 min. followed by a wash-out with 10 μl G-buffer. Nonspecific binding was 
blocked by perfusion of the chamber with 10 μl 3 mg/ml casein (Sigma-Aldrich; USA) diluted in HB 
buffer (25 mM HEPES, pH 7.4, 2 mM, MgCl2, 2 mM EGTA, 0.1 mM EDTA) for 5 min. Subsequently, 
excess F-actin and casein were washed out by 10 μl HBS (HB containing 10 % sucrose and 0.3 mg/ml 
casein). Binding reaction mixtures were prepared in HBS on ice with a final volume of 8-10 μl. 
Reaction mixtures were freshly prepared in the following order: 1.) HBS, 2.) phagosomes, 3.) cytosol 
and 4.) additional factors, such as lipids, inhibitors etc. Isolated latex bead phagosomes were usually 
diluted to a working concentration of 0.006 % [wt/vol]. Binding reaction mixtures were perfused into the 
chamber and incubated for 20 min. Afterwards, unbound phagosomes were washed out by perfusion 
of 10 μl HBS. Chambers were sealed using VaLaP (vaseline, lanolin and paraffin at the same ratio).  
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 Phagosomal binding was analysed by fluorescence microscopy (Fig. 5C) or video-enhanced 
contrast differential interference contrast (VEC-DIC) microscopy using a Nikon Diaphot 300 inverted 
microscope equipped with an oil immersion condenser (numerical aperture 1.4) and a 60x DIC 
PlanApo oil objective (numerical aperture 1.4; Nikon, Japan). Bound phagosomes were counted by 
eye per view field, and in each experiment, values from at least 20 fields were averaged. The error 
bars reported are standard deviations of at least three independent experiments.  
 
Figure 5. Light microscopy images illustrating purity of isolated latex bead phagosomes (LBP). During 
isolation, post-nuclear supernatant containing several cell organelles (A’) was separated from pelleted 
cell nuclei and whole intact cells (A”). Purified, enriched LBP were obtained after discontinuous 
sucrose gradient centrifugation (B). Subsequently, binding of LBP to F-actin networks (red) in vitro was 
analysed by binding assays in the absence (C, left) and presence of isolated cytosol (C, right). 
Material & Methods 34 
 
Table 1. List of used lipids and inhibitors in binding assay studies: 
Component Assay conc. Solvent Supplier 
    
Arachidonic Acid (AA) 125 μM EtOH Sigma-Aldrich, USA 
Ceramide (Cer) 5 μg/ml EtOH Sigma-Aldrich, USA 
C16Ceramide (C16Cer) 5 μg/ml EtOH Sigma-Aldrich, USA 
Diacylglycerol (DAG) 50 μM EtOH Avanti Polar Lipids, USA 
Eicosapentaenoic acid (EPA) 10 μM EtOH Sigma-Aldrich, USA 
Leukotriene B4 0.1-1 μM EtOH Sigma-Aldrich, USA 
Prostaglandin A1 0.1-1 μM EtOH Sigma-Aldrich, USA 
Prostaglandin F2 alpha 0.1-1 μM EtOH Sigma-Aldrich, USA 
PtdIns (4,5)-bisphosph. (PIP2) 50 μM EtOH Sigma-Aldrich, USA 
Sphingomyelin (SM) 10 μM EtOH Sigma-Aldrich, USA 
Sphingosine (Sph) 10 μM EtOH Sigma-Aldrich, USA 
Sphingosine-1-phosphate (S1P) 10 μM MeOH Merck, Calbiochem, Germany 
    
Na-ATP 1 mM A. dest. Sigma-Aldrich, USA 
    
Genistein 10 μM DMSO Merck, Calbiochem, Germany 
LY294002 50 μM DMSO Merck, Calbiochem, Germany 
Ocadaic acid 0.02 μM DMSO Merck, Calbiochem, Germany 
PLA2 inhibitor 1 μM DMSO Merck, Calbiochem, Germany 
Sodium vanadate 1 mM DMSO Merck, Calbiochem, Germany 
Staurosporine 2 μM DMSO Merck, Calbiochem, Germany 
Wortmannin 1 μM DMSO Merck, Calbiochem, Germany 
    
2.6 Light microscopy studies 
2.6.1 Fusion assay and analysis of phagocytic uptake rates 
Analysis of phagosome-lysosome fusion events was carried out by detection of lysosomal markers, 
such as LAMP-2, on phagosomes by immunofluorescence labelling or by another, more elegant 
approach applicable in live cells that was recently described (Anes et al. 2006). For this, 10 nm gold 
particles prepared according to Slot and Geuze (Malik et al., 2003) were saturated with 20 % of BSA 
and centrifuged for 45 min. at 10.000 g at 4 °C. The pellet was resuspended in PBS containing 1 
mg/ml rhodamine-NHS (N-hydroxysuccinimide) esters (Invitrogen, Germany) and rotated on a wheel 
for 1 hr. The suspension was washed three times with PBS containing 50 mM glycine and was 
resuspended in PBS containg 50 mM glycine and 0.02 % sodium azide for storage. The OD was 
estimated at 520 nm and rhodamine-conjugated gold particles were used with an OD520 nm =1 in culture 
medium in all fusion experiments. Macrophages were pulsed for 1 hr. with labelled gold particles, 
washed three times with PBS and chased for another hour in culture medium leaving particles time to 
accumulate within lysosomes. Uptake of latex beads coupled to different ligands diluted at a ratio of 
1:100 in internalisation medium (corresponding to 0.01 % solids) was then allowed for different times. 
After incubation, cells were fixed and, in the case of avidin, outside beads were stained by anti-avidin 
antibody before cell permeabilisation. Similarly, in IgG samples outside beads were labelled by 
Material & Methods 35 
 
Alexa488 goat anti-mouse antibody for 20 min. After permeabilisation, in avidin samples all beads 
were stained for 20 min. with FITC-conjugated biotin. In the remaining samples (gelatin, LPS, 
mannan), F-actin was labelled by FITC-phalloidin for 30 min. In all samples, 50 cells were analysed by 
confocal microscopy to determine total number of beads, the amount of internalised beads and the 
percentage of LBP positive for the lysosomal markers LAMP-2 and rhodamine-gold, respectively. 
Avidin and IgG samples could be analysed by the described inside-outside stain. In the other samples 
containing fluorescent latex beads, 30 z-stacks of each field were recorded and internalised beads 
could be distinguished by the help of F-actin staining using the cross-section view of the confocal 
software. For uptake experiments, at least two independent experiments were analysed and averaged.  
Table 2. List of markers and antibodies used for immunofluorescence labelling (IF), western blotting 
(WB) and antibody inhibitor experiments in actin-binding assays: 
Label Host  Used dilution Supplied by 
    
PRIMARY ANTIBODIES 
   
    
anti-mouse CD14 rat 1:500 BD Pharmingen, Germany 
anti-mouse Fc receptor I rat 1:500 R&D Systems, USA 
anti-mouse Mannose receptor rat 1:1000 P. Stahl (Fiani et al. 1998) 
anti-Actin mouse 1:2000 Abcam, UK 
anti--Tubulin, clone B-5-1-2 mouse 1:5000 Sigma-Aldrich, USA 
anti-Dynamin-A rabbit 1:1000 D. Manstein (Wienke et al. 1999) 
anti-Ezrin rabbit 1:500 Cell Signaling, USA 
anti-phospho ERM rabbit 1:1000 Cell Signaling, USA 
anti-Filamin-A rabbit 1:1000 Cell Signaling, USA 
anti-IQGAP1 rabbit 1:500 R. Grosse (Fukata et al. 2002) 
anti-mDia1 rabbit 1:500 R. Grosse (Brandt et al. 2007) 
anti-Moesin, clone 38 mouse 1:500 BD Pharmingen, Germany 
anti-Myosin Va (DIL-2) rabbit 1 μg/ml J.A. Hammer (Wu et al. 1997) 
anti-N-WASP rabbit 1:500 S. Marion (Egile et al. 1999) 
anti-Cathepsin-D goat 1:200 Santa Cruz Biotechnology, USA 
anti-LAMP-2 rat 1:200 (IF) / 1:1000 (WB) Iowa Hybridoma bank, USA  
anti-Phosphotyrosine mouse 1:1000 Sigma-Aldrich, USA 
anti-Tumor necrosis factor alpha mouse 0.5 μg/ml BD Pharmingen, Germany 
    
SECONDARY ANTIBODIES 
   
 
 
  
anti-goat HRP donkey 1:10000 Dianova, Germany 
anti-mouse HRP sheep 1:5000 GE Healthcare, UK 
anti-rabbit HRP donkey 1:5000 GE Healthcare, UK 
anti-rat HRP goat 1:5000 Pierce Biotechnology, USA 
anti-mouse Alexa-488 and -594 goat 1:300 Invitrogen, Germany 
anti-rabbit Alexa-488 and -594 goat 1:300 Invitrogen, Germany 
anti-rat Cy3 goat 1:300 Invitrogen, Germany 
  
  
MARKERS 
 
  
  
  
Hoechst bisbenzimide (DNA) - 1:1000 Sigma-Aldrich, USA 
FITC-phalloidin (F-actin label) - 1:500 Sigma-Aldrich, USA 
TRITC-phalloidin (F-actin label) - 1:500 Sigma-Aldrich, USA 
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2.6.2 Fixation and labelling of cells 
Cells were fixed in PBS containing 4 % paraformaldehyde and 4 % sucrose (pH 7.4; Sigma-Aldrich, 
USA) for 20 min. at RT followed by quenching in PBS containing 50 mM NH4Cl (Merck, Germany) for 
10 min. at RT. Permeabilisation, when required, was achieved by treatment with 0.2 % Triton X-100 
(Roth, Germany) in PBS for 5 min. at RT. After blocking of unspecific binding sites with PBS containing 
1 % white gelatin ‘gold’ (Sigma-Aldrich, USA) for 60 min., samples were incubated with primary 
antibody (see table 2) diluted in blocking solution for 60 min. at RT, followed by three washes with PBS 
containing 0.2 % gelatin. Secondary antibodies (see table 2) were applied for 45 min. at RT, again 
followed by three washes. If necessary, samples were stained with markers for actin or cell nuclei for 
20 min. at RT. Coverslips were washed in PBS containing 0.2 % gelatin, PBS alone, in Aqua dest. and 
were mounted on glass slides (Menzel GmbH, Germany) using ProLong gold mounting medium 
(Invitrogen, Germany). Fluorescence labelling and viability test of mycobacteria were performed as 
described (Anes et al. 2003; Kühnel et al. 2006). 
2.6.3 Conventional and confocal microscopy 
Actin-binding assays were analysed by conventional epifluorescence microscopy as described 
previously (Al-Haddad et al. 2001) or, in the case of non-fluorescent LBP, by video-enhanced 
differential interference contrast (VEC-DIC) microscopy according to Allen (Weiss et al. 1999). A 
Diaphot 300 inverted microscope (Nikon, Japan) equipped with an oil immersion condenser (NA 1.4) 
and a 60x DIC PlanApo oil immersion objective (NA 1.4) and a mercury arc lamp HBO 103W (Osram, 
Germany) were used for microscopic observations. A C2400-07 Newvicon camera was used for 
acquiring DIC images (Hamamatsu Photonics, Germany). First, all video signals were subjected to 
analogue contrast enhancement followed by a real-time digital image processing with the following 
steps: 1. subtraction of an out-of-focus background, 2. averaging of images to increase signals-to-
noise ratio and 3. digital contrast enhancement by selection of desired range of gray levels. Analogue 
and digital image processing of VEC-DIC signals was performed using an Argus 20 real-time image 
processor (Hamamatsu Photonics, Germany). Images were transferred to a MacIntosh 9600 computer 
(Apple, USA) equipped with a LG-3 frame-grabber (Scion, USA) using IPLab Spectrum software 
(Scanalytics, USA). Fluorescence images were recorded by a chilled SenSys CCD camera system 
(Photometrics Inc., USA) and an Uniblitz D122 shutter (Vincent Associates, USA). For selective 
excitation and specific detection of emitted radiation of used fluorescent dyes, different filter sets were 
available (Nikon, Japan). Images were again transferred to a MacIntosh computer and analysed by 
IPLab Spectrum software. 
 Live cell imaging at 37 °C and analysis of fusion assays as well as uptake rates of fixed 
macrophages were performed by confocal fluorescence microscopy using a TCS SP2 laser-scanning 
microscope (Leica, Germany) equipped with a 405 nm diode laser, an argon-krypton laser with lines at 
458, 476, 488, 514 nm and helium-neon lasers with 543, 594 and 633 nm lines. The system also 
contained acousto-optical tuneable filters (AOTF), an acousto-optical beam splitter (AOBS) and four 
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prism spectrophotometer detectors that permitted simultaneous excitation and detection of multiple 
fluorochromes. Three-dimensional scans of usually 30 z-stacks were recorded and analysed by the 
help of the cross-sectioning option of Leica confocal software. Staining of cellular F-actin allowed to 
distinguish between outside or only attached latex beads and fully internalised beads forming latex 
bead phagosomes. Additionally, LBP were analysed for the presence of lysosomal markers (LAMP-2, 
rhodamine-gold particles). Only phagosomes completely surrounded by lysosomal markers were 
counted as positive for phagosome-lysosome fusion events. 
2.7 Investigation of macrophage gene expression by 
 microarray analysis  
2.7.1 Used material, reagents and instruments 
o RNAeasy Mini kit and DNase I (Qiagen, Germany) 
o NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific, USA) 
o CodeLink™ iExpress expression assay reagent kit containing a bacterial mRNA 
control set (Applied Microarrays, Inc., USA) 
o CodeLink™ Mouse Whole Genome Bioarray, spotted oligonucleotide (Applied 
Microarrays, Inc., USA); platform ID used in NCBI GEO database GPL5825, 
EMBL30807 
o Bioanalyzer and GeneSpring GX software (Agilent Technologies, Inc., USA) 
o Excel Compare software (Formula Software, Inc., USA) 
o Two Tone Table Lens (TTTL) programmed by Mathias John, Christian Tominski 
and Heidrun Schumann (Institute for Computer Science, University of Rostock, 
Germany) 
2.7.2 RNA isolation, preparation of cRNA and hybridization 
J774 macrophages were seeded into 6-well plates two days prior the experiment and were grown as 
monolayer. After reaching around 75 % confluency, cells in passage 19 were used for feeding 
experiments with latex beads conjugated to avidin, the Fc fragment of mouse IgG, LPS from Klebsiella 
pneumoniae and mannan from Saccharomyces cerevisiae as described before. Macrophages were 
washed with PBS and incubated in serum-free DMEM containing 0.02 % coupled latex beads (1 % 
stock solution at a ratio of 1:50, corresponding to final OD=3.6) for 30 and 60 minutes at 37 °C and 5 
% CO2. Controls were incubated with serum-free DMEM without latex beads. All samples including 
controls (one well per sample) were processed in duplicates. Cells were washed three times with PBS 
and lysed using the lysis buffer supplied by the RNAeasy Mini kit. Isolation of total RNA was carried 
out using this kit following the manufacturers’ instructions. After the addition of DNase to all samples, 
the concentration and purity of isolated RNA was determined by the NanoDrop photospectrometer. 
Isolated RNA was stored in RNase-free tubes at -70 °C. 
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 The preparation of cRNA and hybridization was carried out using the CodeLink™ iExpress 
expression assay reagent kit following the manufacturers’ instructions by the help of the Genomics 
Core facility (EMBL Heidelberg). Briefly, the biotin-labelled cRNA target was prepared by a linear 
amplification method. The poly(A)+ RNA (mRNA) subpopulation within the total RNA population was 
primed for reverse transcription by a DNA oligonucleotide. After second-strand cDNA synthesis, the 
cDNA served as the template for an in vitro transcription (IVT) reaction to produce the target cRNA. 
The IVT was performed in the presence of biotinylated nucleotides to label the target cRNA. This 
method produced approximately 1,000- to 5,000-fold linear amplification of the input RNA. 
Hybridization was performed overnight in a shaking incubator at 37 °C and 300 rpm. Post-hybridization 
processing included a stringent wash to remove unbound and non-specifically hybridized target 
molecules, a secondary labelling step using a Cy5-Streptavidin conjugate and several washing steps 
to remove unbound conjugate. Following a final rinse, the Mouse Whole Genome bioarrays were dried 
by centrifugation and scanned. The intensity values were normalised against median of spot-based 
raw intensity. 
2.7.3 Data processing and comparison 
Bioarray data was processed using the GeneSpring GX software by the help of Bibhuti Mishra 
(Molecular Pathogenesis Centre, University of Lisbon, Portugal). First, all array data were normalised 
and clustered using the ‘condition tree’ method. Similar branches were merged and computed locally 
to analyse whether duplicates of controls and different bead types cluster together. The controls as 
well as the samples of the same bead type were found in clusters, therefore gene expression of the 
J774 mouse macrophage-like cell line could be analysed after importing mouse whole genome data 
into the software. Due to the high amount of sample data, in this study only the significant upregulation 
of genes was analysed. Data were filtered on fold change and all bead coating conditions were 
compared to untreated control conditions or versus each other. Because of the existence of all 
conditions in duplicates, each comparison resulted in four test possibilities (upregulation of coating X1 
vs. control 1 and control 2 as well as coating X2 vs. control 1 and control 2). Data arrays of gene 
upregulation were exported as Excel files. For further comparison, only upregulated genes were 
analysed, which appeared minimum two times in all four test possibilities. By the help of Excel 
Compare software, upregulated genes, which appeared common to all coatings, as well as genes, 
which were upregulated uniquely for a particular coating ligand, were determined. All microarray data 
were submitted to the NCBI Gene Expression Omnibus (GEO) public database and can be found as 
accession GSE9859 (http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE9859). To 
confirm the observed changes in gene expression, a limited number of expressed proteins were 
analysed in these samples by western blotting.  
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2.8 One-dimensional SDS-PAGE and Immunoblotting 
2.8.1 Used reagents and instruments 
SDS PAGE (according to Laemmli 1970) 
o 4x Protein sample buffer, pH 6.8: 250 mM Trizma base, 30 mM EDTA, 40 % 
glycerol, 4 % 2-mercaptoethanol, 4 % sodium dodecyl sulfate (SDS), 0.01 % 
bromphenolblue (all from Sigma-Aldrich, USA) 
o 10 % separation gels: 13.33 ml 30 % acrylamide/bisacrylamide (Roth, Germany), 
10 ml 4x LGS (1.5 M Trizma base, pH 8.8, 0.4 % SDS), 16.66 ml Aqua bidest., 45 
μl TEMED and 20 μl 40 % ammonium peroxide sulfate (all from Sigma-Aldrich, 
USA); 12 % separation gels were adjusted to necessary acrylamide concentration. 
o Stacking gels: 0.575 ml 30 % acrylamide/bisacrylamide (Roth, Germany), 1.25 ml 
4x UGS (0.5 M Trizma base, pH 6.8, 0,4 % SDS), 3.175 ml Aqua bidest. + 15 μl 
TEMED + 6.3 μl 40 % ammonium peroxide sulfate (all from Sigma-Aldrich, USA) 
o Running buffer: 25 mM Trizma base, 192 mM glycine, 0.1 % SDS (all from Sigma-
Aldrich, USA) 
o Coomassie staining solution: 0.125 % Coomassie R250 (Serva, Germany), 50 % 
methanol and 10 % acetic acid (both from Roth, Germany); Destain solution I: 50 
% methanol and 10 % acetic acid; Destain solution II: 5 % methanol + 7 % acetic 
acid 
o Molecular weight marker (BioRad, USA)  
o Thermostat 5320 (Eppendorf, Germany), Mighty Small II electrophoresis device 
(Hoefer, Inc., USA), PowerPac 200 (BioRad, USA)  
Immunoblotting (according to Towbin et al. 1979)  
o Used antibodies: see list in chapter 2.6 
o Blot buffer: 25 mM Trizma base, 200 mM glycine, 20 % methanol 
o TBS, adjusted to pH 7.4: 10 mM Trizma base, 149 mM NaCl (Merck, Germany) 
o TTBS: TBS containing 0.1 % Tween-20 (Merck, Germany) 
o Blocking buffer: TTBS containing 5 % non-fat dry milk (Nestlé Food Co., USA) 
o Ponceau S staining solution: 0.2 % Ponceau S, 3 % TCA (Serva, Germany) 
o Hybond nitrocellulose membranes, Hyperfilm and ECL western blot detection 
reagent (Amersham, GE Healthcare, UK) 
o MiniProtean tank blotting device (BioRad, USA) 
2.8.2 1D SDS-PAGE 
Cells were washed with PBS twice and 1x SDS sample buffer was added to lyse cells. Isolated 
phagosomes, cytosol and actin fractions were incubated with 1x SDS sample buffer directly. 
Subsequently, all SDS samples were boiled at 90 °C for 5 min. to denaturate proteins. Remaining DNA 
was destroyed by a short ultrasonic treatment on ice. The proteins were separated by vertical gel 
electrophoresis using 10 % or 12 % polyacrylamide gels. The samples were migrated in 1x running 
buffer in an electrophoresis device per gel set to constant 10 mA for around 15 min. followed by a run 
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at constant 20-30 mA for 70-100 min. After separation, proteins were stained using Coomassie or 
silver staining or were transferred onto nitrocellulose membranes for further immunoblotting (2.8.3). 
 For Coomassie staining, gels were incubated with Coomassie R250 staining solution for 45 
min. under vigorous shaking. Afterwards the stained gels were washed and fixed with destain solution 
I for 45 min. and destain solution II for minimum 60 min. Silver staining was carried out following the 
manufacturer’s instructions. Images of stained gels were taken with a conventional flat-bed scanner. 
2.8.3 Immunoblotting 
Following separation in acrylamide gels, protein mixtures were transferred to nitrocellulose (NC) 
membranes to analyse them for the presence of specific proteins applying antibodies, a method 
known as immuno- or western blotting. NC membranes, filter papers, sandwich pads and migrated 
acrylamide gels containing proteins were equilibrated in blot buffer for 20 min. and assembled in 
cassettes following the manufacturer’s instructions. The samples were transferred onto nitrocellulose 
membranes using a tank blotting device in blot buffer at constant 30 V overnight. Success of transfer 
was checked by protein staining using Ponceau S solution for 3 min. Afterwards the membranes were 
rinsed with Aqua dest. and images were taken using a conventional flat-bed scanner.  
 Before labeling, the membranes were incubated in blocking buffer containing 5 % dry milk or, 
dependent on the antibody, BSA to block unspecific binding sites. Afterwards dilutions of primary 
antibodies were prepared in blocking buffer and were applied for 1 hr. at RT or overnight at 4 °C. 
Membranes were washed with TTBS three times for 10 min. followed by incubation with horseradish 
peroxidase (HRP)-conjugated secondary antibodies for 45-60 min. After another three washes in 
TTBS for 10 min. and a final rinse in TBS, the NC membranes were exposed to ECL solution for 5 min. 
at room temperature. Subsequently, chemiluminescent signals were visualised onto films and scanned 
for quantification. 
2.8.4 Quantification of stained gels, NC membranes and films 
Protein signals were quantified using Image Gauge software (Fujifilm, Japan) to determine quantity 
differences between samples. After scanning, images were converted to PICT format and analysed 
without further image enhancement. Whole lanes or single spots were selected manually followed by 
automatic measurement of grey levels. Relative signal intensities were compared using MS Excel. 
2.9 Two-dimensional SDS-PAGE  
2.9.1 Used material, reagents and instruments 
o Acetone, methanol, urea, CHAPS, 2-iodoacetamide, tris-(hydroxymethyl)-amino-
methane, ammonium peroxodisulfate, glycine, SDS, TEMED, sodium thiosulfate, 
silver nitrate, sodium carbonate, formaldehyde, formic acid (Merck, Germany) 
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o Biolyte pH 3-10, Ready Strip™ IPG strips, tributyl phosphine (TBP) and 
acrylamide/bisacrylamide solution (BioRad, USA) 
o DTT, Triton X-100, protease inhibitor cocktail P2714 (Sigma-Aldrich, USA) 
o Protean™ IEF Cell and II xi 2-DE Cell (BioRad, USA) 
2.9.2 2D SDS-PAGE 
Two-dimensional gel electrophoresis was performed by the help of Sabrina Rüggeberg (Proteomics 
core facility, EMBL Heidelberg) according to the procedures reviewed by Görg et al. (2000). The same 
amount (100 μl; OD=0.18) of isolated phagosomes (1 hr./1 hr.) containing latex beads coupled to the 
Fc fragment of mouse IgG and mannan, respectively, were used. After lysis in 2 % Triton-X100, 10 
mM DTT, 50 mM Tris pH 8.0 and protease inhibitors for 15 min. at 4 °C, latex beads were removed by 
centrifugation and phagosomal proteins were precipitated in acetone for two hours at -20 °C. The 
solutions were centrifuged with 14.000 rpm for 60 min. at 4 °C and precipitates were solubilised in 
sample solution (9 mol/L urea, 16 mmol/L CHAPS, 2 mmol/L TBP, 0.25 % Biolyte, protease inhibitor 
cocktail). Both samples were applied to 11 cm IPG strips at pH 3 to 10 with rehydration loading 
overnight as described elsewhere (Bjellqvist et al. 1982). The samples were mixed with rehydration 
solution (8 mol/L urea, 16 mmol/L CHAPS, 2 mmol/L TBP, 0.25 % Biolyte) giving a final volume of 200 
μL. For isoelectric focusing (first dimension), the Protean™ IEF Cell was loaded with re-hydrated IPG 
strips and focused for about 80 kV/h at a maximum voltage of 6.000 V at 20 °C. After focusing, each 
IPG strip was emerged first for 10 min. into reduction solution (6 mol/L urea, 30 % glycerol, 0.05 mol/L 
Tris pH 8.8, 173 mmol/L SDS, bromophenolblue) containing 5 mmol/L TBP and then into alkylation 
solution containing 270 mmol/L 2-iodoacetamide. Subsequently, the IPG strips were loaded on top of 
the gel for the second dimension for separation by size. The Protean™ II xi 2-DE was used to run 12 
% SDS polyacrylamide gels according to the method described in Laemmli (1970). The gels were run 
for 45 min. at 20 mA per gel and then for 600 V/h at 15 mA/gel in a second step. Visualisation was 
achieved by using the silver staining method according to Shevchenko et al. (1996).  
2.10 Liquid chromatography and tandem mass 
 spectroscopy (LC-MS/MS)  
The same samples were also used for mass spectroscopy to identify phagosomal proteins. The same 
amount of phagosomes isolated after 1 hr./1 hr. containing latex beads coupled to the Fc fragment of 
mouse IgG and mannan were used (500 μl; OD=0.18). Additionally, LBP coated with avidin isolated 
following the same method after same pulse and chase times were used for analysis (kindly provided 
by Sabrina Marion, EMBL Heidelberg). Purified phagosomes were lysed in 2 % Triton X-100, 10 mM 
DTT, 50 mM Tris, pH 8.0 and protease inhibitors by vortexing and incubation at 4 °C for 15 min. Latex 
beads were removed by centrifugation and phagosomal proteins were precipitated in acetone for two 
hours at -20 °C. The solutions were centrifuged with 14.000 rpm for 60 min. at 4 °C. The pellet was 
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dissolved, reduced with DTT and alkylated with iodoacetamide before being digested with 1 μg of 
Promega-modified trypsin for 24 hrs. at room temperature. A second 1 μg of trypsin was added and 
digestion was allowed to proceed for 24 more hours. The sample was acidified to 5 % acetic acid and 
then desalted on a C18 column. Approximately 25 % of the digest was introduced into the mass 
spectrometer for analysis using two run conditions. The complete procedure for LC-MS/MS was 
performed by the Biomolecular Research Facility at the Virginia University in Charlottesville, USA by 
the group of Dr. Nicholas Sherman. The LC-MS system consisted of a Finnigan LCQ ion trap mass 
spectrometer system (Thermo Fisher Scientific, Inc., USA) with a Protana nanospray ion source 
interfaced to a self-packed 8 cm  75 μm id Phenomenex Jupiter 10 μm C18 reversed-phase capillary 
column. The extracts (0.5-10 μl volumes) were injected and the peptides were eluted from the column 
by an acetonitrile/0.1 M acetic acid gradient at a flow rate of 0.25 μl/min. The nanospray ion source 
was operated at 2.8 kV. The digest was analysed using the double play capability of the instrument 
acquiring full scan mass spectra to determine peptide molecular weights and product ion spectra to 
determine amino acid sequence in sequential scans. This mode of analysis produces approximately 
3000 CAD spectra of ions ranging in abundance over several orders of magnitude.  
 The data were analysed by database searching using the Sequest algorithm (developed by 
J. Eng and J. Yates, The Scripps Research Institute, La Jolla, USA) against mouse IPI accessions. 
This program converted the character-based representation of amino acid sequences in a protein 
database to fragmentation patterns, which were compared against the MS/MS spectrum generated on 
the target peptide. The algorithm initially identified amino acid sequences in the database that match 
the measured mass of the peptide, compared fragment ions against the MS/MS spectrum and 
generated a preliminary score for each amino acid sequence. Then, a cross-correlation analysis was 
performed by correlating theoretical, reconstructed spectra against the experimental spectrum. 
Identified proteins were analysed using Scaffold software (Proteome Software, Inc., USA) applying 
different protein identification probability filter settings. The correlation score (Xcorr), which was included 
by the mass spectrometry lab in Virginia, was corrected for length of the peptide that gives a very high 
probability of being correct, but excluded proteins with lower probability, peptide length etc., which 
were expected on LBP known from comparable previous studies (Garin et al. 2001, Rogers & Foster 
2007). Therefore, in this study I used a different scoring system for the proteomic analysis based on 
the peptide/protein prophet included in the software. By this analysis, less protein sequences were 
covered by unique peptide spectra, slightly increasing the chance of false positives and negatives 
appearing in the list, but still gave identification results of high confidence. Used filter settings were: 
 - minimum protein identification probability1: 80 % 
 - minimum number of peptides2: 1 
 - minimum peptide identification probability3: 95 % 
                                                           
1
 minimum requirement for Scaffold's calculated probability of correct protein identification (ID) 
2
 number of unique peptides that must be found for one protein in order to consider to be identified 
3
 how certain a peptide ID must be before it can be counted toward the minimum number of peptides 
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3.1 Characterization of the binding of phagosomes to F-
 actin using an in vitro binding assay 
Phagosomes are membrane bound organelles, which associate with many cytoskeleton 
components. Actin filaments and their associated proteins play an important role during 
particle uptake and formation of phagosomal membranes from the plasma membrane, but it 
is also well accepted that phagosomes rapidly lose their abundant actin coats within minutes 
of finishing the internalisation process. The participation of actin and its associated proteins 
in later events of phagocytosis like the maturation of phagosomes, which includes 
acidification by fission and fusion events with compartments of the endo /lysosomal system, 
is less clear. There are several hints which support an involvement in these processes, like 
the capability of maturing phagosomes to nucleate actin (Defacque et al. 2000, Jahraus et al. 
2001), to interact with and recruit actin associated proteins (Stockinger et al. 2006) as well as 
the presence of actin and many of its proteins in mature phagosomes determined by 
proteomic analysis (Desjardins et al. 1994, Garin et al. 2001, Gotthardt et al. 2006). Besides 
the ability of phagosomes to nucleate actin de novo, it is still an open question what an 
impact the binding of phagosomes to F actin possesses during their maturation. However, 
given the plethora of actin binding proteins (17 identified ones in the study of Garin et al. 
2001) it seems inescapable that they must bind F actin in cells.  
 To investigate the binding of phagosomes to actin filaments and the contribution of 
their associated proteins, an in vitro assay was developed in our lab, which allows analysis of 
these events step by step. By the help of this assay, it already could be demonstrated that 
binding between actin filaments and phagosomes containing latex beads (LBPs), a well
characterized model system, occurs in vitro. Furthermore, the interactions between LBPs and 
F actin were dependent on actin binding proteins (ABPs), which contribute to this binding 
differently. So far, three different factors were found to be involved, two stimulatory ones and 
one inhibitory factor of low molecular mass. Of the stimulatory factors, one high molecular 
weight protein functions independent of ATP, whereas the other one could be identified as 
the ATP dependent motor protein Myosin Va (Al Haddad et al. 2001). 
 The actin binding assay relies on the step wise perfusion of components in small 
chambers on a glass slide. After the formation of stabilised actin networks on coverslips 
coated with poly L lysine and blocking of unspecific binding sites, phagosomes and 
additional factors are perfused into the chamber to allow binding to these pre formed actin 
networks. After incubation unbound components are washed out and samples are analysed 
by conventional fluorescence microscopy by determining numbers of bound phagosomes to 
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actin filaments per microscopic field (see chapter 2.5). This simple assay is not only highly 
reproducable, but also gives highly quantitative results. 
 In this study, I wanted to extend the investigation of phagosomes and their capability 
to bind to actin filaments, not only those enclosing latex beads but also pathogenic and non
pathogenic bacteria. They represent important targets of professional phagocytes like 
macrophages, which help to destroy invading microorganisms and are essential part of the 
innate immune system.   
3.1.1 Binding of isolated phagosomes containing latex beads 
Phagosomes containing inert latex particles of same size provide an elegant model system to 
study different aspects of phagocytosis and can be isolated in high purities. The analysis of 
these phagosomes and their binding to actin filaments in vitro is important to understand the 
underlying molecular mechanisms, if they are compared to phagosomes containing 
microbes. It was therefore important to investigate these organelles in more detail. The 
experiments of the Al Haddad et al. study (2001) were carried out using phagosomes 
containing 1 μm latex beads coated non specifically with fish skin gelatin (FSG), which were 
isolated from macrophages by sucrose gradient centrifugation after one hour pulse followed 
by an additional chase time of one hour. In this study, I started with the same phagosomes to 
analyse and confirm the basic conditions of LBP binding to F actin in vitro.   
 First, the system was validated and basic conditions were controlled. The formation 
of homogenous actin networks on coverslips need a pre coating of glass surfaces with 0.1 
mg/ml poly L lysine (Fig. 5). Blocking of non specific binding sites of F actin is sufficient to 
maintain stable phagosomal binding to filaments and reduces background interactions of 
components. Non coated latex beads do not bind to these networks in the absence and 
presence of cytosol. Coated latex beads without surrounding phagosome membrane only 
bind weakly to actin networks (Fig. 6A). After checking the basic conditions phagosomal 
binding could be investigated in the assay.  
 Phagosomes containing FSG coupled latex beads were analysed without any 
further treatment after isolation or the addition of cytosolic factors to the assay. Interestingly, 
these phagosomes were able to bind to actin filaments in vitro in the absence of cytosolic 
components (Fig. 6A). This demonstrates that LBPs carry the factors, which are involved in 
mediating binding to F actin, also after their isolation. The addition of different concentrations 
of cytosol isolated from non activated J774 macrophages induced no stimulation of 
phagosomal binding (Fig. 6A). As expected, a salt stripping of these phagosomes strongly 
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reduced the binding capability in the assay by removing membrane bound proteins, like 
motor enzymes, whereas the addition of J774 cytosol again restored the binding of stripped 
phagosomes (Fig. 6A). The range of the stimulatory potential was dependent on individual 
cytosols used in combination with individual phagosomes, but the addition of low 
concentrations of cytosolic factors was already sufficient to mediate binding of salt stripped 
LBPs to actin networks. During this study, 16 different J774 cytosol isolations were carried 
out, which possessed their most stimulatory capability at protein concentrations between 
0.05 and 2 mg/ml (see example in Fig. 6B, black line). Higher protein concentrations always 
caused reduced binding capabilities of phagosomes, most probably because of the increased 
presence of a low molecular mass inhibitor (Al Haddad et al. 2001), which still remains to be 
characterized. I was also able to confirm that the stimulatory activity of cytosolic factors is 
partly ATP dependent, because the addition of 1 mM Na ATP to the assay caused a 
reduction in binding activity of more than 50 %, demonstrating that ATP dependent actin
binding proteins (ABPs) are involved, namely motor proteins of the myosin superfamily. The 
participation of Myosin Va in mediating binding of LBPs to actin filaments has been already 
shown in our lab as well as the fact, that Myosin II is not involved in this process (Al Haddad 
et al. 2001).  
 Immunoblotting analysis of phagosomes is supporting these findings, because actin
binding proteins (like Moesin, mDia1 and Myosin Va) can be removed by salt stripping or 
restored by re incubation with cytosol. As an example, immunoblotting with an antibody 
against Myosin Va is shown in Fig. 6A’. The protein is present on non stripped phagosomes, 
salt stripping removes it from phagosomal membranes. After an incubation of salt stripped 
LBP with 1 mg/ml cytosol on ice for 20 min. followed by re flotation over a sucrose gradient, 
Myosin Va is again detectable on the organelle membrane. Immunoblotting using an 
antibody against actin revealed that it also rebinds to phagosomes, if they are incubated with 
cytosol (Fig. 6A’), arguing that the observed association of phagosomes to actin networks 
could be due to actin actin interactions by actin crosslinkers. However, previous experiments 
with the actin depolymerising drugs cytochalasin D and latrunculin already have shown that 
actin actin interactions are not responsible and that binding proteins contribute to this 
association (Al Haddad et al. 2001). Besides Myosin Va, it is known that many different 
motor proteins are involved in the interaction of phagosomes with actin filaments. However, 
actin binding proteins without motor activity can also have an impact on these processes and 
different classes of these proteins were identified in different phagosome proteomes (see 
references in Griffiths & Mayorga 2007). Many of them belong to the groups of cross linkers, 
bundling proteins and actin nucleators.   
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Figure 6. Binding behaviour of isolated J774 latex bead phagosomes in vitro. (A) Shown are averages 
of bound LBPs of 20 analysed microscopic fields in the actin-binding assay. Pure coated latex beads 
(LB) without a phagosomal membrane bind weakly to F-actin. Non-stripped LBPs (black bars) are able 
to bind in the absence of cytosolic factors, whereas salt-stripping (grey bars) causes a reduction of 
binding capability. The addition of cytosol isolated from J774 macrophages to the assay restores 
binding of salt-stripped but exhibits no effect on non-stripped phagosomes. (A’) Analysis of 
components applied in the binding assay by immunoblotting using an antibody against actin and the 
actin-binding protein Myosin-Va. Actin is present in cytosol (lane 4) and rebinds to phagosomes (lane 
3). Myosin-Va is detectable in cytosol (lane 4) and on non-stripped LBPs (lane 1), but can be removed 
from phagosomes by salt-stripping (lane 2). Myosin-Va rebinds to salt-stripped LBPs, if they are 
incubated with cytosol (lane 3; shown are only pre-incubated phagosomes after re-flotation in a 
sucrose gradient). The same amount of phagosomes was loaded in lanes 1-3 as well as the same 
concentration of cytosol in lanes 3 and 4. (B) The stimulatory capability of cytosol is located between 
protein concentrations of 0.05 and 2 mg/ml determined in the actin-binding assay (black line). An 
addition of 1 mM Na-ATP to the assay (red line) reduced binding by 55 % at 0.05 mg/ml cytosol and 
by 52 % at 0.5 mg/ml cytosol. Furthermore, the stimulatory potential is also dependent on individual 
cytosol preparations, e.g. comparison of cytosol XIV in (A) and cytosol VIII in (B). 
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 In this study, I concentrated on the influence of some likely candidates of the last 
group to investigate how they alter the observed association of phagosomes with F actin in 
the in vitro binding assay. Antibodies (see Table 2 in chapter 2.6) were used at 0.5 mg/ml to 
block the function of Ezrin, Moesin, N WASP, mDia1 and IQGAP1, respectively. Ezrin, 
Moesin and N WASP are nucleating actin on membranes, whereas mDia1 and IQGAP1 are 
activators of the actin nucleating machinery. Previous studies demonstrated that they are 
associated with phagosomes or they could be identified on phagosomal membranes by mass 
spectrometry. In addition to the proteins mentioned above, an antibody against Myosin Va 
was also used in the assay to validate the results of this experiment with previous findings 
(Al Haddad et al. 2001). To exclude an influence of the order of application of phagosomes, 
cytosol and antibody in assay samples, a pre incubation of cytosol and antibody was tested 
on ice for 20 min. as well as the direct application of all three components in the assay. No 
differences could be detected between these two experimental conditions. 
 The antibody against Myosin Va reduced binding of salt stripped phagosomes to F
actin in vitro in the presence of cytosol by nearly 40 % (Fig. 7, upper chart), confirming it’s 
role in maintaining interaction between phagosome and actin filaments. The same 
experiment in the absence of cytosol caused no effect (data not shown), which again 
indicates that Myosin Va is recruited from the cytosol. Significant influences on binding of 
salt stripped LBPs to F actin in vitro also appeared, when antibodies against Ezrin and N
WASP were applied (Fig. 7, upper chart). Here, an increased binding activity could be 
observed, both of around 40 %, arguing for inhibitory functions of these proteins in the assay. 
Blocking of Moesin, IQGAP1 and mDia1 caused no significant differences (Fig. 7, upper 
chart), although it cannot be excluded that the antibodies used in the assay were not blocking 
their functions properly. The inhibitory function of Ezrin and N WASP, proteins expected to be 
part of the actin nucleation machinery, on binding observed in the assay was surprising. 
These data gave the first hint that the nucleation of actin on phagosomal membranes could 
play the opposite role than the binding of phagosomes to actin filaments. 
 I further investigated whether the antibodies, which exhibited significant effect in the 
binding assay, are able to detect the particular protein in J774 macrophages and analysed 
their sub cellular localisation. The cells were allowed to internalise FSG coated latex beads 
for 1 hour followed by a chase time of 1 hour to maintain the same phagosomes that were 
used in the in vitro assay. The samples were fixed with paraformaldehyde, permeabilised and 
afterwards labelled with the respective antibody. Both antibodies were able to confirm the 
presence of Myosin Va and Ezrin on phagosomes in macrophages (Fig. 7,middle) and 
support the effects observed in vitro. 
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Figure 7. Upper chart: Binding of salt-stripped LBP to F-actin in vitro in presence of 0.5 mg/ml J774 
cytosol. Shown are relative effects in phagosomal binding compared to mock controls, when 
antibodies against actin-binding proteins were applied to the assay at 0.5 mg/ml. Significant inhibitory 
and stimulatory influence on binding could be demonstrated for antibodies against Myosin-Va, Ezrin 
and N-WASP, whereas blocking of Moesin, IQGAP1 and mDia1 exhibited no or only weak differences. 
Significance of results was tested using Student’s t-test (** P<0.01). images, middle: Two of these 
antibodies were probed to detect Myosin-Va and Ezrin (both in green) in fixed J774 cells by confocal 
microscopy. Shown are single z-stacks of whole cells and phagosomes after 1 hr. pulse and 1 hr. 
chase that displayed detectable protein signals (arrow), also shown as insets. Bars represent 10 μm. 
Lower chart: A similar result could be obtained, when cytosol isolated from wild type (WT) and 
Myosin-Va knock-out (KO) primary macrophages was added to LBP in the in vitro actin-binding assay. 
Binding was inhibited in the absence of Myosin-Va (inset: western blot image of total cell lysates). 
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 Additionally, it was interesting to analyse whether kinases or phosphatases are able 
to alter the stimulatory activity of cytosolic components, because many membrane proteins 
including several actin binding proteins are regulated by phosphorylation and 
dephosphorylation events. The addition of kinase and phosphatase inhibitors to the assay 
(see table 1 in chapter 2.5) allowed the investigation of these enzymes under in vitro 
conditions. Staurosporine was used to block kinases in general (especially protein kinases 
like PKC and calmodulin dependent kinases), sodium vanadate to inhibit phosphatases non
specifically. PI3 kinase was affected by using two inhibitors, wortmannin and LY294002, and 
tyrosine kinase by the addition of genistein to the assay. The phosphatases 1A and 2A were 
specifically blocked by ocadaic acid. All inhibitors were used at concentrations, which affects 
these enzymes under in vitro conditions as shown in a comparable in vitro assay developed 
in our lab (Wöllert et al. 2002) and tested for significance versus DMSO mock controls.  
 The inhibition of all tested kinases and phosphatases did not affect significantly, or 
only slightly, the binding behaviour of salt stripped phagosomes in the absence and presence 
of cytosolic factors (Fig. 8). These results suggest that phosphorylation and 
dephosphorylation events are not involved in the binding of phagosomes to actin filaments at 
later phagocytic stages. Of course, the phosphorylation of ABPs, e.g. Myosin Va, is likely to 
be essential for the regulation of these proteins in living cells, but an inhibition seems to not 
disturb the binding of phagosomes to actin networks in vitro. 
 
Figure 8. Binding behaviour of salt-stripped latex bead phagosomes in the in vitro binding assay in the 
absence and presence of 0.5 mg/ml J774 cytosol after the addition of kinase and phosphatase 
inhibitors. Shown are averages of LBP’s bound to F-actin of 20 analysed microscopic fields. No effect 
had the inhibition of kinases in general (staurosporine), of PI3-kinase using wortmannin, of 
phosphatases in general (sodium vanadate) and of phosphatase-1A and -2A (ocadaic acid). Only the 
addition of the inhibitor LY294002 to block PI3-kinase and genistein to affect tyrosine kinases had 
slight effects. Significance of results was tested using Student’s t-test (* P<0.05). 
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 In summary, the analysis of the binding behaviour of phagosomes containing latex 
beads in vitro showed that these phagosomes need cytosolic factors to interact with F actin, 
one factor was previously identified as the motor protein Myosin Va. The majority of these 
factors is still present on phagosomal membranes after isolation, because non stripped 
phagosomes also bound in the absence of cytosol. Salt stripping of phagosomes removed 
membrane proteins and reduced phagosomal binding to actin networks, which could be 
restored by the addition of isolated cytosols at concentrations between 0.05 and 2 mg/ml 
dependent on individual cytosols. The addition of salt stripped phagosomes, cytosol and 
additional factors allowed a step wise investigation of these events. Experiments with kinase 
and phosphatase inhibitors showed no differences relative to control conditions, 
demonstrating that phosphorylation and dephosphorylation events are not important for 
regulating in vitro binding. Studies with antibodies against some actin binding proteins 
interfered with phagosomal binding to actin filaments, pointed to contradictory roles of 
binding and actin nucleation events. 
3.1.2 Binding of isolated phagosomes containing pathogenic and 
 non-pathogenic bacteria 
After investigating the binding of LBPs to F actin in more detail, the next aim of this study 
was the analyis of the binding behaviour of phagosomes containing non pathogenic and 
pathogenic species of mycobacteria. Members of this family, Mycobacterium tuberculosis 
and M. leprae, are causative agents of the infectious diseases tuberculosis and lepra and, in 
the case of tuberculosis, are responsible for the death of more than 1.6 million humans 
annually (http://www.who.int/tb/en/). Phagocytes are internalising mycobacteria by selective, 
receptor mediated uptake. Depending on bacterial species and pathogenicity, different 
receptor types can be involved in this process. In the case of M. tuberculosis it is well 
accepted that the mannose receptor (MR), the complement receptor 3 (CR3), scavenger 
receptors and, after opsonisation, Fc receptors contribute to its internalisation (Ernst 1998). 
After uptake, mycobacteria are localised in vacuoles that display characteristics of 
phagosomes of early endosomal origin, like the presence of their markers Rab5 and early 
endosomal antigen 1 (EEA1), but pathogenic species are able to interfere with subsequent 
steps of phagosome maturation. They modulate several host cell mechanisms, like 
phagosomal acidification, to prevent their killing and moreover, are able to replicate within 
these cells to spread infection in the host (Russell et al. 2001, Vergne et al. 2004, Kusner et 
al. 2005). In addition to alterations in phagosome maturation, it was found that pathogenic 
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mycobacteria also prevent actin nucleation on their phagosome membranes, whereas 
phagosomes containing non pathogenic species polymerise actin de novo (Anes et al. 2003). 
It was therefore of interest to examine, whether binding of phagosomes to actin filaments in 
vitro is also influenced by mycobacteria and is of importance during phagosome maturation. 
 After their isolation, phagosomes containing the non pathogenic strain 
Mycobacterium smegmatis as well as the pathogenic species M. avium and M. bovis BCG 
were compared in the actin binding assay. As controls latex bead phagosomes were also 
analysed in the same assays. All phagosomes containing mycobacteria failed to bind to actin 
networks in vitro in the absence (data not shown) as well as in the presence of cytosol (Fig. 
9A), whereas LBPs bound to F actin as decribed in chapter 3.1.1. To exclude the influence of 
endogenous or exogenous factors on this result, several possibilities were tested in the in 
vitro assay. All phagosomal samples where titrated and analysed in assays to avoid that 
concentration dependent effects influence the association with actin filaments. However, 
independent on the used concentrations mycobacterial phagosomes exhibited no 
comparable binding to actin networks. In opposite to LBPs, which contain undegradable 
content, mycobacterial phagosomes mature differently compared to LBP. Previous studies 
showed that phagosomes containing M. smegmatis are dynamic compartments and do not 
degrade their content linearly. Moreover, initial killing phases are followed by bacterial 
multiplication and additional killing phases afterwards (Anes et al. 2006; Jordao et al. 2007). 
 In order to avoid the possibility that different maturation stages of mycobacterial 
phagosomes are responsible for the lack of actin interaction, isolations of different ages were 
also tested in actin binding assays. The following phagosomes were checked for binding to 
F actin in vitro: M. smegmatis 1 hr./1 hr., 1 hr./2 hrs., 1 hr./7 hrs., 1 hr./11 hrs. and 1 hr./23 
hrs.; M. avium 1 hr./1 hr. and 1 hr./11 hrs. and M. bovis BCG 1 hr./3 hrs. and 1 hr./23 hrs. 
None of these isolations contained phagosomes that were able to bind to actin networks in 
the presence of 1 mg/ml J774 cytosol (Fig. 9A). I also analysed whether the physiological 
state of the phagosome content possessed an influence and studied phagosomes containing 
not only live mycobacteria but also heat killed M. smegmatis (1 hr./11 hrs. and 1 hr./23 hrs.) 
and M. bovis BCG (1 hr./3 hrs. and 1 hr./23 hrs.), but no different results could be obtained 
(Fig. 9B). Additionally to mycobacterial species, I also checked phagosomes containing 
another Gram positive, rod shaped bacterium of relatively the same size (non pathogenic E. 
coli GFP strain TG1 used in Kunert et al. 2003) in binding to actin networks in vitro to exclude 
that mycobacteria family specific factors, signalling pathways or signatures are involved in 
preventing binding. As shown in Fig. 9A, E. coli phagosomes did also not bind to F actin in 
vitro significantly.  
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Figure 9. (A) Binding behaviour of phagosomes to actin networks in vitro isolated from J774 
macrophages containing latex beads and bacteria in the presence of 1 mg/ml J774 cytosol. Shown are 
results of 1 hr./1 hr. phagosomes (FSG-coated latex beads, Mycobacterium smegmatis, M. avium and 
E. coli) and 1 hr./3 hrs. phagosomes (M. bovis BCG). (B) Phagosomal binding to F-actin in vitro of 
LBP and phagosomes containing live or heat-killed M. smegmatis isolated after 1 hr. pulse and 23 hrs. 
maturation. No binding above background conditions occured in bacteria-containing phagosomes at all 
tested conditions (different bacteria species, maturation ages, live or dead individuals etc.). 
 Phagosomes containing latex beads with membranes tightly located around the 
bead differ ultrastructurally and physiologically from phagosomes containing mycobacteria 
species with membranes losely around the bacterium because of sugar residues in bacterial 
cell walls. Isolated phagosomes were checked for membrane integrity by staining them for 
LAMP 1, a lysosomal membrane protein, which also appears on mature phagosome 
membranes as well as labeling of bacterial DNA using propidiumiodide and ethiumbromide 
(see material and methods for more details). In both tests more than 70 % of isolated 
mycobacterial phagosomes possessed closed membranes, showing that the investigated 
phagosomes were mostly intact. Moreover, also pure M. smegmatis individuals were not able 
to bind to actin networks in vitro. The mycobacterial cell wall, comprised predominantly of 
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lipids and carbohydrates, is the first to contact host cellular constituents, and therefore play a 
major role in facilitating host cell entry and response. To check whether mycobacterial cell 
wall components interfere with the phagosome membrane and therefore modulate or prevent 
binding to actin filaments, the phagosomal membrane was pre treated and then studied in 
the binding assay. Phagosomes containing M. smegmatis were salt stripped with 1.3 M 
NaCl, permeabilised with Triton X 100 or dialysed against buffer containing no sucrose to 
analyse whether factors around the membrane, like proteins and lipids or sugars from the 
isolation buffer, prevent phagosomal binding to actin filaments. However, also after these 
treatments no difference in binding behaviour of phagosomes could be observed. 
 Besides the phagosomes, another factor important in the assay is the addition of 
cytosol to mediate binding between F actin and phagosomes. So far only cytosol 
preparations isolated from non stimulated macrophages were analysed, but macrophages 
are often getting activated, if they meet microorganisms, especially pathogens, to induce 
increased signalling and defense strategies. Therefore, also cytosols isolated from J774 
macrophages activated by incubation with live M. smegmatis for 2 hrs. or LPS from E. coli (6 
hrs. at 1 μg/ml) were added to mycobacterial phagosomes in the assay, but did not have an 
influence on binding. Finally, it was investigated whether the addition of isolated actin binding 
protein or Myosin V fractions from J774 cytosols do mediate binding of phagosomes 
containing M. smegmatis, but did not alter the results shown before.  
 So far, it is not clear whether the lack of binding of mycobacterial compared to latex 
bead phagosomes to actin filaments in vitro is a physiological phenomenon or is due to 
technical problems linked to the assay conditions. However, I decided to apply another 
approach to study the binding of bacteria containing phagosomes to F actin by combining the 
latex model system with some characteristics of pathogenic bacteria. The latex bead surface 
was coated with ligands present on the surface of microorganisms or with host components 
involved in opsonin mediated uptake. Feeding of these particles partly mimicked bactera 
entry, triggered receptor specific uptake and caused ligand specific phagocytosis functions. 
3.1.3 Binding of isolated phagosomes containing latex beads 
 coupled to different ligands 
Ligand receptor interactions are an essential part of phagocytosis not only during 
internalisation but also for the intracellular fate of phagosomes. The uptake of pathogens but 
also of other particles like cell debris in macrophages is associated with many early 
intracellular signalling events and the contribution and number of involved receptors are 
tremendous. Dependent on the characteristics of the ligand on the surface, target specific 
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receptors are triggered and mediate receptor dependent phagocytosis. Pathogenic 
mycobacteria, like M. tuberculosis, are believed to be recognised and internalised in non
opsonic pathways predominantly by mannose receptors, whereas opsonised particles, like 
erythrocytes, are taken up by immunoglobulin dependent Fc receptors. 
 The surface of latex beads can be coupled to a variety of ligands to get internalised 
by phagocytes in receptor specific pathways. So far the results in this study were obtained by 
the use of latex beads coupled to fish skin gelatin, a protein coating which causes non
specific uptake via a mixture of different receptors. Carboxylated microspheres offer the 
possibility to interact with different proteins and carbohydrates, which form covalent bounds 
with the surface of the bead. To enter cells in different receptor dependent pathways, latex 
beads were coupled to murine immunoglobulin G (whole molecule or only partly in form of 
the Fc fragment), complement isolated from mouse serum, lipopolysaccharides (LPS) 
obtained from Klebsiella pneumoniae and mannan from Saccharomyces cerevisiae. These 
coupling agents triggered specific uptake via receptor classes which are mainly involved in 
the recognition of these ligands: IgG via Fc and complement via complement receptors, both 
opsonic receptor classes, whereas the recognition of LPS via CD14 and toll like receptors 
and of mannan predominantly via the mannose receptor belong to non opsonic receptor 
classes.  
 As it was already mentioned in the introduction in more detail, particle recognition 
and uptake are not results of single receptor molecules, but are based on the cooperation of 
specific receptor classes, which interact and identify pattern on the particle surface. In 
comparison to these receptor specific internalisation processes beads coupled to gelatin and 
avidin were used for comparison. Both are ligands which are believed to be taken up in non
specific receptor pathways by the help of different receptor classes, e.g. by the involvement 
of scavenger receptors.  
 The J774 macrophage cell line, originally isolated in 1968 and deposited by P. 
Ralph (Ralph et al. 1976), possesses different receptor expression patterns dependent on 
the used clone. In this study, we were using the A.1 clone, which displays expression of 
FcRI (Sears et al. 1990), of CR3 (Ralph et al. 1977), of MR (Fiani et al. 1998) as well as of 
CD14 (Hara Kuge et al. 1990), TLR2/4 (Yang et al. 2001, Jouault et al. 2003) and others, like 
scavenger receptors (Nishikawa et al. 1990). These findings make this cell line suitable for a 
detailed analysis of phagocytic processes using ligands named above. 
 The coupling of latex bead surfaces was carried out following protocols described in 
chapter 2.2 and J774 macrophages were fed with the same amount of the different coated 
beads. All phagosome types were isolated after one hour pulse and one hour chase by the 
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same method using flotation over a sucrose gradient. The optical density of all isolated 
phagosomes was determined to maintain that the same number of phagosomes was used in 
experiments. Afterwards, LBP were analysed for their ability to bind to actin networks in vitro. 
First, titration experiments were carried out to exclude that phagosomes display differences 
in binding due to over saturating concentrations. Reproducible results, which are comparable 
to former studies could be achieved when phagosomes were used at 0.006 % solids in 
solution. All phagosome types were used at this concentration and analysed for their binding 
behaviour in the absence and presence of cytosolic components.  
 Surprisingly, the tested phagosome types exhibited different capabilities to bind to F
actin in vitro in the binding assay in the presence of cytosol (Fig. 10). Phagosomes 
containing beads coupled to mannan showed higher binding compared to control levels 
(binding capability of FSG  and avidin LBP), whereas phagosomes containing IgG , 
complement  and LPS beads possessed a decreased ability to bind to actin filaments. 
 
Figure 10. Binding behaviour of phagosomes containing latex beads coupled to different ligands in the 
in vitro binding assay in the absence and presence of 0.5 mg/ml J774 cytosol. Particles coated with 
FSG and avidin were internalised non-specifically via mixed receptors and their formed phagosomes 
were used as controls, whereas particles coupled to IgG, complement, LPS and mannan entered cells 
in receptor-dependent pathways predominantly via their specific receptor families. All phagosomes 
were isolated after 1 hr. pulse followed by 1 hr. chase and the same concentration was used in all 
assays for all samples as determined by their optical density. Shown are averages of at least two 
independent experiments. Significance of results was tested using Student’s t-test (** P<0.01). 
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 An increased binding capability to F actin could suggest that in cells organelles 
display an increase in attachment and anchoring to cortical, actin rich regions. Receptor
dependent uptake of particles triggers different signalling pathways that influence the later 
stage of phagosome maturation. Since the analysed LBP were isolated after two hours, they 
already undergo maturation events. Binding to actin filaments seems to be not only important 
at early times of the phagocytic process. It also contributes differently dependent on the type 
of internalised particles and the involved receptors. This was one of the first hints in this 
study, pointing out that receptor specific interactions at the cell surface can influence 
phagosome functions not only during internalisation but also at later events of phagocytosis.  
 Phagosomal maturation and actin dependent processes are influenced significantly 
by various signalling molecules, such as certain lipids. Detailed analysis of actin nucleation 
on phagosomal membranes containing latex beads and non pathogenic as well as 
pathogenic mycobacteria species revealed several lipids having an impact on phagosome 
maturation (Anes et al. 2003). Therefore, it was of special interest whether these signalling 
mediators also alter the binding capability of LBP coupling to ligands to F actin in vitro. Since 
the mannose receptor is significantly involved in the uptake of mycobacteria species and 
mannan coated LBP exhibited more efficient binding to F actin, I compared these 
phagosomes together with FSG coupled LBP in this analysis. Different glycerophospholipids, 
sphingosines and phosphoinositides were tested in binding assays mainly at concentrations 
shown to have an influence on actin nucleation (see table 1 in chapter 2.5) and results were 
compared to mock controls.  
 Several lipids had both, inhibitory and stimulatory, effect on phagosomal binding 
dependent on the presence or absence of cytosolic factors, but also in dependence on the 
type of phagosome (table 3). For example, the key regulator of various membrane
associated signalling events, arachidonic acid (AA), had less stimulatory impact on mannan
LBP than on FSG LBP in the presence of cytosol, whereas the addition of its synthesised 
cellular products, prostaglandins and leukotrienes, did not alter the binding of phagosomes to 
F actin. Interestingly, some lipids exhibited specific effects only on one type of phagosome, 
e.g. diacylglycerol only inhibited binding of FSG LBP. Furthermore, it is notable that, in the 
absence of cytosol, many tested lipids exhibited the opposite effect on phagosomal binding 
to actin compared to the actin nucleation activity, which was analysed without additional 
cytosolic components. For example, AA, PIP2, SM and S1P stimulated actin nucleation but 
inhibited binding to F actin in vitro, in general more strongly in FSG LBP samples. 
Results 57 
 
Table 3. Results of actin-binding assay studies using LBP containing gelatin- (FSG) and mannan-
coupled beads in the presence of signalling lipids (see chapter 2.5 for applied lipid concentrations). 
Shown are relative effects compared to solvent controls (mock) in the presence or absence of 0.5 
mg/ml J774 cytosol averaged of at least two independent experiments. Stimulatory (green) and 
inhibitory (red) influences on the binding capability of LBP to F-actin in vitro are highly significant 
(P>0.01) as determined by Student’s t-test. 
 w/o Cytosol with Cytosol 
 FSG-LBP Man-LBP FSG-LBP Man-LBP 
  Arachidonic Acid (AA) -80 % -90 % +250 % +90 % 
  Eicosapentaenoic acid (EPA) -100 % -80 % +110 % +200 % 
  Diacylglycerol (DAG) -40 %    0    -50 %    0    
  PtdIns 4,5-bisphosphate (PIP2) -70 % -90 %    0    -60 % 
  Sphingomyelin (SM) -60 %    0    +60 % +60 % 
  Sphingosine (Sph) +80 % +130 %    0       0    
  Sph-1-phosphate (S1P) -60 %    0       0       0    
  Ceramide (Cer)    0       0       0       0    
  C16Ceramide (C16Cer)    0       0       0       0    
  Prostaglandin A1 and F2    0       0       0       0    
  Leukotriene B4    0       0       0       0    
 After the detailed analysis of phagosomal interaction to actin in vitro, which suggested 
that phagosomes are equipped with an early ‘signature’ influencing their intracellular fate, I 
decided to better characterise the impact of such an early event as receptor ligand, 
interaction, on both the cell level and the phagosome itself. First, I applied light microscopy
based methods to investigate the rate of phagocytic uptake and fusion of LBP coupled to 
different ligands (chapter 3.2). Second, I wanted to find out how the ligand recognition at the 
cell surface influenced macrophage signalling and immune responses by determining gene 
expression changes early after the exposure of coated latex beads using a microarray 
approach (chapter 3.3). And third, what conclusions can be drawn from the dissection of the 
proteome of maturing phagosomes containing different ligand coated beads (chapter 3.4), 
possibly helping to explain observed differences of phagosomal properties in dependence on 
their receptor specific uptake. 
3.2 Investigation of phagocytosis of latex beads coupled 
 to different ligands in mouse macrophages 
3.2.1 Phagocytic uptake and fusion with lysosomal compartments 
Involvement of different receptors at the macrophage surface during particle recognition 
implies different phagocytic efficiency in dependence on the triggered signalling events, 
which are essential for particle engulfment and subsequent phagosome maturation. J774 
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mouse macrophages were pulsed with similar concentrations of fluorescent 1 μm latex beads 
coated with avidin, FSG, IgG, LPS or mannan and fixed at different time points. 
Internalisation was studied on cross sections of images taken by confocal microscopy using 
either inside/outside labelling of beads (avidin  and IgG beads) or by staining cell cortical F
actin using FITC phalloidin to analyse full particle enclosure. Only particles that were fully 
internalised into the cell were included into quantification. Latex beads that were bound to the 
cellular surface of macrophages or particles that were only engulfed by plasma membrane 
extensions were not included into analysis of phagosomes.  
 All ligands coupled to latex beads induced a linear uptake of beads over a time 
course of 60 min. However, many significant differences were seen between the different 
receptor dependent internalisation pathways. Mannan coated beads were internalised at the 
highest rate, followed by LPS beads and the ones coupled to the Fc fragment of IgG (Fig. 
11A). The uptake of gelatin  and avidin coated latex beads displayed the lowest uptake rate, 
which could be increased to rates comparable to mannan beads by exposing cells to four 
times higher numbers of beads. 
 Next, I asked whether subsequent stages of phagocytosis, such as fusion of 
phagosomes with late endosomal and lysosomal compartments, are also influenced by 
receptor mediated uptake. These fusion events are linked to phagosomal acidification and 
the release of hydrolases, all processes known as phagosome maturation that usually lead to 
the digestion of enzymatically susceptible phagosome content. As a fluid phase endocytic 
marker, which accumulates in late endosomes and lysosomes (Anes et al. 2006), J774 
macrophages were allowed to internalise 10 nm rhodamine conjugated gold particles before 
beads were added. Macrophages that had internalised latex beads coupled to different 
ligands for different times were fixed and secondary accumulation of rhodamine conjugated 
gold in phagosomes was analysed by confocal microscopy. Surprisingly, phagosomes 
containing mannan coated latex beads acquired the marker more rapidly, because more than 
90 % of them were already positive for rhodamine gold after 5 min. (Fig. 11B, C). In contrast, 
the frequency of fusion events for phagosomes containing LPS  and IgG coupled beads 
appeared significantly slower. After 5 min., around 60 % of IgG  and 70 % of LPS bead
containing phagosomes were positive rhodamine gold. Rates of 90 % could only be 
observed after incubation times of 30 min. or longer. Fusion of phagosomes containing 
gelatin coupled beads started to occur later, after around 15 min. Labelling using an antibody 
against the lysosome associated membrane protein 2 (LAMP 2), a specific marker of late 
endosomes and lysosomes, confirmed these results (Fig. 11D, E). Again, LBP containing 
mannan beads acquired the lysosomal marker rapidly after internalisation. 
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Figure 11. (A) Internalisation rates of 1 μm latex beads coupled to avidin, the Fc fragment of IgG, LPS 
and mannan in J774 macrophages over a time course of 60 min. The same concentration of beads 
(OD=1.6) was applied to all samples and 50 cells were analysed. Shown are averages of two 
independent experiments. Uptake of gelatin-coupled beads (not shown) was comparable to avidin. (B) 
Fusion of phagosomes with lysosomal compartments over a time course of 30 min. determined by 
their colocalisation with rhodamine-gold particles. Shown are relative numbers of phagosomes that 
were positive for rhodamine-gold analysed in 50 cells per latex bead ligand and time point. (C-E) 
Confocal images of fixed J774 cells pulsed with mannan-coated latex beads (blue) for 5 min. (C, D) 
and 2 hrs. (E). Late endosomal/lysosomal compartments (red) were labelled with rhodamine-gold (C) 
or an antibody against LAMP-2 (D, E). F-actin (green) was stained with FITC-phalloidin. Arrows 
indicate phagosomes that were positive for lysosomal markers already after 5 min. Bar (in C): 5 μm
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3.2.2 Analysis of receptor expression and tyrosine 
 phosphorylation events during phagocytosis 
The observed differences of phagocytic uptake in response to the type of phagocytic particle 
raised the question of how the expression of involved receptors is modulated during 
phagocytosis. As mentioned above, the murine J774A.1 clone is equipped with a variety of 
different receptors. Protein expression levels of the receptors thought to be involved in the 
uptake IgG , mannan  and LPS beads, the Fc receptor I (FcRI), the mannose receptor 
(MR) and CD14, respectively, were analysed by western blotting using specific antibodies. 
J774 cells were incubated with beads coupled to these ligands at the same concentration of 
previous experiments over a time course of four hours and total cell lysates were prepared 
after 10, 30, 60, 120, 180 and 240 min. Same protein amounts were used for western 
blotting, demonstrated by ponceau S staining (Fig. 12A) and detection of other cellular 
proteins that should remain constant (Fig. 15). All three probed receptors displayed bead  
and time dependent differences in their expression (Fig. 12A), which were quantified by 
Image Gauge software (Fig. 12B D). Although, quantification was associated with a high 
error due to the quality of protein signals (which could not be improved by several tries) and 
measurements avoiding noisy quantification areas, tendencies in response to coupled beads 
were visible (Fig. 12B D). The mature form of the MR (172 kDa) was expressed at higher 
rates in response to mannan especially after three to four hours (Fig. 12B’), whereas 
expression of the precursor (157 kDa) also increased upon addition of IgG and LPS beads 
(Fig. 12B”). CD14 expression was increased at earlier times in mannan samples, but was  
finally expressed nearly three times more in both, LPS and mannan samples, after four hours 
compared before the addition of beads. The expression of FcRI was higher during the first 
two hours of phagocytosis of latex beads coupled to the Fc fragment of IgG and mannan. 
 Receptor engagement during phagocytosis can be associated with tyrosine 
phosphorylation events, which influence signalling and induce engulfment. Therefore, it also 
was of interest to analyse modulation of these processes during phagocytosis of beads 
coupled to different ligands. A monoclonal anti phosphotyrosine antibody was used for 
western blotting of cell lysates to detect changes in tyrosine phosphorylation in general and 
revealed differences between the bead ligands (Fig. 13). The total level of tyrosine 
phosphorylation was slightly increased, but remained relatively constant during phagocytosis 
of avidin  and IgG coupled beads over a period of four hours. However, uptake of mannan  
and LPS coupled caused a significant decrease of the total level of tyrosine phosphorylation 
over time. Additionally, selected spots of high signal intensity of around 90, 50, 30 and 17 
kDa size were analysed, which exhibited similar patterns: IgG beads (and for some extent 
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avidin ones) caused an increase in phosphorylation, whereas mannan and LPS beads 
caused an increase only at very early time points of phagocytosis but predominantly reduced 
tyrosine phosphorylation over time.     
A  
 
B’ B”  
 
C D  
Figure 12. (A) Western blotting of J774 lysates probed for mannose receptor (MR), CD14 and Fc 
receptor I (FcRI). Before lysis, J774 cells were incubated with latex beads coupled to different ligands 
for designated times. Protein staining using Ponceau S (PonS) demonstrates equal loading. 
Quantification of expression levels of MR, both the mature (B’) and the precursor form (B”) as well as 
of CD14 (C) exhibited clear differences dependent on the bead ligand, whereas expression of FcRI 
remained more constant over time and was only increased slightly soon after the addition of IgG and 
mannan beads.      
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Figure 13. Western blotting of J774 lysates probed for tyrosine phosphorylation of cellular proteins. 
Before lysis, J774 cells were incubated with latex beads coupled to different ligands for designated 
time points. Relative tyrosine phosphorylation of proteins was quantified in total (analysis of the whole 
lane) as well as of four selected spots of different molecular weights (shown in the image above). 
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3.3 Influence of phagocytosis of ligand-coupled latex 
 beads on macrophage gene expression  
So far, this study provided a number of hints that receptor ligand interactions are able to 
modulate phagosome characteristics and functions. Previous work of numerous labs 
presented evidences that ligand recognition at the cell surface triggers many signalling 
cascades, which lead to changes in the expression of several genes involved in phagocytosis 
and inflammation. In addition, the changes that I observed in the expression of receptors and 
tyrosine phosphorylation events suggest that different bead ligands could differently influence 
signalling and gene expression. To test this hypothesis, a microarray approach was applied 
using the whole mouse genome library to validate the influence of receptor ligand 
interactions on macrophage gene expression. 
 J774.A1 cells were incubated with internalisation medium containing 0.01 % latex 
beads coupled to avidin, the Fc fragment of mouse IgG, LPS and mannan for 30 and 60 
minutes to concentrate on early events during phagocytosis. Controls were incubated with 
internalisation medium in the absence of beads. All samples were carried out in duplicates. 
After incubation, total RNA of macrophages was extracted and each sample was hybridised 
to CodeLink™ mouse whole genome bioarray slides. Due to the high amount of obtained 
data, only the upregulation of genes versus control conditions was analysed in this study. 
Comprehensive data sets of this analysis can be found at the NCBI Gene Expression 
Omnibus (GEO) website as accession GSE9859 (http://www.ncbi.nlm.nih.gov/projects/ 
geo/query/acc.cgi?acc=GSE9859).   
3.3.1 Global study of changes in gene expression determined by 
 microarray analysis 
As a first step of analysis, upregulation of genes was investigated on a global scale to identify 
the contribution of specific ligands on the whole level of gene expression. In table 4 total 
numbers of upregulated genes are shown for both time points of phagocytic uptake as well 
as the numbers of genes that were common to all or unique to either one of the ligands. 
Additionally, pie charts are illustrating the relative distribution of genes (Fig. 14). Surprisingly, 
the percentage of upregulated genes that were common to cells incubated with avidin, IgG, 
LPS or mannan was not more than 10 %. Furthermore, genes that shared appearance in 
only two or three of the samples contributed with less than 15 %. The majority of identified 
genes switched on after 30 min. and 60 min. of phagocytic uptake was unique to each ligand. 
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Table 4. Summary of gene upregulation in J774 cells 30 and 60 min. after the addition of coated latex 
beads in comparison to control conditions determined by microarray analysis.  
 30 min. 60 min. 
Total number of identified genes 4904 6157 
Common to all samples 846 938 
Unique to avidin 388 1731 
Unique to IgG 502 365 
Unique to LPS 563 292 
Unique to mannan  744 497 
 
             30 min.                                                    60 min. 
         
    
         
 
         
Figure 14. Pie charts representing the relative distribution of upregulated genes in J774 macrophages 
incubated with latex beads coupled to different ligands for 30 min. (left) and 60 min. (right) compared 
to untreated controls determined by microarray analysis. Percentage values display the distribution of 
common, overlapping and unique genes in these samples. 
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3.3.2 Upregulated genes common to all latex bead ligands 
The data of the global analysis argue that only a small subset of common genes are 
activated by all the ligands analysed. These genes can be predicted to play general roles in 
the process of phagocytosis independent on the signalling induced by specific receptors. 
Some common upregulated genes encode proteins with ‘house keeping’ functions, such as 
metabolic enzymes, several protein phosphatases and ion channel subunits. However, the 
majority were molecules, which are involved in different stages of phagosome maturation and 
signal transduction and were upregulated at both tested time points. For example, genes of 
proteins could be identified that modulate phagosomal acidification like proton ATPase 
subunits and lysosomal proteases as well as signalling molecules, like CD47, various 
chemokines and interleukin 17, which participate in immune responses of macrophages. 
Additionally, several actin associated proteins could be found, supporting the importance of 
the actin cytoskeleton during phagocytosis; as well as Rab37, a GTPase believed to play a 
role in secretory vesicular trafficking. A selection of identified upregulated genes that are 
common to all samples is shown in table 5 categorised into functional groups of metabolism, 
receptors, signalling molecules, cytoskeletal proteins and trafficking regulators.  
Table 5. Functionally classified list of selected genes commonly upregulated in J774 macrophages 
when latex beads coupled to avidin, IgG, LPS and mannan were added for 30 and 60 min. Fold 
changes of gene expression are colour-coded by their values (see legend).  
 
Fold change:       not upregulated 
 
     < 2.0 
 
 
  
  2.1-3.0 
 
     3.1-4.0 
 
 
  
  4.1-5.0 
 
     > 5.0 
 
  
    Avidin     IgG      LPS      Man 
Gene name Description 30' 60'  30' 60'  30' 60'  30' 60' 
             
METABOLISM            
             
GE1536298 ATPase, aminophospholipid transporter, class I                       
GE36869 ATPase, aminophospholipid transporter-like, class I                       
GE1547926 ATPase, H+ transporting, V1 subunit B                       
GE41425 ATPase, H+ transporting, V1 subunit E-like 2                       
GE1438002 ATPase, Na+/K+ transporting, alpha 1 polypeptide                       
GE1388523 Similar to ATP synthase, H+ transporting, mitoch. F1                       
GE38157 Cathepsin M                       
GE1568879 Cathepsin Q                       
GE37739 Cathepsin R                       
GE1532833 Inositol polyphosphate-4-phosphatase, type I                       
GE1558757 Inositol polyphosphate-4-phosphatase, type II                       
GE1493428 Peroxisomal biogenesis factor 6                       
GE1464801 Similar to Phosphoinositide-3-kinase, subunit 4                       
GE1434800 Phospholipase C, epsilon 1                       
GE129835 Proteasome 26S subunit, non-ATPase, 14                       
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GE1537300 Protein kinase C, epsilon                       
GE34217 Protein kinase C, theta                       
GE1557430 Protein kinase C, zeta                       
             
RECEPTORS            
             
GE36960 Complement component 6                    
GE1436911 Complement component factor h                    
GE42474 Complement component factor i                    
GE1394498 G protein-coupled bile acid receptor 1                    
GE138620 G protein-coupled receptor 26                    
GE112563 G protein-coupled receptor 30                    
GE1499256 G protein-coupled receptor 61                    
GE1518573 G protein-coupled receptor 150                    
GE1396962 Similar to Ig heavy-chain (V-J-region) precursor                    
GE1456115 Similar to Immunoglobulin light chain variable region                    
GE1573808 Interleukin 7 receptor                    
GE1462835 Mannose receptor-like precursor                    
GE1536109 Peroxisome proliferative activated receptor, gamma                       
GE126397 Prostaglandin E receptor 1 (subtype EP1)                    
GE35960 Prostaglandin E receptor 3 (subtype EP3)                    
GE1488284 Purinergic receptor P2Y, G-protein coupled 10                    
GE137828 Scavenger receptor class A, member 3                    
             
SIGNALLING            
             
GE32954 CD8 antigen, alpha chain                    
GE1482495 CD47 antigen (integrin-associated signal transducer)                    
GE33486 CD59a antigen                    
GE1468507 CD72 antigen                    
GE118349 Chemokine (C-X-C motif) ligand 2                    
GE39024 Chemokine-like factor super family 2A                    
GE1554492 Similar to Defensin beta 123 precursor                    
GE35301 Defensin beta 2                    
GE1536704 Defensin beta 35                    
GE130058 Ephrin A3                    
GE1462654 Similar to Interferon-inducible GTPase                    
GE118971 Interleukin 17                    
GE1424617 Phosphodiesterase 4D, cAMP specific                    
GE1458683 Phosphodiesterase 8B                    
GE128101 Phosphodiesterase 10A                    
             
CYTOSKELETON            
             
GE41402 Actin related protein M2                    
GE32927 Actin, alpha 1, skeletal muscle                    
GE121211 Actin-like 7b                    
GE37971 CDC42 effector protein (Rho GTPase binding) 5                    
GE1501704 Similar to Elongation factor 2 (EF-2)                    
GE110761 Formin-like 1                    
GE36667 Integrin alpha 3                    
GE1440188 Kinesin family member 13A                    
GE1463528 Kinesin family member 14                    
GE34068 Myosin Vb                    
GE1502859 Myosin XVIIIb                    
GE119117 Myosin, light polypeptide 2, regulatory, cardiac, slow                    
GE42771 Profilin 2                    
GE124879 Profilin 3                    
GE1423786 Wiskott-Aldrich syndrome protein interacting protein                    
             
TRAFFICKING            
             
GE112275 ADP-ribosylation factor-like 4                    
GE1393824 ADP-ribosylation factor-like 6 interacting protein 1                    
GE37628 Coatomer protein complex, subunit zeta 2                    
GE37942 Rab37                    
                          
Results 67 
 
3.3.3 Upregulated genes unique to each latex bead ligand 
The global analysis of gene expression demonstrated that the majority of upregulated genes 
during phagocytosis were unique to each bead ligand suggesting a receptor dependent 
‘signature’ of gene regulation. Interestingly, the higher percentage of unique upregulated 
genes (50 %) were found in macrophages internalising avidin coupled latex beads for 60 
min. (Fig. 14). This finding argues that time dependent signalling and trafficking events take 
place at a later time point in cells that internalised “non specificic” ligand coated beads. The 
involvement of specialised receptors like FcR, CD14, TLR4 and MR during phagocytosis 
stimulated an upregulation of different genes. A selection of identified upregulated genes that 
are unique to either one of the ligands at a given time point is shown in table 6, again 
categorised into the same functional groups as shown in table 5. 
 Phagocytic uptake of latex beads coupled to avidin caused an upregulation of 
interleukins 9 and 20, several phosphodiesterases and phospholipases, but also of actin
dependent motor proteins like myosin IB and IIIA. The uptake of IgG coated latex beads 
caused stimulated gene expression of protein tyrosine phosphatases, CD63 and CD83, the 
interleukins 1 and 10, chemokines and tumor necrosis factor (TNF) as well as numerous of 
TNF related proteins, suggesting a pro inflammatory immune response. Striking is the fact 
that less cytoskeletal proteins and trafficking regulators were stimulated upon addition of IgG
beads. Only IQGAP1 was found to be upregulated uniquely to the IgG beads. Macrophages 
internalising latex beads coupled to LPS exhibited an upregulation of specific 
phosphodiesterases, interferon induced proteins and defensin beta, but of less receptors and 
cytoskeletal proteins. Mannan coupled beads stimulated the expression of other chemokines 
than the ones found in IgG samples and of pro inflammatory cytokines, such as interleukins 
12b and 1a, suggesting a different immune response. Major histocompatibility complex 
(MHC) molecules and many cytoskeleton proteins were found to be upregulated during 
uptake of mannan beads, e.g. dynamin, filamin, myosin Vc and Rab8b, demonstrating the 
important contribution of trafficking events during maturation of these phagosomes. This data 
could be related to the highest and fastest rate of maturation of these phagosomes compared 
to all other ligand coated beads tested in this study. Surprisingly, several enzymes, such as 
matrix metalloproteinases, tyrosine phosphatases and phosphodiesterases, exhibited 
isotype  or class dependent changes implicating fine tuned responses to ligand specific 
uptake. However, not only the unique appearance of gene upregulation was striking between 
the bead ligands, also fold change differences found for some genes suggest receptor
specific ‘signatures’ during phagocytosis. For example, the prostaglandin E receptor 3 was 
upregulated three times more in mannan samples than in avidin, IgG and LPS (table 5). 
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Table 6. Functionally classified list of selected genes upregulated in J774 macrophages unique to 
either one of the bead ligands at 30 min. or 60 min. of incubation. Fold changes of gene expression 
are colour-coded by their values (see legend). 
 
Fold change:       < 2.0 
 
 
  
  2.1-3.0 
 
     3.1-4.0 
 
 
  
  4.1-5.0 
 
     > 5.0 
 
  
  Avidin  IgG  LPS  Man 
Gene name Description 30' 60'  30' 60'  30' 60'  30' 60' 
             
METABOLISM            
             
GE1494005 ATPase, H+ transporting, lysosomal V0 subunit a1             
GE34881 Carboxypeptidase D             
GE37629 Cathepsin F             
GE1499721 Cathepsin O             
GE36392 Cathepsin W             
GE1403879 Diacylglycerol kinase, beta             
GE119542 G protein-coupled receptor kinase 1             
GE34507 Glycosylphosphatidylinositol phospholipase D1             
GE126950 Inositol 1,4,5-trisphosphate 3-kinase C             
GE1389505 Inositol polyphosphate-5-phosphatase D             
GE37558 Matrix metalloproteinase 16             
GE37943 Matrix metalloproteinase 19              
GE121873 Matrix metalloproteinase 28 (epilysin)             
GE128735 Peroxisomal acyl-CoA thioesterase 2A             
GE1444288 Phosphatidylinositol 4-kinase, catalytic, beta             
GE33242 Phospholipase A1 member A             
GE1522516 Phospholipase A2, group IIC             
GE121922 Phospholipase A2, group III             
GE42118 Phospholipase C, zeta 1             
GE114922 Proteasome 26S subunit, non-ATPase, 1             
GE42712 Protein tyrosine phosphatase, non-receptor type 5             
GE35969 Protein tyrosine phosphatase, non-receptor type 21              
GE33006 Protein tyrosine phosphatase, receptor type, B             
GE1472788 Protein tyrosine phosphatase, receptor type, D             
GE33007 Protein tyrosine phosphatase, receptor type, F             
             
RECEPTORS            
             
GE1415468 Cd200 receptor 2              
GE35170 Chemokine (C-C motif) receptor 6              
GE33509 Chemokine (C-C motif) receptor 7             
GE33510 Chemokine (C-C motif) receptor 8             
GE37196 Chemokine (C-C motif) receptor-like 2             
GE42896 Chemokine-like receptor 1             
GE123906 G protein-coupled receptor 23             
GE38153 G protein-coupled receptor 35             
GE1510061 G protein-coupled receptor 64             
GE1521225 G protein-coupled receptor 68             
GE1542692 G protein-coupled receptor 113             
GE1388074 G protein-coupled receptor 114             
GE1507650 G protein-coupled receptor 133             
GE1477361 G protein-coupled receptor 155              
GE113679 G protein-coupled receptor 171             
GE1392764 Inositol 1,4,5-triphosphate receptor 3             
GE35229 Interleukin 8 receptor, beta             
GE118001 Interleukin 18 receptor 1             
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GE137047 Killer cell lectin-like receptor family E member 1             
GE35658 Killer cell lectin-like receptor subfamily C, member 2             
GE35926 Peroxisome proliferator activated receptor gamma             
GE34289 Prostaglandin E receptor 4 (subtype EP4)             
GE37767 Purinergic receptor P2Y, G-protein coupled, 14              
             
SIGNALLING            
             
GE1526117 Annexin A5             
GE33483 CD1d2 antigen             
GE33027 CD34 antigen             
GE34829 CD63 antigen              
GE35188 CD83 antigen             
GE120028 CD160 antigen             
GE33950 Chemokine (C motif) ligand 1             
GE36049 Chemokine (C-C motif) ligand 2              
GE36050 Chemokine (C-C motif) ligand 3             
GE36045 Chemokine (C-C motif) ligand 12             
GE37868 Chemokine (C-X-C motif) ligand 10              
GE37421 Chemokine (C-X-C motif) ligand 11             
GE37451 Chemokine (C-X-C motif) ligand 14             
GE129362 Defensin beta 7             
GE1548281 Defensin related cryptdin 5              
GE1544467 Histocompatibility 60              
GE1571183 Interferon induced with helicase C domain 1             
GE119745 Interferon response element binding factor 1             
GE36900 Interferon, alpha-inducible protein             
GE35586 Interferon-induced protein with TPR 3             
GE35598 Interleukin 1 alpha             
GE34640 Interleukin 1 beta             
GE118015 Interleukin 9             
GE35595 Interleukin 10             
GE34632 Interleukin 12b             
GE130876 Interleukin 17D             
GE120607 Interleukin 20             
GE37054 Phosphodiesterase 1A, calmodulin-dependent              
GE34174 Phosphodiesterase 1B, Ca2+-calmodulin dependent             
GE33089 Phosphodiesterase 3B, cGMP-inhibited             
GE1574898 Phosphodiesterase 6B, cGMP, beta polypeptide             
GE1410436 Phosphodiesterase 7B              
GE34291 Prostaglandin I2 (prostacyclin) synthase             
GE35961 Prostaglandin-endoperoxide synthase 2             
GE107990 Regulator of G-protein signalling like 2             
GE36806 Tumor necrosis factor              
GE35385 Tumor necrosis factor (ligand) superfamily, 6             
GE36222 Tumor necrosis factor (ligand) superfamily, 7             
GE33829 Tumor necrosis factor (ligand) superfamily, 9             
GE1421441 Tumor necrosis factor (ligand) superfamily, 11             
GE33827 Tumor necrosis factor receptor superfamily, 18             
GE1517077 Tumor necrosis factor receptor superfamily, 1a             
GE42133 Tumor necrosis factor, alpha-induced protein 9             
GE118972 Type 1 tumor necrosis factor receptor regulator             
             
CYTOSKELETON            
             
GE38166 Actin-binding LIM protein 1             
GE126449 Dynamin 2             
GE137904 Dynamin 3             
GE34375 Fascin homolog 1, actin bundling protein              
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GE1390121 Fascin homolog 2, actin-bundling protein             
GE1419956 Filamin, beta             
GE36669 Integrin beta 7             
GE1491767 IQ motif containing GTPase activating protein 1             
GE1395625 Kinesin family member 2B             
GE34693 Kinesin family member 5A             
GE115401 Kinesin family member 7             
GE1424158 Myosin binding protein C, fast-type             
GE131310 Myosin IB             
GE136335 Myosin IIIA             
GE130925 Myosin VC             
GE1440347 Myosin, heavy polypeptide 4, skeletal muscle             
GE1498071 Myosin, heavy polypeptide 8, skeletal muscle             
             
TRAFFICKING            
             
GE41582 ADP-ribosylation factor 4-like             
GE102188 ADP-ribosylation factor related protein 1             
GE33341 ADP-ribosylation factor-like 6 interacting protein 4              
GE34812 Caveolin 3              
GE41484 Rab3C             
GE123053 Rab6             
GE38685 Rab6 interacting protein 1             
GE1568848 Rab6 interacting protein 2             
GE1405969 Rab8B             
GE40540 Rab27A             
GE39534 Rab-like 4             
                          
3.3.4 Analysis of altered gene expression on the protein level  
The microarray approach detected several changes in macrophage gene expression during 
the phagocytic uptake of latex beads coupled to different ligands. To determine whether 
these changes are also visible on the protein level and could be associated to obtained 
microarray results, J774 lysates were probed for selected proteins (Fig. 15). Interestingly, 
expression of LAMP 2, of actin and some of the analysed actin associated proteins (filamin, 
myosin Va and dynamin) exhibited ligand specific regulation during uptake of coupled latex 
beads, although these changes could not be directly linked to the microarray results. 
However, the changes in protein expression observed for tumor necrosis factor alpha (TNF) 
by western blotting confirmed findings of the microarray analysis. Both experimental 
approaches demonstrated that phagocytic uptake of IgG coupled beads increased TNF 
gene and protein expression early after internalisation (30 to 60 min.), whereas uptake of 
LPS beads increased its expression at a later time point (4 hrs.). Mannan  and avidin coated 
beads only resulted a decrease or no changes in TNF expression over the whole analysed 
period. Although the presence of TNF in the culture medium of these cell samples was not 
investigated and secretion of this cytokine could not be analysed, its higher subcellular 
abundance in response to two of the ligands demonstrates a modulated immune response.  
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Figure 15. Western blotting of J774 cell lysates after incubation with latex beads coupled to different 
ligands for designated time points using 10 % (proteins of more than 50 kDa) and 12 % 
polyacrylamide gels (proteins less than 50 kDa). Equal protein concentrations were loaded in all lanes. 
Lysates were probed for different actin-binding proteins, the lysosomal marker LAMP-2 and tumor 
necrosis factor alpha (TNF-a) using specific antibodies (see table 2).  
3.4 Proteomic analysis of phagosomes containing latex 
 beads coupled to different ligands  
The results obtained in this study so far, demonstrated that phagocytosis of coupled latex 
beads stimulated many cellular functions including particle uptake, phagosome maturation, 
their interaction with actin filaments as well as gene expression in response to the ligand. 
These findings raised the hypothesis that the protein composition of phagosomes containing 
different ligand coated beads exhibits many differences as well, possibly helping to explain 
the observed differences of phagosomal properties in dependence on their receptor specific 
uptake. Therefore, maturing phagosomes were isolated after one hour pulse and one hour 
chase and were analysed by two dimensional SDS PAGE and mass spectroscopy to dissect 
their proteomes. This time point has been most commonly used for many assays, including 
other proteomic studies (Garin et al. 2001; M. Desjardins, personal communication). 
3.4.1 Two-dimensional SDS-PAGE of phagosomal proteins  
First, isolated phagosomes containing latex beads coupled to the Fc fragment of IgG 
(representing an opsonic phagocytosis pathway) and to mannan (representing a non opsonic 
pathway) were migrated in 2D gels, which were processed for silver staining. The results 
after two dimensional migration of phagosomal proteins are shown in figure 16. 
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Figure 16. Silver-stained gels after two-dimensional gel electrophoresis of phagosomes containing 
latex beads coupled to the Fc fragment of IgG and mannan isolated from J774 macrophages after one 
hour pulse followed by one hour chase. The same amount of protein was used for gel migration 
allowing qualitative and quantitative assessment of phagosome samples. In both, proteins can be 
found that are unique, either to IgG- or mannan-LBP (arrows), as well as proteins that appear at 
different abundances in the stained gels (arrowheads). 
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 Although the same sample concentration of both phagosome types was used, 
qualitative as well as quantitative differences between them could be detected in the stained 
gels. The finding that some proteins appeared at different abundances in the two samples 
(arrowheads in Fig. 16) demonstrates how, on one hand, these phagosomes are equipped 
with the same protein, but on the other hand, are also specifically modulated in its 
appearance. Other proteins could only be found unique to one of the samples (arrows in Fig. 
16) arguing that different proteins are also influencing the intracellular fate of these 
phagosomes at a particular time point. Due to the low protein amount in the gels, it was not 
possible to pick and identify certain protein spots, but the same LBP samples were prepared 
for direct application in a mass spectroscopy approach to dissect proteomic similarities and 
differences between these phagosomes.  
3.4.2 Phagosomal protein composition determined by mass 
 spectroscopy (LC-MS/MS)  
The phagosomes made in response to beads coupled to the Fc fragment of IgG, mannan 
and, additionally, to avidin were isolated after 2 hours internalisation and phagosomal 
proteins were precipitated. Liquid chromatography and tandem mass spectroscopy (LC
MS/MS) of these samples were carried out by Dr. Nicholas Sherman in the Biomedical Mass 
Spectrometry Laboratory of the University of Virginia, USA as described in chapter 2.10. The 
analysis of identified proteins revealed several interesting findings, supporting the hypothesis 
that receptor specific uptake is influencing subsequent phagosome functions to a high extent. 
Surprisingly, less than 20 % of all identified proteins were common to all three LBP types. 
Similar to results obtained by the microarray approach, the majority of proteins was unique to 
avidin, IgG or mannan phagosomes (table 7, figure 17). Interestingly, like in the micorarray, 
avidin samples possessed most of the unique ones again (30 % of all identified proteins).  
Table 7. Summary of identified proteins from isolated 
phagosomes (1 hr./1 hr.) containing latex beads 
coupled to avidin, IgG and mannan as determined by 
mass spectroscopy. Figure 17. Pie chart shows 
distribution of common, overlapping and unique 
proteins in these samples.  
 N 
Total number of identified proteins 1194 
Common to all samples 224 
Unique to avidin 359 
Unique to IgG 193 
Unique to mannan  189 
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 A more detailed look at the identified proteins demonstrated that differences between 
the three LBP types can be found in several functional classes. In table 8 a selection of them 
is shown subdivided in receptors, antigen interaction molecules, phagosomal and lysosomal 
markers, Rab GTPases and actin associated proteins. A comprehensive list of all 1194 
proteins identified by mass spectroscopy including numbers of their unique spectra during 
identification is shown in the supplement at the end of this thesis. 
 Many known phagosomal proteins were found in all LBP types, such as several 
ATPase subunits, LAMP 1 and 2, cathepsins B and D as well as Rab5 and 7. The presence 
of various receptors in phagosome samples demonstrated that numerous of them could be 
involved in internalisation and could be detected even after two hours. Many actin associated 
proteins were also found in maturing phagosomes supporting the findings that actin and its 
associated proteins are not only important during early stages of phagocytosis, but also could 
contribute to functions during phagosome maturation. Interestingly, isoform dependent 
differences were found for some of these proteins, e.g. filamin A, coronin1, Rab5 and Rab8, 
arguing for fine tuned control and modulation of phagosome functions. 
 Although the presence or absence of proteins in LBP samples determined by mass 
spectroscopy cannot be linked directly to differences in gene expression detected by 
microarray analysis, a few results associated both techniques. For example, in the 
microarray, many genes encoding MHC molecules were upregulated upon response to 
mannan coated beads. Mass spectroscopy also detected several MHC molecules exclusively 
in phagosomes containing these beads confirming microarray findings. 
 In order to validate findings of the LC MS/MS approach, phagosomes containing latex 
beads coupled to avidin, IgG and mannan were also analysed by western blotting using 
specific antibodies to confirm the absence or presence of some proteins (Fig. 18). 
Unfortunately, I was unable to validate mass spectroscopy results by this method, e.g. 
IQGAP1 was found in all three LBP types by western blotting, but quantitative differences 
could be detected. For example, moesin was found at higher quantities on IgG phagosomes, 
whereas more cathepsin D could be detected in mannan phagosomes. 
 In summary, results of several experimental approaches in this study demonstrated 
and supported the hypothesis that uptake of ligand coated beads triggered specific events on 
the gene, on the protein as well as on the functional level that lead to different phagocytic 
functions of formed phagosomes. This raised the idea of ligand specific ‘signatures’ that 
influence several aspects during receptor mediated phagocytosis.       
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Table 8. Selection of identified proteins in isolated 1 hr./1 hr. LBP samples determined by LC-MS/MS 
sorted in functional groups. Figure 18. Selected proteins were also identified by western blotting.  
 Av IgG Man 
    
Receptors    
CD14 x x x 
Ig gamma-1, membrane-bound form  x  
IgG, Fc receptor, isoform 1  x x 
LDL receptor-related protein 1  x x 
MCSF-1 receptor  x x 
Mannose-6-phosphate receptor x  x 
Peroxisome prolif.-activated receptor  x  
Scavenger receptor, types I and II  x x 
Toll-like receptor 7 precursor  x x x 
Toll-like receptor 12 precursor  x  
Transferrin receptor protein 1 x x x 
    
Antigen interaction    
Histocompatibility, class I, H2-D1 x x x 
Histocompatibility, class II, Cd74    x 
Histocompatibility 2, H2-K1   x 
Minor histocompatibility, H13   x 
    
Phagosomal/lysosomal markers    
ATPase, H+ transporting, various x x x 
ATP synthase, vacuolar, various x x x 
Cathepsins-B, -D, -Z x x x 
Cathepsin-L  x x 
Cathepsin-S   x 
EEA1  x x 
Flotillin-1 x   
Flotillin-2   x 
LAMP-1, -2 x x x 
Lysosome membrane protein 2 x x x 
    
Rab proteins    
Rab-5A  x  
Rab-5B, -5C, -7 x x x 
Rab-8A  x  
Rab-8B x  x 
Rab-11B  x x 
    
Actin & associated proteins    
Actin, cytoplasmic x x x 
alpha-Actinin x x x 
Arp2/3 complex x x x 
CapZ (F-actin capping protein) x x x 
Cofilin-1, -2 x x x 
Coronin-1A x x x 
Coronin-1C  x  
Elongation factor  1 and 2 x x x 
Filamin-A, isoform 1 x x x 
Filamin-A, isoform 2   x 
Formin-like protein 1  x  
IQGAP1 x x  
Moesin x x x 
Myosin-IB, -IC   x 
Myosin-II, heavy polypeptide 9 x x x 
    
 
 Discussion
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4.1 The latex bead phagosome system and receptor-ligand 
interactions 
Phagocytosis, which is initiated by particle recognition at the plasma membrane, and its sub
stages of internalisation, phagosomal trafficking and maturation are highly complex 
processes. It is well established that the initial contact of any ligand coated bead (or 
pathogen) with cell surface receptors triggers an immediate signalling response. It is also 
clear that different receptors on cells, such as macrophages, induce different patterns of 
signalling. When several ligands are present on the surface of the phagocytosed particle, as 
it is the case for microbes, there is an extensive overlap and crosstalk between different 
pathways. It is then difficult to specify the detailed signalling response of one defined 
receptor (Lee & Kim 2007). Several studies on pathogens, such as Mycobacterium 
tuberculosis (Clemens & Horwitz 1995) and Toxoplasma gondii (Mordue & Sibley 1997), 
gave evidence that recognition events at the phagocyte surface modulate phagosomal fate. 
Although the influence of receptors and associated signalling pathways were analysed in 
previous studies (Stahl & Ezekowitz 1998; Blander & Medzhitov 2004), their contribution to 
later stages of phagocytosis are still poorly understood. 
 The major questions of this study were: “How do macrophages respond to the 
binding and phagocytic uptake of beads covered with different ligands?” and “How does this 
receptor ligand interaction influence the intracellular fate of phagosomes?”. The applied latex 
bead system was well suited to find answers to these questions since 1.) it allows to isolate 
phagosomes with a high degree of purity, 2.) the isolated organelle is functionally active for a 
wide spectrum of functions (Desjardins & Griffiths 2003) and 3.) a number of proteomic 
analyses have been published in different eukaryotic systems unravelling around 1000 
different proteins and several hundreds of lipids (Griffiths & Mayorga 2007). In addition, 
another major advantage was the possibility to couple latex beads to single ligands and study 
their selective receptor mediated uptake and following maturation processes in more detail. 
In this study, interactions of macrophages with beads conjugated to IgG, mannan, LPS, 
avidin and gelatin were analysed. Irrespective of the ligand, the macrophage was able to bind 
and internalise the beads in a morphologically similar manner. The investigations included 
functional assays in macrophages, such as measuring the rate of phagocytic uptake and 
phagosomal fusion with lysosomal compartments, as well as performing an in vitro assay to 
examine the capability of phagosomes to associate with actin filaments. Furthermore, these 
functional analyses were extended by investigating cellular gene expression changes upon 
internalisation of a specific ligand coated bead and the proteomic composition of the 
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subsequent isolated phagosomes. This study allowed to gain more insight in defining how 
early phagocytic events modulate different phagosomal functions.  
4.2 The binding to F-actin is important for latex bead 
phagosomes during their maturation. 
Interaction between phagosomes and cytoskeleton components play an essential role for the 
maturation of these organelles. Actin with its associated proteins is a major component in 
phagocytosis not only for the actin driven engulfment of particles but also at later stages 
during phagosomal maturation (Guerin & de Chastellier 2000; Anes et al. 2003; Kjeken et al. 
2004). Previous work using an in vitro assay, which was developed in our lab, could 
demonstrate that phagosomal binding to actin filaments is essential to modulate the 
switching of phagosomes from cortical F actin to microtubules (Al Haddad et al. 2001). This 
marks one of the first steps of phagosome maturation, because microtubules and their motor 
proteins are believed to be important for the long range centripetal movement of 
phagosomes towards the cell center during their maturation (Blocker et al. 1996; Blocker et 
al. 1997; Harrison et al. 2003). In addition, maturing phagosomes were shown to nucleate 
actin filaments (Defacque et al. 2000; Jahraus et al. 2001, Anes et al. 2003) and recruit actin
associated proteins (Stockinger et al. 2006). It was suggested that the de novo actin filament 
assembly regulates phagosome fusion with lysosomes. During the first part of my work, I 
examined in more detail the F actin binding activity of isolated latex bead phagosomes. In 
particular, I analysed how different ligands on the surface of the bead and therefore different 
phagosome contents influence the phagosome binding capability. I also analysed the role of 
some proteins and signalling molecules in this activity. LBP were isolated after 1 hr. pulse 
and 1 hr. chase, which represents a model system of maturing phagosomes. The capability 
of non stripped LBP to bind to F actin in the absence of cytosol to the same extent as salt
stripped LBP in the presence of cytosolic components clearly demonstrates that phagosomes 
carry the binding machinery at their membranes. I could also show by western blotting that 
cytosolic proteins were recruited to salt stripped phagosomes to mediate their binding to 
cytoskeleton components. From the Al Haddad et al. study it is known that the motor protein 
myosin Va as well as an unknown protein of high molecular weight stimulate the binding of 
LBP to F actin. Whereas the unknown protein is going to be characterized by an 
accompanying study in our lab, I could confirm the function of myosin Va as one responsible 
membrane protein that mediates binding of LBP to F actin in a concentration  and ATP
dependent manner.  
Discussion 78 
 
 Interestingly, binding assays in the presence of functional antibodies against 
different actin associated proteins revealed that proteins previously known to activate actin 
nucleation on LBP phagosomal membranes in macrophages (ezrin, moesin, N WASP) 
downregulate the F actin binding capability. Both activities play a role in phagosome 
maturation. It was shown that conditions activating the actin nucleation process lead to an 
increase of phagosome fusion with lysosomes and subsequent killing of mycobacteria, 
whereas negative regulation of phagosomal actin assembly facilitate growth of these 
pathogens (Anes et al. 2003). In opposite, studies on phagosomes containing other 
pathogens, such as Leishmania donovani, have shown that F actin accumulation around 
these phagosomes is able to delay or prevent their maturation (Lerm et al. 2006). 
 Similar conclusions can be drawn from results of binding assays using signalling 
molecules like certain lipids. Whereas previous studies have provided evidence that lipids 
like arachidonic acid (AA) and phosphatidylinositol (4,5) bisphosphate (PIP2) stimulate 
polymerisation of actin on phagosomal membranes (Anes et al. 2003), they exhibited 
inhibiting effects on binding of LBP to F actin in the absence of cytosol during my 
experiments. Although the addition of metabolic products of AA (prostaglandins and 
leukotrienes) and the involved enzymes (cyclooxygenase and lipoxygenase) had no direct 
influence in the assay, the lipid itself clearly exhibited a concentration dependent effect on 
phagosomal binding. In previous studies it was shown that arachidonic acid indeed alters the 
actin cytoskeleton (Anes et al. 2003; Fischer et al. 2005). Numerous findings support the fact 
that also PIP2 has a broad range of potential to alter actin not only during phagocytosis 
(Hilpelä et al. 2004; Scott et al. 2005).  
 My results on LBP suggested that the de novo actin assembly and F actin binding 
activities could influence these organelles in a ‘tug of war’ mechanism. In a state where 
nucleation is ‘switched on’, the binding capability is ‘switched off’ and vice versa. We can 
propose that LBP at early stages of their maturation process may need to be anchored to the 
actin cytoskeleton and thereby be transiently “immobilised”. This phenomenon could facilitate 
their fusion with early endosomal compartments and/or delay their displacement towards the 
lysosomal system. The de novo actin assembly at the phagosome membrane has been 
shown to promote the phagosome fusion with late endosomal compartments and lysosomes, 
but the mechanism underlying this function is still unknown (Kjeken et al. 2004). However, 
recent studies from Gareth Griffiths’ lab showed that phagosomes nucleating de novo actin at 
their membrane can be propulsed throughout the cell by the formation of an actin comet. 
Experiments need to be done in order to clarify this hypothesis, in particular, it is important to 
confirm that phagosomes that have nucleated actin at their membrane are indeed blocked in 
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binding a pre formed actin network. Another important aspect is to find conditions where the 
actin binding capability of phagosomes is inhibited in cells and examine the consequences 
on their maturation process and particular the rate of fusion with late endosomal 
compartments.  
Surprisingly, in this study it was impossible to reconstitute any significant binding of bacterial 
phagosomes to F actin in vitro. Numerous strategies to induce binding of phagosomes 
containing live and heat killed non pathogenic (Mycobacterium smegmatis) as well as 
pathogenic mycobacteria (M. avium; M. bovis BCG) to F actin in vitro failed. Any change of 
assay conditions, like addition of cytosol isolated from activated and non activated 
macrophages or even purified actin binding protein fractions, had no influence on the 
obtained results. Moreover, various treatments of the phagosomal membranes, such as 
permeabilisation or salt stripping before the addition of cytosolic binding factors, caused no 
binding of mycobacterial phagosomes to F actin.  
 The capacity of mycobacteria to interfere with host phagosome lysosome fusion 
pathways relies on the expression of several virulence factors and the influence of host cell 
and mycobacterial lipids that ensure their retention within mycobacterial phagosomes 
(Vergne et al. 2005; Nguyen & Pieters 2005). Previous studies have shown that 
mycobacteria are able to rearrange the membrane cytoskeleton network during phagocytosis 
(Peyron et al. 2000; Gatfield et al. 2005). For example, coronin 1 transiently accumulates on 
phagosomal membranes and is actively retained by mycobacteria to block phagosome
lysosome fusion (Jayachandran et al. 2007). Notably, the lipid rich cell wall of mycobacteria 
containing glycosylated lipoarabinomannans and phosphatidylinositol mannosides has also 
been recognised to have an effective influence on the innate immune defense (Briken et al. 
2004). Therefore, the observed incapability of mycobacterial phagosomes to bind to F actin 
in vitro could be a physiological phenomenon, although some of the results (E. coli or heat
killed mycobacterial phagosomes do not bind) argue against being a phenomenon 
specifically associated with the bacteria. Further evidences are necessary to finally conclude 
that mycobacterial phagosomes that can nucleate actin (Anes et al. 2003) are indeed 
incapable to bind to F actin in vitro and in vivo. One hypothesis would be that the specific 
rod like shape of phagosomes containing mycobacteria, in opposite to the round shape of 
LBP, decreases the actin binding capability in a two dimensional network, which might not be 
the case in the three dimensional actin network existing in cells. Investigations with latex 
beads coated with purified mycobacterial cell wall components and binding assays applying 
phagosomes with coccal instead of rod shaped pathogenic and non pathogenic bacteria, or 
alternatively latex beads of various shapes, could provide further insight into the physiological 
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relevance of the observed phenomenon. It can also be mentioned that preliminary 
experiments, in which isolated mycobacterial phagosomes were ‘forced’ onto actin filaments 
using an optical tweezer system, also failed to induce significant binding (Holger Kress & Eik 
Hoffmann, unpublished results). 
4.3 Receptor-mediated uptake regulates the actin-binding 
activity of late phagosomes. 
In this study, another alternative was used to investigate the binding behaviour of bacteria
like phagosomes. By coupling latex beads to single ligands, surface characteristics of 
bacteria were partly mimicked and receptor dependent uptake in macrophages was 
stimulated. Beads coated with mouse IgG or complement imitated opsonised targets and 
were internalised by Fc receptors and complement receptors, respectively (Le Cabec et al. 
2002), whereas particles coupled to mannan and LPS engaged predominantly the mannose 
receptor or toll like receptor 4 and CD14 (Shibata et al. 1997; Berntzen et al. 1998), 
respectively. Latex beads coated with fish skin gelatin or avidin were used for, what is 
generally considered as, non specific phagocytic uptake (Muller et al. 1989), and were 
compared to the ones triggering more specific receptor mediated phagocytosis. All these 
LBP were isolated after one hour pulse followed by one hour chase to analyse maturing 
phagosomes and tested in actin binding assays. Interestingly, many differences could be 
found in their binding capability, implicating that phagosomes possess specific membrane 
characteristics depending on receptor ligand interactions during their recognition and 
formation at the plasma membrane, which could also influence their subsequent trafficking 
during maturation. Phagosomes containing IgG , complement  and LPS coated beads bound 
less to F actin in vitro compared to gelatin  and avidin beads, whereas latex beads coupled 
to mannan displayed higher binding capabilities.  
 Few is known about how the first step of ligand receptor interaction influences 
phagosomal functions at later stages of phagocytosis, such as the binding of phagosomes to 
the actin cytoskeleton. It was shown that Rho GTPases play an important role in initiating a 
specific signalling pathway upon receptor binding. They are considered as main molecular 
switches that could differentiate the fate of opsonin dependent receptor mediated 
phagocytosis (Fc and complement; Caron & Hall 1998) from the opsonin independent 
phagocytosis reported for the mannose receptor (Zhang et al. 2005). One interesting 
candidate that could be involved in the observed differences in the phagosome binding 
activity is moesin. In cells, moesin mediates the direct link between the plasma membrane 
and the underneath actin cytoskeleton. This protein is present on late phagosomes (1 hr./1 
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hr.) and could play a role in anchoring directly the phagosome to actin filaments. In addition, 
it was shown that moesin interacts with CD93, which is implicated in FcR  and CR mediated 
uptake (Zhang et al. 2005). My data also support this observation, because I could detect by 
western blotting that moesin is more abundant on isolated IgG LBP compared to mannan  
and avidin LBP (Fig. 18), supporting a putative role of this cross linker in the actin binding 
activity of phagosomes. Further studies on this protein are now currently performed in the lab 
to confirm this hypothesis. 
 The receptor dependent uptake of particles, followed by phagosome formation and 
subsequent interactions of phagosomes with actin based motor enzymes are not well 
understood. Several myosins are modulated and linked to organelle membranes by Rab 
GTPases (Seabra & Coudrier 2004). Although several myosin classes are implicated in 
endosomal trafficking, only myosins of class V seem to interact with fully internalised and 
maturing phagosomes in macrophages. Myosin Va, the motor shown to be involved in 
binding phagosomes to F actin in vitro (Al Haddad et al. 2001), interacts with Rab27a (Wu et 
al. 2002). Myosin Vb has been shown to associate with Rab11a (Lapierre et al. 2001) and 
Rab8a (Roland et al. 2007), whereas myosin Vc could be involved in cellular distribution of 
distinct endocytic compartments labelled for Rab8 and the transferrin receptor (Rodriguez & 
Cheney 2002). Giving the complexity of Rab GTPase association with organelles and 
receptors (Schwartz et al. 2007), it is possible that these interactions are influencing 
dynamics of maturing phagosomes in a receptor dependent manner, which could be one 
explanation for the observed differences in the binding assay. 
 In conclusion for this part of my work, I could emphasise that an activity such as the 
capability of phagosome to bind to actin filaments, which plays a crucial role in regulating the 
maturation process of the phagosome, seems to be already regulated at the first step of 
receptor ligand interaction. Some interesting questions rise from this observation: Are 
phagosomes carrying the complete programme that decides their fate as soon as they are 
internalised? How much is the maturation process of phagosomes regulated by the 
surrounding environment in the cell, participating in the intracellular fate of maturing 
phagosomes?  
4.4 In macrophages, latex beads coupled to mannan are taken 
up at higher rates and fuse faster with lysosomes than beads 
coupled to other ligands. 
After the first hints obtained by the in vitro assay that receptor ligand interactions can 
influence particular phagosome functions, such as binding to actin filaments, it was of impact 
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to investigate phagocytosis in the context of a whole cell. For this purpose, same numbers of 
latex beads coupled to IgG, mannan, LPS, gelatin and avidin were applied to J774 
macrophages and receptor expression, phagocytic uptake rates and lysosomal fusion of 
phagosomes were analysed.  
 The expression of all three tested receptors  FcRI (CD64), CD14 and MR  was 
analysed by western blotting of total cell lysates over a time course of four hours and was 
found to be influenced in response to ligand coupled beads. The expression of FcRI was 
higher during the first two hours of phagocytosis of beads coupled to IgG and mannan, 
implicating that this receptor is predominantly responsible for the uptake of IgG beads but 
may also be affected by mannan coupled beads. CD14 expression was increased at earlier 
times in mannan samples, but was finally expressed nearly three times more in both, LPS 
and mannan samples, after four hours compared before the addition of beads. CD14, an 
abundant protein in macrophages, is a co receptor for the recognition of bacterial 
lipopolysaccharides present on the surface of bacteria, but seems to participate also in the 
interaction with mannose groups. Moreover, CD14 was also present on isolated phagosomes 
containing different ligand coupled beads determined by proteomic analysis. 
 The mannose receptor showed differences in the expression level of its precursor 
form and the mature receptor upon response to different ligands. The addition of mannan
coupled latex beads increased the expression of the mature MR as well as slightly the 
addition of LPS beads, whereas the two other bead types had no effect or a reduced MR 
expression (Fig. 12). Recognition of LPS by the MR was previously described (Zamze et al. 
2002). The addition of all coated latex beads increased the expression levels of the inactive 
MR precursor compared to the rate before phagocytosis. From these results it remains to be 
determined, how much of the mature MR is expressed at the cell surface, because 
macrophages contain a large intracellular pool of MR (Stahl et al. 1984). Additionally, the MR 
undergoes continual rapid recycling (5 to 10 minutes) to the cell surface (Stahl et al. 1980). 
The expression of the MR in J774.A1 cells, which were used in this study, only appears at 
moderate levels in comparison to the J774.E clone (Fiani et al. 1998), but seems to be very 
important for the uptake of mannan coated beads like results from microarray and mass 
spectrometry approaches implicated.  
 The analysis of phagocytic uptake rates and lysosomal fusion of phagosomes 
exhibited clear differences between the different phagosome types and again, mannose 
receptor mediated phagocytosis exhibited the strongest effect. Latex beads coupled to 
mannan were internalised at clearly higher rates (at 30 min.: 6 fold more compared to avidin, 
5 fold to IgG and 1.6 fold to LPS) and fused very rapidly with late endosomal/lysosomal 
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compartments. More than 90 % of the phagosomes containing mannan beads acquired pre
loaded gold nanoparticles from lysosomes already after five minutes uptake time. In contrast, 
less than 60 % of the phagosomes containing beads coated with IgG, and less than 70 % of 
the LPS LBP acquired the lysosomal marker at this time. Phagosomes containing latex 
beads coupled to gelatin and avidin started to fuse efficiently with these compartments not 
before 15 minutes after internalisation. Labelling for the lysosome associated membrane 
protein 2 (LAMP 2) confirmed these results, because mannan LBP recruited this late 
endosome/lysosome marker more rapidly than phagosomes containing other bead types. 
 Previous observations provided evidence that receptor engagement at the cell 
surface and different subsequent signalling pathways could trigger different uptake rates 
during receptor mediated phagocytosis (Ward & Kaplan 1990). It has been already shown 
that dependent on the type of particle or bacterium, phagocytosis occurs with different 
efficiency (O'Brien & Melville 2003). The mannose receptor, which is predominantly engaged 
for the non opsonic internalisation of several pathogens, including Candida albicans and 
mycobacteria, was shown to play an important role in the uptake process (Kaposzta et al. 
1999). Previous work using beads coated with terminal mannosyl units of the M. tuberculosis 
surface lipoglycan demonstrated that uptake via MR mediated phagocytosis occurs very 
rapidly within minutes (Kang & Schlesinger 1998). On the other hand, a contrary study using 
IgG opsonised (FcR engagement) and non opsonised zymosan particles (MR and beta
glucan R engagement) showed that opsonised particles were taken up at slightly higher rates 
than non opsonised ones (Allen et al. 2002).  
 The finding of this study that MR mediated internalisation stimulated lysosome 
fusion very rapidly is in good agreement with a previous study analysing uptake of Candida 
yeast cells (Kaposzta et al. 1999). There, the majority of phagosomes containing Candida 
albicans also started to fuse with late endosomes and lysosomes already after 5 minutes. 
Other findings in alveolar macrophages demonstrated that the MR stimulates the secretion of 
lysosomal enzymes (Ohsumi & Lee 1987), which facilitates extracellular degradation. 
Moreover, a recent study showed that innate immune recognition triggers the secretion of 
lysosomal enzymes, such as GILT, cathepsin D and S and prosaposin in a TLR mediated 
inflammatory response (Lackman et al. 2007). Although it remains to be proven, it is 
conceivable that, in addition to having a secretory function, these vesicles can also deliver 
their contents to phagosomes and contribute to the observed rapid acidification of 
phagosomes containing beads conjugated to mannan and LPS. 
 Interactions between mannan as bead ligand and mannose receptors seems to 
trigger fast uptake into macrophages and signalling pathways, which mediate fast acquisition 
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of lysosomal enzymes and therefore rapid phagosome maturation. Phagosome maturation is 
a complex process, and different results suggest that not only the ligand receptor interactions 
but also the nature of the internalised particle itself plays an important role in modulating the 
rate and perhaps the quality of the process. A previous study demonstrated that the fusion 
capacity of phagosomes containing Staphylococcus A particles internalised via the Fc 
receptor were restricted to early endosomes and did not fuse with lysosomes (Mayorga et al. 
1991). Thus, it is likely that both the receptor that mediates particle internalisation and the 
nature of the internalised particle (e.g. live versus dead pathogen) play important roles in 
phagosome maturation and phagosome lysosome fusion. 
 Additional to the quantification of phagocytic uptake rates and phagosome lysosome 
fusion events, tyrosine phosphorylation in macrophages was analysed. FcR mediated 
phagocytosis stimulated several tyrosine protein kinases and induced tyrosine 
phosphorylation of many proteins (Majeed et al. 2001). In this study, I was able to show that 
IgG coupled beads triggered tyrosine phosphorylation at a greater extent than the other 
coated beads. This is supported by the finding of the tyrosine protein kinase Yes uniquely on 
IgG LBP, which was confirmed by a recent study (Rogers & Foster 2007). Previous work has 
shown that Yes is rapidly activated on interaction with IgG coated particles, localises to both, 
forming and closed phagosomes, in close contact with F actin and could help to regulate 
phagosome lysosome fusion (Majeed et al. 2001). 
4.5 Macrophage gene expression is strongly influenced by the 
type of analysed receptor-ligand interaction compared to 
changes of genes with common function. 
To gain more insight of the impact of receptor mediated phagocytosis on cellular signalling, 
gene expression of macrophages was analysed using a microarray approach. In this study, 
up regulation of genes was analysed 30 and 60 minutes after the addition of IgG , mannan , 
LPS  and avidin coupled latex beads. The used CodeLink microarray chip contained the 
whole mouse genome and analysis of gene upregulation in macrophages during 
phagocytosis compared to control conditions (resting macrophages) revealed many 
astonishing results.  
 The pie charts of Fig. 14 show the comparison of the list of genes that were 
upregulated in response to the different bead ligands. What is particularly striking is the fact 
that only about 10 % of these genes were common to all ligands. These genes included 
metabolic enzymes, such as ATPases and phosphatases, receptors that were triggered by 
all ligands, signalling molecules, membrane trafficking regulators and some cytoskeleton 
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proteins. Surprisingly, the majority of upregulated genes that were common to samples of all 
four different coatings were not directly linked to general phagocytic functions. For example, 
in all cases the beads are internalised in a phagocytic cup that shared similar morphologic 
criteria. One could expect that known genes involved in actin dynamics during phagocytic 
cup formation, such as N WASP, Arp2/3, PI3 kinase, will be upregulated. We found only few 
common upregulated genes linked to these dynamics. This suggests that those proteins are 
not de novo synthesised upon bead internalisation, but rather that the existing cellular pool is 
enough to sustain the entry of the beads and the subsequent trafficking of phagosomes. A 
higher upregulation could only be found for the Wiskott Aldrich syndrome protein interacting 
protein (Wip), forming like 1 and profilin. Wip participates in the reorganisation of the actin
based cytoskeleton and stabilises actin filaments (Antón et al. 2007). Recently, formin like 1 
was also implicated in actin reorganisation (Gomez et al. 2007), whereas profilin was 
associated directly with phagocytic events (Pearson et al. 2003). 
 However, a larger fraction of upregulated genes were unique to each ligand receptor 
interaction. This argues that each receptor stimulates its own specific ‘signature’ of gene 
expression. Quite prominent was the upregulation of pro inflammatory and anti inflammatory 
cytokines in response to the bead ligands. Macrophages play a critical role in the initiation, 
maintenance and resolution of inflammation and are getting activated and deactivated in the 
inflammatory process. Pro inflammatory cytokines, such as gamma interferon, tumor 
necrosis factor alpha (TNF) and bacterial lipopolysaccharides stimulate macrophage 
activation, whereas anti inflammatory cytokines, like interleukin 10 and transforming growth 
factor beta, cause a deactivation (Martinez et al. 2008). 30 min. after the addition of IgG
coated latex beads, TNF and related proteins were strongly upregulated, which could be 
shown by microarray analysis as well as on the protein level by western blotting of cell 
lysates treated with these beads. Interestingly, IgG beads also caused on upregulation of the 
anti inflammatory cytokine interleukin 10 after 60 min. incubation, arguing for a deactivation 
of macrophages at later time points of IgG bead phagocytosis. In contrast, Mannan coated 
beads stimulated an upregulation of other interleukins, such as interleukin 12b and 1a, 
suggesting a different inflammatory response (Shibata et al. 1997). Several other 
chemokines and interleukins were triggered by specific receptor ligand interactions 
suggesting signalling processes closely linked to the type of coated bead. Furthermore, the 
isotype specific and time dependent regulation of phosphodiesterase classes, enzymes that 
are essential for signal transduction (Jin et al. 2005), also supports the hypothesis of a 
specific signalling ‘signature’ upon the contact between ligand and receptor.  
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 Striking was the fact that opsonin dependent phagocytosis (IgG beads) stimulated 
nearly no upregulation of cytoskeletal proteins and trafficking regulators, whereas non
opsonic uptake of mannan coated latex beads caused an upregulation of major 
histocompatibility complex (MHC) molecules, Rab proteins as well as dynamin, filamin and 
myosin Vc. Previous studies have shown that the MR represents an important pathway for 
antigen recognition, uptake and delivery to MHC class I and II molecules (Apostolopoulos & 
McKenzie 2001). The proteomic identification of several MHC molecules, CD74 and 
cathepsin S on phagosomes containing mannan beads confirmed this importance. CD74 is 
the cell surface form of the MHC class II invariant chain (Leng et al. 2003), which is 
processed by the protease cathepsin S (Maubach et al. 2007). The finding of an upregulation 
of myosin Vc upon addition of mannan coupled latex beads is supported by the proteomic 
result of the presence of myosin Vc on mannan LBP (although myosin Vc could only be 
detected when protein identification filter settings were decreased to 40 %, see chapter 2.10). 
Myosin Vc is implicated to be associated with transferrin receptor trafficking (Rodriguez & 
Cheney 2002), but may also be involved in phagosome dynamics. In contrast, myosin Vb, 
which participates in non clathrin dependent endocytosis and recycling (Roland et al. 2007), 
was found to be upregulated in response to all coated beads, but at a different extent. 
Additionally, Rab8a, Eps 15 and Arf6 interacting proteins were upregulated in cells pulsed 
with different latex beads, all three molecules, which help to facilitate association between 
phagosomes and myosin Vb (Roland et al. 2007). 
4.6 Phagosomal protein composition displays similar unique 
changes after receptor-dependent internalisation. 
A significant number of the proteins that are synthesised in response to a phagocytic signal 
can be expected to play a general role in phagosome maturation and functions. The most 
obvious class of proteins that can influence these processes are those that are inserted into 
the membrane or delivered within the lumen of the phagosome. Given that each receptor 
induced a significant fraction of its own specific set of genes, it was interesting to compare 
the protein composition of the different phagosomes. For this purpose, latex bead 
phagosomes are well equipped since they can be easily purified from cells after sucrose 
gradient purification (Griffiths 2003). At this stage, it was of great interest to analyse the 
protein content of the different bead containing phagosomes. Main questions arise: Which 
proteins are synthesised de novo upon incubation with coated beads or can be found 
localised later to the phagosome itself? Can we find the same degree of differences for the 
phagosome protein content that we have observed for gene expression profiles? 
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 The comparison of phagosomal proteomes after mass spectrometry analysis 
displayed many differences after ligand specific phagosome formation between the samples 
analysed. First of all, the percentages of common, unique and overlapping proteins are 
remarkably similar to the pattern observed for upregulated genes after microarray analysis. 
All three analysed phagosomal proteomes (avidin, IgG and mannan) revealed 1194 proteins 
in total, and only less than 20 % of them shared common appearance. Around 30 % are 
unique for avidin phagosomes and 16 % for each of the other phagosome types (IgG and 
mannan). This pattern supports the hypothesis that receptor ligand interactions during 
particle recognition at the cell surface are essential determinants of phagosomal fate 
including maturation and trafficking events. 
 Several phagosomal and lysosomal markers, such as LAMP 1 and 2, cathepsin B, 
D and Z, Rab7 and various proton ATPase subunits, could be detected in all three 
phagosome types and were already found in LBP proteomic approaches before (Garin et al. 
2001, Stuart et al. 2007). However, two cathepsins, namely L and S, were only found in IgG  
and mannan  or in mannan LBP alone, respectively. It is known that cathepsins are regulated 
differently in a cell (Brix et al. 2007) and previous results have demonstrated that hydrolases 
of the cathepsin family are not delivered simultaneously to phagosomes during their 
maturation (Munier Lehmann et al. 1996). A proteomic study of LBP in mouse macrophages 
has presented evidence that cathepsin A is the earliest one followed later by B, Z, and D, 
whereas the acquisition of cathepsin L and especially cathepsin S take place after several 
hours (Garin et al. 2001). So, the appearance of cathepsin S exclusively in 1 hr./1 hr. 
mannan LBP but not in IgG  or avidin LBP could be a hint of more rapid maturation events of 
these phagosomes as detected by their faster acquisition of lysosomal markers, such as pre
loaded rhodamine gold particles.  
 The appearance of the membrane bound Ig gamma 1 chain on IgG LBP is 
consistent with these phagosomes being formed as a consequence of FcR mediated 
phagocytosis, although also a precursor of FcR was found, implicating that other Fc 
receptors could be additionally involved. The specific presence of the Rab5A isoform on 
these phagosomes points to macrophage activation events, because previous work has 
shown that this GTPase isoform is involved in trafficking in activated macrophages, whereas 
Rab5B, 5C, 7 and 11 remained unaffected in the same study (Alvarez Dominguez & Stahl 
1998). Rab5A appears to play two roles: (1) by mediating fusion events within the 
phagosomal endosomal compartment and (2) by facilitating or initiating phagosome 
maturation culminating in phagosome lysosome fusion (Alvarez Dominguez & Stahl 1998).  
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 Recently, a sophisticated, quantitative proteomic analysis of phagosomes containing 
IgG coupled latex beads in RAW 264.7 macrophages was published following different time 
points over a maturation period of two hours (Rogers & Foster 2007). Nearly two third (60 %) 
of the 317 identified proteins from the Rogers & Foster study could be found in the list of the 
588 identified proteins of the IgG Fc coupled phagosomes of this study (see table S1 in the 
supplement). Their findings also confirmed the presence of some proteins, which seems to 
be unique to IgG phagosomes, such as Rab5A and the membrane bound Ig gamma 1 chain.  
 At the first glance, high throughput analyses, such as cellular gene expression 
profiling and mass spectrometry of phagosomes, show the complexity of phagocytic 
processes. In this study, the results obtained from these approaches were mostly used for 
meta analyses to define functional groups of genes or proteins to compare them between the 
different receptor ligand responses. However, these data can be used in several ways: (1) 
they can be scanned, and individual genes or proteins can be picked for more detailed 
studies; (2) more focused experiments, for example using defined cellular mutants, can be 
performed; (3) detailed regulator gene analyses can be carried out; and (4) the data from all 
types of experiment can be collated and more sophisticated meta analyses can be 
performed. 
4.7 Advantages of the latex bead model system for the study of 
receptor-mediated phagocytosis – future prospects. 
Latex bead phagosomes are a versatile model system, which allows the detailed analysis of 
a variety of functions during phagocytosis in vitro and in cells. Work on LBP over the last 15 
years led to the development of several in vitro assays using isolated phagosomes for 
detailed proteomics and lipidomics analyses and the characterization of various phagosome 
functions in living macrophages (Desjardins & Griffiths 2003; Griffiths & Mayorga 2007). In 
vitro assays were applied to monitor microtubule binding and motility, actin assembly and 
binding as well as fusion events with different endocytic compartments (Desjardins & Griffiths 
2003). Furthermore, the in vitro actin assembly assay has opened up a system to analyse 
pathogen induced signalling networks regulating defined and complex membrane functions 
(Anes et al. 2003; Kalamidas et al. 2006).  
 In the case of membranous organelles, an obvious requirement for in vitro assays 
and biochemical analyses is that these organelles be as pure as possible. For most 
intracellular organelles, including phagosomes containing microorganisms, it is very difficult 
to achieve this goal and a variable, and often significant, extent of contamination can hardly 
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be avoided. Therefore it seems an inescapable conclusion that many groups will continue to 
use the powerful latex bead phagosome system towards improving our understanding the 
molecular mechanisms that are responsible for all the complex functions that are undertaken 
by phagosomes. 
 However, a limiting factor in our understanding until now is that crucial receptors that 
internalise beads or pathogens are either unknown or too many to be analysed in detail. 
There is also a kind of broad consensus about the fact that phagosome maturation indeed 
exists and vectorially follows a kind of ‘clock’ as the cellular set of phagosomes lose and gain 
proteins, lipids and functions. One might expect that phagosomes containing a given microbe 
or type of particle that entered cells via the same receptors would behave the same, at least 
in a single cell. Surprisingly, different findings show that phagosomes formed via the same 
receptors can find themselves in different chemical states even within the same macrophage 
supporting the idea of the ‘individuality’ of phagosomes (Griffiths 2004).  
 By using coated latex beads, this study and the approaches it introduces provide a 
platform for understanding interactions between phagocytic particles having defined ligands 
with specific receptors on macrophages and open ways to determine how many different 
phagosomal states are possible in a single cell. Although it is important to address 
phagocytic processes and signalling events at cellular and tissue levels, it seems likely that 
detailed mechanisms will ultimately emerge from the use of in vitro systems where all 
components are under the control of the investigator. 
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Table S1. List of all identified proteins in isolated 1 hr./1 hr. phagosomes containing latex beads 
coupled to avidin (Av), the Fc fragment of IgG (IgG) and mannan (Man) determined by LC-MS/MS. 
*Legend: MW (protein molecular weight in kDa), PIDP (protein identification probability), UP (number of unique 
peptides), US (number of unique spectra), TS (number of total spectra), SCov (Sequence coverage) 
Av IgG Man Protein name Accession # MW* PIDP* UP* US* TS* SCov* 
x x x - 11 kDa protein IPI00458748 11 88,0% 1 1 2 13,7% 
x x x - 17 kDa protein IPI00275455 17 88,0% 1 1 1 6,3% 
x x x - 18 kDa protein IPI00458341 18 99,8% 2 2 2 14,6% 
x x x - 39 kDa protein IPI00133580 39 100,0% 2 2 4 6,3% 
x x x 
2210013K02Rik Blastocyst blastocyst cDNA, 
RIKEN full-length enriched library, 
clone:I1C0023I18 product:Spinster-like protein 
IPI00111254 57 88,0% 1 1 1 2,7% 
x x x 
2400001E08Rik UPF0404 protein C11orf59 
homolog IPI00315187 18 100,0% 2 3 5 16,1% 
x x x 
Abcb6 Mitochondrial ATP-binding cassette sub-
family B member 6 IPI00120094 94 99,8% 2 2 2 3,8% 
x x x Acta1 Actin, alpha skeletal muscle IPI00110827 42 100,0% 8 11 18 26,8% 
x x x Actb Actin, cytoplasmic 1 IPI00110850 42 100,0% 7 8 13 30,9% 
x x x Actn4 Alpha-actinin-4 IPI00118899 105 88,0% 1 1 1 1,2% 
x x x Actr2 Actin-like protein 2 IPI00177038 45 88,0% 1 1 1 3,1% 
x x x Actr3 Actin-like protein 3 IPI00115627 47 88,0% 1 1 1 2,4% 
x x x Ahnak AHNAK nucleoprotein isoform 1 IPI00553798 604 98,9% 1 1 1 0,3% 
x x x Alb1 Serum albumin precursor IPI00131695 69 88,0% 1 2 3 2,1% 
x x x Aldoa Fructose-bisphosphate aldolase A IPI00221402 39 100,0% 6 6 7 22,3% 
x x x Anxa2 Annexin A2 IPI00468203 39 100,0% 13 16 36 47,2% 
x x x Anxa4 29 kDa protein IPI00830586 29 88,0% 1 1 2 3,9% 
x x x Anxa4 Annexin A4 IPI00353727 36 100,0% 8 11 24 33,2% 
x x x Anxa5 Annexin A5 IPI00317309 36 100,0% 6 7 12 19,1% 
x x x 
Anxa6 13 days embryo forelimb cDNA, RIKEN 
full-length enriched library, clone:5930413M14 
product:annexin A6, full insert sequence 
IPI00310240 75 99,9% 2 2 2 4,8% 
x x x Arbp 60S acidic ribosomal protein P0 IPI00314950 34 99,8% 2 2 3 7,9% 
x x x Arhgdia Rho GDP-dissociation inhibitor 1 IPI00322312 23 100,0% 3 4 5 22,1% 
x x x Arl8b ADP-ribosylation factor-like protein 8B IPI00133218 22 98,3% 1 1 1 4,8% 
x x x 
Arpc4;Ttll3 Actin-related protein 2/3 complex 
subunit 4 IPI00138691 20 88,0% 1 1 2 6,6% 
x x x Arsb Isoform 2 of Arylsulfatase B precursor IPI00406459 48 88,0% 1 1 1 4,6% 
x x x Asah1 Acid ceramidase precursor IPI00125266 45 99,8% 2 3 3 7,4% 
x x x 
Atp1a1 Sodium/potassium-transporting ATPase 
alpha-1 chain precursor IPI00311682 113 100,0% 4 4 5 4,5% 
x x x 
Atp1a3 Sodium/potassium-transporting ATPase 
alpha-3 chain IPI00122048 112 88,0% 1 1 1 1,1% 
x x x 
Atp5a1 ATP synthase subunit alpha, 
mitochondrial precursor IPI00130280 60 100,0% 6 6 7 13,6% 
x x x 
Atp6v0c Vacuolar ATP synthase 16 kDa 
proteolipid subunit IPI00138378 16 88,0% 1 1 1 11,6% 
x x x Atp6v0d1 Vacuolar ATP synthase subunit d IPI00313841 40 100,0% 4 5 8 12,5% 
x x x 
Atp6v1a Vacuolar ATP synthase catalytic 
subunit A, ubiquitous isoform IPI00119112 68 100,0% 14 14 16 29,0% 
x x x 
Atp6v1b2 Bone marrow macrophage cDNA, 
RIKEN full-length enriched library, 
clone:I830083B18 product:ATPase, H+ 
transporting, V1 subunit B, isoform 2 
IPI00119113 58 100,0% 15 16 27 31,1% 
x x x Atp6v1c1 Vacuolar ATP synthase subunit C IPI00130186 44 100,0% 4 4 5 14,1% 
x x x Atp6v1e1 Vacuolar ATP synthase subunit E IPI00119115 27 100,0% 7 8 10 21,9% 
x x x Atp6v1h Vacuolar ATP synthase subunit H IPI00311461 56 100,0% 6 7 8 20,1% 
x x x Calr Calreticulin precursor IPI00123639 48 100,0% 3 3 4 8,2% 
x x x Cap1 Adenylyl cyclase-associated protein 1 IPI00137331 52 100,0% 7 9 12 17,9% 
x x x Capg Macrophage capping protein IPI00136906 39 99,8% 2 3 3 8,0% 
x x x 
Capzb Isoform 2 of F-actin capping protein 
subunit beta IPI00269481 31 99,8% 2 2 3 8,8% 
x x x Cct3 T-complex protein 1 subunit gamma IPI00116283 61 100,0% 4 4 5 10,6% 
x x x Cct5 T-complex protein 1 subunit epsilon IPI00116279 60 100,0% 3 3 3 8,0% 
x x x Cct6a T-complex protein 1 subunit zeta IPI00116281 58 100,0% 3 3 4 6,6% 
Supplement  
 
x x x 
Cd14 Monocyte differentiation antigen CD14 
precursor IPI00308990 39 88,0% 1 1 1 5,2% 
x x x Cd180 CD180 antigen precursor IPI00343568 74 100,0% 3 3 3 8,0% 
x x x Cd68 Macrosialin IPI00117031 36 88,0% 1 1 3 2,7% 
x x x Cfl2 Cofilin-2 IPI00266188 19 88,0% 1 1 5 6,6% 
x x x Cltc Clathrin heavy chain IPI00169916 192 100,0% 10 11 17 9,5% 
x x x Coro1a Coronin-1A IPI00323600 51 100,0% 3 3 5 6,3% 
x x x Cst7 CMAP IPI00134046 19 88,0% 1 1 2 6,6% 
x x x Ctsa Lysosomal protective protein precursor IPI00137177 54 100,0% 6 8 12 10,1% 
x x x Ctsb Cathepsin B precursor IPI00113517 37 99,9% 2 2 3 8,9% 
x x x Ctsc Dipeptidyl-peptidase 1 precursor IPI00130015 52 100,0% 3 3 3 10,6% 
x x x Ctsd Cathepsin D precursor IPI00111013 45 100,0% 4 7 10 17,1% 
x x x Ctsz Cathepsin Z IPI00125220 34 100,0% 7 7 14 28,3% 
x x x Cybb Cytochrome b-245 heavy chain IPI00117117 65 100,0% 3 3 5 5,6% 
x x x 
D8Ertd354e Heparan-alpha-glucosaminide N-
acetyltransferase IPI00317488 73 88,0% 1 1 1 1,7% 
x x x Eef1a1 Elongation factor 1-alpha 1 IPI00307837 51 99,8% 2 2 2 11,1% 
x x x Eef1a2 Elongation factor 1-alpha 2 IPI00119667 50 99,9% 2 3 4 5,0% 
x x x Eef2 Elongation factor 2 IPI00466069 95 100,0% 8 9 19 11,4% 
x x x 
EG214738;LOC675985 similar to 40S 
ribosomal protein S6 IPI00108454 29 99,8% 2 2 4 9,6% 
x x x 
EG432919;LOC630967 similar to 
Glyceraldehyde-3-phosphate dehydrogenase IPI00135284 36 100,0% 3 4 7 10,8% 
x x x EG619883 similar to ribosomal protein L30 IPI00118775 13 88,0% 1 2 3 13,9% 
x x x 
EG620772 similar to Cofilin-1 (Cofilin, non-
muscle isoform) isoform 1 IPI00409405 18 88,0% 1 1 3 8,4% 
x x x 
EG622339 similar to Glyceraldehyde-3-
phosphate dehydrogenase IPI00123176 37 100,0% 4 5 10 19,8% 
x x x Eif4a1 Eukaryotic initiation factor 4A-I IPI00118676 46 100,0% 5 5 6 16,3% 
x x x Eif5a Eukaryotic translation initiation factor 5A-1 IPI00108125 17 88,0% 1 2 3 7,8% 
x x x Eno1;LOC433182 Alpha-enolase IPI00462072 47 100,0% 4 4 5 10,1% 
x x x Eno2 Eno2 protein IPI00122684 35 88,0% 1 2 2 5,7% 
x x x 
Erp29 Endoplasmic reticulum protein ERp29 
precursor IPI00118832 29 88,0% 1 1 1 3,4% 
x x x 
Fbxw14 In vitro fertilized eggs cDNA, RIKEN 
full-length enriched library, clone:7420414F09 
product:F-box only protein 12 
IPI00224904 54 88,0% 1 1 1 3,4% 
x x x 
Fcer1g High affinity immunoglobulin epsilon 
receptor gamma-subunit precursor IPI00119293 10 100,0% 3 4 5 25,6% 
x x x Fcgr2b 34 kDa protein IPI00117140 34 98,2% 1 1 1 5,3% 
x x x Flna Isoform 1 of Filamin-A IPI00131138 281 99,5% 1 1 1 0,5% 
x x x Ftl2 Ferritin light chain 2 IPI00228379 21 99,8% 2 2 3 17,5% 
x x x 
Fv4 Retrovirus-related Env polyprotein from Fv-
4 locus IPI00114007 74 99,8% 2 3 6 3,1% 
x x x Gaa Lysosomal alpha-glucosidase precursor IPI00111960 106 88,0% 1 1 1 2,8% 
x x x 
Ganab Isoform 2 of Neutral alpha-glucosidase 
AB precursor IPI00115679 109 88,0% 1 1 1 1,6% 
x x x 
Gapdhs glyceraldehyde-3-phosphate 
dehydrogenase, spermatogenic IPI00108939 47 88,0% 1 2 4 3,2% 
x x x Gba Glucosylceramidase precursor IPI00108811 58 100,0% 5 5 6 15,5% 
x x x Glb1 Beta-galactosidase precursor IPI00135915 73 88,0% 1 2 2 2,3% 
x x x 
Gnai2 Guanine nucleotide-binding protein G(i), 
alpha-2 subunit IPI00228617 40 100,0% 3 4 9 10,4% 
x x x Gnai3 Guanine nucleotide-binding protein G IPI00338854 41 88,0% 1 1 1 2,8% 
x x x 
Gnao1 Guanine nucleotide-binding protein G(o) 
subunit alpha 2 IPI00115546 40 98,8% 1 1 2 3,1% 
x x x 
Gnb1 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta 1 IPI00120716 37 100,0% 5 5 6 19,4% 
x x x 
Gnb2 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta 2 IPI00162780 37 100,0% 4 4 4 14,7% 
x x x 
Gnb2l1 Guanine nucleotide-binding protein 
subunit beta 2-like 1 IPI00317740 35 100,0% 6 6 7 22,1% 
x x x 
Gnb3 Guanine nucleotide-binding protein 
G(I)/G(S)/G(T) subunit beta 3 IPI00116938 37 99,8% 1 1 1 2,1% 
x x x Gns N-acetylglucosamine-6-sulfatase precursor IPI00221426 61 100,0% 5 5 9 10,3% 
x x x Gpr84 Probable G-protein coupled receptor 84 IPI00118169 44 88,0% 1 1 1 6,3% 
Supplement  
 
x x x H2afj;LOC632401 H2afj protein IPI00153400 14 100,0% 2 3 6 21,7% 
x x x 
H2-D1 H-2 class I histocompatibility antigen, D-
D alpha chain precursor IPI00110805 41 100,0% 3 3 3 12,1% 
x x x 
Hexa Beta-hexosaminidase alpha chain 
precursor IPI00125522 61 100,0% 5 6 8 12,5% 
x x x 
Hexb Beta-hexosaminidase beta chain 
precursor IPI00115530 61 100,0% 10 11 12 19,6% 
x x x 
Hist1h2bj;Hist1h2bf;Hist1h2bn;Hist1h2bl 
Histone H2B type 1-F/J/L IPI00114642 14 99,8% 2 4 8 19,8% 
x x x 
Hist1h4i;Hist1h4b;Hist4h4;Hist1h4h;Hist1h4d;Hi
st1h4k;Hist1h4m;Hist1h4c;Hist2h4;Hist1h4j;Hist
1h4a;Hist1h4f;4930558J22Rik 10 days embryo 
whole body cDNA, RIKEN full-length enriched 
library, clone:2610027B07 product:histone 4 
protein, full insert 
IPI00329998 11 88,0% 1 1 2 9,7% 
x x x Hsp90ab1 Heat shock protein 84b IPI00229080 83 100,0% 17 20 38 30,9% 
x x x Hsp90b1 Endoplasmin precursor IPI00129526 92 100,0% 6 6 9 10,8% 
x x x Hspa1l Heat shock 70 kDa protein 1L IPI00133208 71 100,0% 3 4 11 6,2% 
x x x 
Hspa5 78 kDa glucose-regulated protein 
precursor IPI00319992 72 100,0% 16 18 29 32,8% 
x x x Hspa8 Heat shock cognate 71 kDa protein IPI00323357 71 100,0% 15 21 28 28,0% 
x x x 
Hspd1 60 kDa heat shock protein, mitochondrial 
precursor IPI00308885 61 100,0% 9 10 14 25,7% 
x x x 
Hyou1 Activated spleen cDNA, RIKEN full-
length enriched library, clone:F830010A06 
product:hypoxia up-regulated 1 
IPI00123342 111 88,0% 1 1 1 1,6% 
x x x Ifitm2 Ifitm2 protein IPI00114948 16 88,0% 1 1 2 5,6% 
x x x 
Ifitm3 10 day old male pancreas cDNA, RIKEN 
full-length enriched library, clone:1810061A10 
product:INTERFERON-INDUCIBLE PROTEIN 
homolog 
IPI00133243 15 100,0% 3 7 14 27,0% 
x x x Krt1 Keratin, type II cytoskeletal 1 IPI00625729 66 99,8% 2 2 3 1,9% 
x x x Krt2 keratin complex 2, basic, gene 17 IPI00622240 71 88,0% 1 1 1 2,0% 
x x x Krt28 similar to Keratin, type I cytoskeletal 10 IPI00750213 107 100,0% 3 3 5 3,4% 
x x x Krt73 Keratin 73 IPI00347110 59 88,0% 1 1 1 2,2% 
x x x 
Lamp1 Adult male lung cDNA, RIKEN full-
length enriched library, clone:1200007I01 
product:lysosomal membrane glycoprotein 1 
IPI00469218 44 99,9% 2 3 5 5,7% 
x x x 
Lamp2 Isoform LAMP-2A of Lysosome-
associated membrane glycoprotein 2 precursor IPI00134549 46 88,0% 1 1 1 1,9% 
x x x 
Laptm4a lysosomal-associated protein 
transmembrane 4A IPI00122648 35 88,0% 1 1 2 4,2% 
x x x Lcp1 Plastin-2 IPI00118892 70 100,0% 14 16 21 33,2% 
x x x Ldha L-lactate dehydrogenase A chain IPI00319994 36 100,0% 8 8 11 20,5% 
x x x Lgals3 Galectin-3 IPI00131259 27 88,0% 1 1 1 4,2% 
x x x Lgals3bp Mama protein IPI00119809 64 88,0% 1 1 1 2,3% 
x x x Lgmn Legumain precursor IPI00130627 49 100,0% 3 5 7 8,5% 
x x x 
Lipa Lysosomal acid lipase/cholesteryl ester 
hydrolase precursor IPI00129265 46 99,8% 2 2 5 5,3% 
x x x LOC432548 similar to 40S ribosomal protein SA IPI00111272 33 99,8% 2 2 3 10,5% 
x x x 
LOC629750;LOC639383 similar to ubiquitin A-
52 residue ribosomal protein fusion product 1 IPI00108590 15 100,0% 3 5 10 28,4% 
x x x 
LOC633858;LOC626683 similar to 60S 
ribosomal protein L7a IPI00122931 30 100,0% 3 3 4 12,4% 
x x x 
LOC672854;LOC668706 similar to 60S 
ribosomal protein L12 IPI00338838 18 100,0% 3 4 5 24,9% 
x x x 
LOC672898 similar to 60S ribosomal protein 
L18 IPI00465823 34 100,0% 3 3 3 11,7% 
x x x 
Lyzs Osteoclast-like cell cDNA, RIKEN full-
length enriched library, clone:I420013M05 
product:lysozyme, full insert sequence 
IPI00107952 18 100,0% 3 5 8 28,8% 
x x x 
Man2b1 Lysosomal alpha-mannosidase 
precursor IPI00381303 115 88,0% 1 1 2 1,1% 
x x x 
Mapbpip Mitogen-activated protein-binding 
protein-interacting protein IPI00119807 13 88,0% 1 1 1 8,0% 
x x x Mela Envelope protein IPI00406960 74 88,0% 1 1 1 2,7% 
x x x Mon2 MKIAA1040 protein (Fragment) IPI00330176 189 88,0% 1 1 2 0,9% 
x x x Mpeg1 Mpeg1 protein IPI00126418 78 100,0% 9 11 17 17,8% 
Supplement  
 
x x x Msn Moesin IPI00110588 68 99,9% 2 2 2 7,5% 
x x x Myh9 Myosin-9 IPI00123181 226 100,0% 3 3 3 2,5% 
x x x 
Naga Alpha-N-acetylgalactosaminidase 
precursor IPI00315593 47 100,0% 4 5 8 11,8% 
x x x Naglu Naglu IPI00314726 83 88,0% 1 1 2 2,3% 
x x x Napa Alpha-soluble NSF attachment protein IPI00118930 33 100,0% 3 3 3 13,2% 
x x x Ncl Nucleolin IPI00317794 77 100,0% 10 10 21 16,4% 
x x x Nkx2-9 Homeobox protein Nkx-2.8 IPI00119496 26 88,0% 1 1 1 7,2% 
x x x Nme2 Nucleoside diphosphate kinase B IPI00127417 17 100,0% 3 4 5 25,0% 
x x x Npc1 Niemann-Pick C1 protein precursor IPI00132600 143 88,0% 1 1 1 0,9% 
x x x Npm1 Nucleophosmin IPI00127415 33 100,0% 3 6 7 14,7% 
x x x 
Nsf 13 days embryo lung cDNA, RIKEN full-
length enriched library, clone:D430035B05 
product:N-ethylmaleimide sensitive fusion 
protein, full insert sequence 
IPI00311934 83 100,0% 7 7 11 11,6% 
x x x 
Osbpl1a RCB-0545 OHTA cDNA, RIKEN full-
length enriched library, clone:G430090F17 
product:similar to OSBP-RELATED PROTEIN 1 
IPI00404881 44 88,0% 1 1 1 3,8% 
x x x 
P4hb 17 days embryo kidney cDNA, RIKEN full-
length enriched library, clone:I920160L24 
product:prolyl 4-hydroxylase, beta polypeptide 
IPI00122815 57 100,0% 4 4 4 8,6% 
x x x Pabpc1 Polyadenylate-binding protein 1 IPI00124287 71 99,8% 2 2 2 3,6% 
x x x Pcbp2 Isoform 1 of Poly(rC)-binding protein 2 IPI00127707 38 99,9% 2 2 2 6,9% 
x x x Pdia3 protein disulfide isomerase associated 3 IPI00230108 57 100,0% 4 4 4 8,7% 
x x x 
Pdia6 CRL-1722 L5178Y-R cDNA, RIKEN full-
length enriched library, clone:I730077L17 
product:thioredoxin domain containing 7 
IPI00222496 49 100,0% 3 3 3 10,3% 
x x x Pfn1 Profilin-1 IPI00224740 15 100,0% 5 7 13 38,6% 
x x x 
Pgk1;EG433594;EG668435 phosphoglycerate 
kinase 1 IPI00230002 45 100,0% 4 4 6 13,4% 
x x x Pkm2 Pyruvate kinase isozyme M2 IPI00407130 58 100,0% 24 27 43 55,5% 
x x x Pld3 Phospholipase D3 IPI00130624 54 88,0% 1 1 2 2,5% 
x x x Pld4 Isoform 1 of Phospholipase D4 IPI00221418 56 100,0% 4 4 5 9,5% 
x x x 
Pls3 13 days embryo liver cDNA, RIKEN full-
length enriched library, clone:I920006B08 
product:plastin 3 (T-isoform) 
IPI00115528 71 100,0% 3 4 6 6,5% 
x x x Ppt1 Palmitoyl-protein thioesterase IPI00331318 35 100,0% 4 5 8 20,9% 
x x x 
Prcp Lysosomal Pro-X carboxypeptidase 
precursor IPI00132020 55 88,0% 1 1 1 2,9% 
x x x Prdx1 Peroxiredoxin-1 IPI00121788 22 100,0% 4 4 6 22,6% 
x x x Prss1 Trypsinogen 16 IPI00130391 26 88,0% 1 1 1 8,1% 
x x x 
Psmb6 Proteasome subunit beta type 6 
precursor IPI00119239 25 99,5% 1 1 1 4,6% 
x x x Rab1 Ras-related protein Rab-1A IPI00114560 23 99,8% 2 2 4 13,2% 
x x x Rab10 Ras-related protein Rab-10 IPI00130118 23 88,0% 1 1 3 5,5% 
x x x Rab14 Ras-related protein Rab-14 IPI00126042 24 88,0% 1 1 2 7,0% 
x x x Rab2 Ras-related protein Rab-2A IPI00137227 24 99,8% 2 2 2 11,3% 
x x x Rab21 Ras-related protein Rab-21 IPI00337980 24 88,0% 1 1 1 5,0% 
x x x Rab22a Ras-related protein Rab-22A IPI00116729 22 88,0% 1 1 2 5,7% 
x x x 
Rab33b 16 days embryo head cDNA, RIKEN 
full-length enriched library, clone:C130023M09 
product:RAB33B, member of RAS oncogene 
family, full insert sequence 
IPI00136271 30 99,8% 2 2 3 4,9% 
x x x Rab5b;LOC640369;LOC433464 Rab5B IPI00116563 25 99,8% 2 2 4 9,6% 
x x x Rab5c Ras-related protein Rab-5C IPI00224518 23 100,0% 3 4 7 18,5% 
x x x Rab7 Ras-related protein Rab-7 IPI00408892 23 100,0% 7 9 11 44,9% 
x x x 
Rac1 Mammary gland RCB-0527 Jyg-MC(B) 
cDNA, RIKEN full-length enriched library, 
clone:G930005L08 product:RAS-related C3 
botulinum substrate 1, full insert sequence 
IPI00127408 23 100,0% 4 4 5 18,5% 
x x x 
Rac2 Ras-related C3 botulinum toxin substrate 
2 precursor IPI00137618 21 100,0% 3 4 4 12,5% 
x x x Ralb Ras-related protein Ral-B precursor IPI00121110 23 88,0% 1 1 1 5,3% 
x x x Rap1a Ras-related protein Rap-1A precursor IPI00138406 21 99,9% 2 2 2 14,1% 
x x x Rhoa Transforming protein RhoA precursor IPI00315100 22 88,0% 1 1 1 6,2% 
Supplement  
 
x x x Rpl13 60S ribosomal protein L13 IPI00224505 24 88,0% 1 1 1 6,2% 
x x x Rpl18 60S ribosomal protein L18 IPI00555113 22 88,0% 1 1 2 5,9% 
x x x Rpl22 60S ribosomal protein L22 IPI00222546 15 99,8% 2 2 4 18,8% 
x x x Rpl23 60S ribosomal protein L23 IPI00139780 15 98,3% 1 2 2 14,3% 
x x x 
Rpl24;LOC675789;EG668829 similar to 
ribosomal protein L24 IPI00134202 12 88,0% 1 1 1 12,5% 
x x x 
Rpl35 11 days embryo whole body cDNA, 
RIKEN full-length enriched library, 
clone:2700038I05 product:ribosomal protein 
L35, full insert sequence 
IPI00263879 15 88,0% 1 1 1 10,6% 
x x x Rpl4 60S ribosomal protein L4 IPI00111412 47 100,0% 8 10 12 22,7% 
x x x Rpl6 60S ribosomal protein L6 IPI00313222 33 99,8% 2 3 6 9,5% 
x x x Rpl8 60S ribosomal protein L8 IPI00137787 28 97,6% 1 1 1 4,3% 
x x x Rps24 Isoform 2 of 40S ribosomal protein S24 IPI00402981 15 99,8% 2 2 2 20,8% 
x x x Rps28 40S ribosomal protein S28 IPI00137736 8 99,8% 2 2 4 30,4% 
x x x Rps3a 40S ribosomal protein S3a IPI00331345 30 100,0% 5 6 7 22,7% 
x x x Rps9 40S ribosomal protein S9 IPI00420726 23 99,8% 2 2 2 8,8% 
x x x 
Scamp3 12 days embryo male wolffian duct 
includes surrounding region cDNA, RIKEN full-
length enriched library, clone:6720482P16 
product:secretory carrier membrane protein 3 
IPI00132604 39 99,8% 2 2 2 10,9% 
x x x Scpep1 Serine carboxypeptidase 1 IPI00108371 51 100,0% 3 3 4 6,4% 
x x x Sdcbp Syntenin-1 IPI00117375 32 99,8% 2 2 3 7,0% 
x x x Serinc3 Serine incorporator 3 IPI00319078 53 99,3% 1 1 1 2,5% 
x x x 
Shprh SNF2 histone linker PHD RING helicase 
isoform a IPI00380430 192 99,0% 1 1 1 1,4% 
x x x Slc12a9 CIP1 IPI00117986 96 88,0% 1 2 3 1,8% 
x x x 
Slc2a6 Mammary gland RCB-0526 Jyg-MC(A) 
cDNA, RIKEN full-length enriched library, 
clone:G830035N13 product:solute carrier family 
2 (facilitated glucose transporter), member 6 
IPI00225113 55 100,0% 3 4 5 9,6% 
x x x 
Slc37a2 10 days neonate skin cDNA, RIKEN 
full-length enriched library, clone:4732478E01 
product:solute carrier family 37 (glycerol-3- 
phosphate transporter), member 1 
IPI00404341 55 99,8% 2 3 5 7,7% 
x x x Slc3a2 CD98 heavy chain IPI00114641 59 88,0% 1 1 1 3,8% 
x x x 
Snd1 Staphylococcal nuclease domain-
containing protein 1 IPI00123129 102 99,8% 2 2 2 4,1% 
x x x Snx22;Ppib peptidylprolyl isomerase B IPI00135686 24 100,0% 3 3 4 15,3% 
x x x Stard3 StAR-related lipid transfer protein 3 IPI00122397 50 99,8% 2 2 3 6,3% 
x x x Stard3nl MLN64 N-terminal domain homolog IPI00317163 27 88,0% 1 1 1 4,3% 
x x x 
Stom Erythrocyte band 7 integral membrane 
protein IPI00323748 31 100,0% 5 5 9 25,7% 
x x x Stx12 Syntaxin-12 IPI00111416 31 88,0% 1 1 1 6,2% 
x x x Stx7 Syntaxin-7 IPI00118217 30 100,0% 3 4 8 14,6% 
x x x Sybl1 Synaptobrevin-like protein IPI00137647 25 88,0% 1 1 1 5,5% 
x x x 
Tcirg1 T-cell, immune regulator 1, ATPase, H+ 
transporting, lysosomal V0 protein A3 IPI00119320 93 100,0% 8 9 10 16,6% 
x x x Tkt Transketolase IPI00137409 68 100,0% 4 5 6 9,6% 
x x x Tlr7 Toll-like receptor 7 precursor IPI00122181 122 88,0% 1 1 1 1,1% 
x x x Tmem55b Transmembrane protein 55B IPI00356633 30 88,0% 1 1 1 3,9% 
x x x Tmem63a Transmembrane protein 63A IPI00130474 92 99,8% 2 2 3 2,9% 
x x x Tpi1 Triosephosphate isomerase IPI00467833 27 100,0% 4 5 10 22,9% 
x x x Tpm1 Isoform 1 of Tropomyosin-1 alpha chain IPI00123316 33 99,8% 2 2 3 3,9% 
x x x Try4;1810049H19Rik Pancreatic trypsin IPI00128108 26 87,9% 1 1 4 8,1% 
x x x Tuba1a Tubulin alpha-1 chain IPI00110753 50 100,0% 7 9 14 24,2% 
x x x Tuba1b Tubulin alpha-2 chain IPI00117348 50 88,0% 1 1 1 2,9% 
x x x Tubb2b Tubulin beta-2B chain IPI00109061 50 100,0% 11 12 21 32,6% 
x x x Tubb4 Tubulin beta-4 chain IPI00109073 50 100,0% 3 4 6 11,9% 
x x x Tubb5 Tubulin beta-5 chain IPI00117352 50 99,8% 2 3 7 6,1% 
x x x Unc93b1 Isoform 1 of UNC93 homolog B1 IPI00122625 67 100,0% 3 3 5 7,0% 
x x x Vamp8 Vesicle-associated membrane protein 8 IPI00453589 11 100,0% 3 4 5 32,7% 
x x x 
Vapa Vesicle-associated membrane protein-
associated protein A IPI00125267 28 99,8% 2 2 2 11,2% 
x x x Vcp Transitional endoplasmic reticulum ATPase IPI00622235 89 100,0% 8 8 9 11,0% 
Supplement  
 
x x x 
Vdac1 Isoform Pl-VDAC1 of Voltage-dependent 
anion-selective channel protein 1 IPI00122549 32 99,8% 2 2 2 8,5% 
x x x 
Vdac2 Voltage-dependent anion-selective 
channel protein 2 IPI00122547 32 100,0% 3 3 4 11,9% 
x x x Vim Vimentin IPI00227299 54 100,0% 6 7 9 17,4% 
x x x 
Vti1b Vesicle transport through interaction with 
t-SNAREs homolog 1B IPI00130115 27 88,0% 1 1 1 8,6% 
x x x Ywhaz 14-3-3 protein zeta/delta IPI00116498 28 100,0% 4 4 4 20,0% 
           
x x  - Ig kappa chain V-V region HP 124E1 IPI00464385 12 88,0% 1 1 1 19,4% 
x x  4933429F08Rik Hypothetical protein IPI00223868 77 88,0% 1 1 1 3,3% 
x x  
Abca2 ATP-binding cassette sub-family A 
member 2 IPI00112616 270 88,0% 1 1 1 0,5% 
x x  
Acot7 Isoform B of Cytosolic acyl coenzyme A 
thioester hydrolase IPI00125939 43 88,0% 1 1 2 4,2% 
x x  
Akr1c18 Isoform 1 of Aldo-keto reductase family 
1 member C18 IPI00118068 37 88,0% 1 1 2 3,7% 
x x  Ank Progressive ankylosis protein IPI00310247 54 98,7% 1 1 1 2,4% 
x x  Anxa1 Annexin A1 IPI00230395 39 100,0% 5 7 12 19,9% 
x x  Ap2m1 AP-2 complex subunit mu-1 IPI00116356 50 88,0% 1 1 2 3,7% 
x x  
BC048644 Adult male testis cDNA, RIKEN full-
length enriched library, clone:4930588P05 
product:hypothetical Dictyostelium (slime mold) 
repeat/Cysteine-rich region profile/Insect 
antifreeze protein containing protein 
IPI00652955 24 88,0% 1 1 1 8,3% 
x x  Capza1 F-actin capping protein subunit alpha-1 IPI00330063 33 88,0% 1 2 2 5,3% 
x x  Cct4 T-complex protein 1 subunit delta IPI00116277 58 100,0% 3 4 4 7,4% 
x x  
Cfl1 12 days embryo embryonic body between 
diaphragm region and neck cDNA, RIKEN full-
length enriched library, clone:9430060J01 
product:COFILIN 1, NON-MUSCLE homolog 
IPI00407543 25 88,0% 1 1 3 4,8% 
x x  Dph4 Zinc finger, CSL-type containing 3 IPI00751149 13 88,0% 1 1 1 16,4% 
x x  EG243302 similar to 40S ribosomal protein S25 IPI00115992 14 88,0% 1 1 1 8,0% 
x x  EG243642 similar to 40S ribosomal protein S2 IPI00134607 34 100,0% 3 3 5 11,2% 
x x  EG432865 similar to ribosomal protein S12 IPI00116908 14 99,8% 2 2 2 12,9% 
x x  EG626175 similar to 40S ribosomal protein S26 IPI00261455 13 88,0% 1 1 2 13,0% 
x x  
EG639162;LOC676847 similar to ribosomal 
protein S15a IPI00113394 21 100,0% 3 3 3 16,5% 
x x  Ehd4 EH-domain containing 4-KJR (Fragment) IPI00318671 62 88,0% 1 1 1 3,9% 
x x  Epb4.2 Erythrocyte membrane protein band 4.2 IPI00421166 77 88,0% 1 1 1 1,6% 
x x  Gars Glycyl-tRNA synthetase IPI00112555 82 88,0% 1 1 1 1,8% 
x x  
Gdi2 Isoform 1 of Rab GDP dissociation 
inhibitor beta IPI00122565 51 100,0% 2 2 3 8,1% 
x x  
Gpiap1 Cytoplasmic activation/proliferation-
associated protein 1 IPI00757359 78 88,0% 1 1 1 1,7% 
x x  
Gtdc1 2 days pregnant adult female ovary 
cDNA, RIKEN full-length enriched library, 
clone:E330008O22 product:solute carrier family 
24 (sodium/potassium/calcium exchanger), 
member 2, full insert sequence 
IPI00226094 53 88,0% 1 1 1 2,8% 
x x  
Hnrpa2b1 heterogeneous nuclear 
ribonucleoprotein A2/B1 isoform 2 IPI00405058 32 100,0% 4 4 4 21,6% 
x x  
Hnrph1 Heterogeneous nuclear 
ribonucleoprotein H IPI00133916 49 88,0% 1 2 2 3,8% 
x x  Hspa4 Heat shock 70 kDa protein 4 IPI00331556 94 100,0% 8 8 9 12,7% 
x x  
Iqgap1 Ras GTPase-activating-like protein 
IQGAP1 IPI00467447 189 88,0% 1 1 1 1,0% 
x x  
Jmjd1c similar to jumonji domain containing 1C 
isoform 3 IPI00670418 287 88,0% 1 1 1 0,8% 
x x  Kars Kars protein IPI00469103 71 88,0% 1 1 2 1,8% 
x x  Krt78 keratin Kb40 IPI00348328 90 88,0% 1 1 1 1,4% 
x x  Krt79 Keratin 79 IPI00124499 58 88,0% 1 1 2 2,3% 
x x  
Lipa 2 days neonate thymus thymic cells cDNA, 
RIKEN full-length enriched library, 
clone:C920007B20 product:lysosomal acid 
lipase 1, full insert sequence 
IPI00554860 45 88,0% 1 1 1 6,3% 
x x  
LOC238943 similar to enolase 1, alpha non-
neuron 
IPI00342547 32 88,0% 1 1 1 3,7% 
Supplement  
 
x x  
LOC631010 similar to MAP/microtubule affinity-
regulating kinase 4 IPI00676232 83 97,7% 1 1 1 2,6% 
x x  
LOC671641 similar to 40S ribosomal protein 
S12 IPI00120475 14 88,0% 1 1 1 7,9% 
x x  Lyst Isoform 1 of Lysosomal-trafficking regulator IPI00399954 425 88,0% 1 1 1 0,6% 
x x  
Map2k1ip1;EG545987 Mitogen-activated 
protein kinase kinase 1-interacting protein 1 IPI00133047 14 88,0% 1 1 3 8,9% 
x x  Mdn1 Midasin homolog IPI00458039 630 88,0% 1 1 1 0,3% 
x x  Pdia4 protein disulfide isomerase associated 4 IPI00271951 72 98,8% 1 1 2 2,5% 
x x  
Pgam1;EG667978;LOC669836;EG668045;LOC
675179 Phosphoglycerate mutase 1 IPI00457898 29 100,0% 5 6 9 25,6% 
x x  Pgam2 Phosphoglycerate mutase 2 IPI00230706 29 88,0% 1 1 1 4,0% 
x x  Phf21a Isoform 1 of PHD finger protein 21A IPI00453806 73 88,0% 1 1 1 4,1% 
x x  Pklr Pyruvate kinase isozymes R/L IPI00133605 62 99,3% 1 1 3 1,9% 
x x  Prdx2 Peroxiredoxin-2 IPI00117910 22 88,0% 1 1 1 9,1% 
x x  Psma3 Proteasome subunit alpha type 3 IPI00331644 28 99,8% 2 2 3 8,2% 
x x  
Rgs17 Adult male corpora quadrigemina cDNA, 
RIKEN full-length enriched library, 
clone:B230310H10 product:regulator of G-
protein signaling 17, full insert sequence 
IPI00137195 27 88,0% 1 1 1 7,8% 
x x  Rpl11 60S ribosomal protein L11 IPI00331461 20 88,0% 1 1 1 7,9% 
x x  Rpl13a 60S ribosomal protein L13a IPI00223217 23 99,5% 1 1 1 3,9% 
x x  Rpl18a 60S ribosomal protein L18a IPI00162790 21 88,0% 1 1 1 7,4% 
x x  Rpl3 60S ribosomal protein L3 IPI00321170 46 88,0% 1 1 2 4,0% 
x x  Rpl5 60S ribosomal protein L5 IPI00308706 34 100,0% 3 3 5 13,1% 
x x  Rpl9 60S ribosomal protein L9 IPI00122413 22 99,8% 2 2 2 7,8% 
x x  Rplp1 60S acidic ribosomal protein P1 IPI00113377 11 88,0% 1 2 3 14,0% 
x x  Rps10 40S ribosomal protein S10 IPI00112448 19 88,0% 1 1 1 5,5% 
x x  
Rps13;EG625298;LOC633920 40S ribosomal 
protein S13 IPI00125901 17 88,0% 1 1 1 8,6% 
x x  Rps20 40S ribosomal protein S20 IPI00323819 13 88,0% 1 1 1 9,2% 
x x  Rps21 40S ribosomal protein S21 IPI00132950 9 88,0% 1 1 1 12,1% 
x x  Rps3 40S ribosomal protein S3 IPI00134599 27 100,0% 6 6 8 28,4% 
x x  
Scamp2 Secretory carrier-associated 
membrane protein 2 IPI00319121 36 99,8% 2 2 2 9,7% 
x x  
Serbp1 Isoform 1 of Plasminogen activator 
inhibitor 1 RNA-binding protein IPI00471475 45 88,0% 1 2 2 3,9% 
x x  
Slc38a1 12 days embryo whole body cDNA, 
RIKEN full-length enriched library, 
clone:E970021I18 product:solute carrier family 
38, member 1, full insert sequence 
IPI00459577 54 88,0% 1 1 1 4,3% 
x x  
Slc44a2 Isoform 2 of Choline transporter-like 
protein 2 IPI00169896 80 99,8% 2 2 3 3,8% 
x x  Tcp1 T-complex protein 1 subunit alpha A IPI00118678 60 100,0% 8 8 11 18,7% 
x x  Tmem79 Transmembrane protein 79 IPI00109411 43 88,0% 1 1 1 3,3% 
x x  
Tpm3 15 days pregnant adult female placenta 
cDNA, RIKEN full-length enriched library, 
clone:I530023K22 product:tropomyosin 3, 
gamma, full insert sequence 
IPI00230044 29 100,0% 2 3 3 6,1% 
x x  Wdr1 WD repeat protein 1 IPI00314748 66 88,0% 1 1 1 2,3% 
x x  
Ybx1 Nuclease sensitive element-binding 
protein 1 IPI00120886 36 88,0% 1 1 1 4,7% 
x x  Ywhae 14-3-3 protein epsilon IPI00118384 29 100,0% 3 3 4 16,5% 
x x  Zfp445 Zinc finger protein 445 IPI00336923 115 88,0% 1 1 1 1,4% 
           
x  x 
1700071K01Rik Adult male testis cDNA, RIKEN 
full-length enriched library, clone:1700071K01 
product:Prohibitin (B-cell receptor associated 
protein 32) (BAP 32) homolog 
IPI00126917 29 88,0% 1 1 1 3,7% 
x  x 
1810007P19Rik Organic solute carrier protein 1 
isoform IPI00222008 45 88,0% 1 1 1 3,3% 
x  x Ahcy Adenosylhomocysteinase IPI00230440 48 88,0% 1 1 1 2,6% 
x  x Arhgdib Rho GDP-dissociation inhibitor 2 IPI00122568 23 100,0% 3 3 4 30,5% 
x  x 
Atp5b ATP synthase subunit beta, 
mitochondrial precursor IPI00468481 56 100,0% 5 5 6 14,2% 
x  x 
Atp5o ATP synthase O subunit, mitochondrial 
precursor IPI00118986 23 88,0% 1 1 1 5,2% 
Supplement  
 
x  x 
Atp6v1a Blastocyst blastocyst cDNA, RIKEN 
full-length enriched library, clone:I1C0017M12 
product:ATPase, H+ transporting, V1 subunit A, 
isoform 1, full insert sequence 
IPI00407692 68 88,0% 1 1 1 2,9% 
x  x Atp6v1d Vacuolar ATP synthase subunit D IPI00118787 28 100,0% 3 3 3 19,8% 
x  x Atp6v1g1 Vacuolar ATP synthase subunit G 1 IPI00133163 14 99,8% 2 2 4 26,3% 
x  x 
AU022870 Uncharacterized protein C7orf28 
homolog IPI00224561 55 100,0% 2 2 2 5,2% 
x  x 
BC033915 Isoform 1 of Serine/threonine-protein 
kinase QSK IPI00453673 146 88,0% 1 1 1 1,2% 
x  x Cct8 T-complex protein 1 subunit theta IPI00469268 60 100,0% 4 4 5 8,4% 
x  x 
Cyb5r3 13 days embryo liver cDNA, RIKEN full-
length enriched library, clone:2500002N19 
product:NADH-CYTOCHROME B5 
REDUCTASE (EC 1.6.2.2) homolog 
IPI00110885 34 88,0% 1 1 1 4,0% 
x  x 
Ddx5 Probable ATP-dependent RNA helicase 
DDX5 IPI00420363 69 100,0% 4 4 4 7,3% 
x  x EG245391 similar to 60S ribosomal protein L17 IPI00108337 24 88,0% 1 1 2 4,8% 
x  x 
EG245516 similar to family with sequence 
similarity 48, member A isoform a IPI00355970 57 88,0% 1 1 1 3,1% 
x  x EG382723 similar to ribosomal protein L10a IPI00122598 24 88,0% 1 2 2 6,1% 
x  x 
Gfap Isoform 1 of Glial fibrillary acidic protein, 
astrocyte IPI00117042 50 88,0% 1 1 3 2,6% 
x  x Hist1h1c Histone H1.2 IPI00223713 21 88,0% 1 1 1 5,2% 
x  x 
Hist1h4i;Hist1h4b;Hist4h4;Hist1h4h;Hist1h4d;Hi
st1h4k;Hist1h4m;Hist1h4c;Hist2h4;Hist1h4j;Hist
1h4a;Hist1h4f;4930558J22Rik Hist2h4 protein 
(Fragment) 
IPI00336741 12 88,0% 1 1 1 10,7% 
x  x 
Hnrpu Osteoclast-like cell cDNA, RIKEN full-
length enriched library, clone:I420039N16 
product:heterogeneous nuclear 
ribonucleoprotein U, full insert sequence 
IPI00458583 88 100,0% 5 5 7 8,6% 
x  x Hsp90aa1 Heat shock protein HSP 90-alpha IPI00330804 85 100,0% 6 6 7 11,9% 
x  x 
Hspa9 Stress-70 protein, mitochondrial 
precursor IPI00133903 74 100,0% 3 3 5 6,0% 
x  x 
Igf2r Cation-independent mannose-6-phosphate 
receptor precursor IPI00308971 274 88,0% 1 1 1 0,7% 
x  x Khdrbs2 Khdrbs2 protein (Fragment) IPI00463153 28 88,0% 1 1 3 11,2% 
x  x Krt6b Keratin, type II cytoskeletal 6B IPI00131366 60 88,0% 1 2 2 2,1% 
x  x Lipe lipase, hormone sensitive isoform 1 IPI00228826 88 88,0% 1 1 1 1,4% 
x  x 
Lmbrd1 Isoform 2 of LMBR1 domain-containing 
protein 1 IPI00352845 59 88,0% 1 1 1 3,5% 
x  x 
Lmln Adult male pituitary gland cDNA, RIKEN 
full-length enriched library, clone:5330415H22 
product:LEISHMANOLYSIN-LIKE PEPTIDASE, 
VARIANT 2 (EC 3.4.24.36) homolog 
IPI00223063 77 88,0% 1 1 1 2,5% 
x  x Lmod3 similar to leiomodin 3 IPI00672159 66 88,0% 1 1 2 4,0% 
x  x 
LOC675088;Rpl27;EG621100;LOC669376 60S 
ribosomal protein L27 IPI00122421 16 99,7% 1 1 1 6,6% 
x  x Mdh2 Malate dehydrogenase 2, NAD IPI00331590 36 88,0% 1 1 1 3,6% 
x  x 
Mdh2 Malate dehydrogenase, mitochondrial 
precursor IPI00323592 36 100,0% 5 5 7 19,2% 
x  x mt-Co2 Cytochrome c oxidase subunit 2 IPI00131176 26 88,0% 1 1 1 4,4% 
x  x Pa2g4 Proliferation-associated protein 2G4 IPI00119305 44 100,0% 4 4 4 13,5% 
x  x Pabpc2 poly A binding protein, cytoplasmic 2 IPI00120954 69 100,0% 3 3 3 5,6% 
x  x Pap 19 kDa protein IPI00761692 19 88,0% 1 1 1 16,9% 
x  x 
Pgd 6-phosphogluconate dehydrogenase, 
decarboxylating IPI00466919 53 100,0% 4 4 5 12,8% 
x  x Phb2;Grcc10 Prohibitin-2 IPI00321718 33 99,8% 2 2 2 10,4% 
x  x 
Ppp1ca Serine/threonine-protein phosphatase 
PP1-alpha catalytic subunit IPI00130185 38 88,0% 1 1 1 3,0% 
x  x 
Ptprc Isoform 2 of Leukocyte common antigen 
precursor IPI00126092 140 99,8% 2 2 2 1,7% 
x  x Rab8b Ras-related protein Rab-8B IPI00411115 24 88,0% 1 1 1 6,8% 
x  x Rpl14 60S ribosomal protein L14 IPI00133185 24 100,0% 3 3 4 15,7% 
x  x 
Rpl30;LOC666899;LOC675333;LOC670014 
60S ribosomal protein L30 IPI00222549 13 99,8% 2 2 2 27,0% 
Supplement  
 
x  x Rpl7 60S ribosomal protein L7 IPI00311236 31 100,0% 2 2 3 9,3% 
x  x 
Rps11 Adult male cerebellum cDNA, RIKEN 
full-length enriched library, clone:1500004H08 
product:ribosomal protein S11 
IPI00117569 19 100,0% 3 3 5 23,5% 
x  x 
Rps23 11 days embryo whole body cDNA, 
RIKEN full-length enriched library, 
clone:2700086E01 product:ribosomal protein 
S23, full insert sequence 
IPI00131357 16 88,0% 1 1 1 7,6% 
x  x Rps4x 40S ribosomal protein S4, X isoform IPI00331092 30 100,0% 5 6 9 18,3% 
x  x 
Sfrs3 Isoform Long of Splicing factor, 
arginine/serine-rich 3 IPI00129323 19 98,6% 1 1 2 8,5% 
x  x 
Slc25a3 Phosphate carrier protein, 
mitochondrial precursor IPI00124771 40 99,7% 1 1 1 3,4% 
x  x Slc25a4 ADP/ATP translocase 1 IPI00115564 33 88,0% 1 1 1 3,4% 
x  x 
Slc2a1 Solute carrier family 2, facilitated 
glucose transporter member 1 IPI00308691 54 88,0% 1 1 2 2,0% 
x  x 
Slco2b1 Solute carrier organic anion transporter 
family member 2B1 IPI00465991 75 88,0% 1 1 2 2,2% 
x  x Snrpd1 Small nuclear ribonucleoprotein Sm D1 IPI00322749 13 88,0% 1 1 1 10,9% 
x  x Tln1 Talin-1 IPI00465786 270 100,0% 3 3 4 1,6% 
x  x Tmem55a Transmembrane protein 55A IPI00113239 28 88,0% 1 1 1 4,3% 
x  x Tubb2c Tubulin beta-2C chain IPI00169463 50 88,0% 1 1 2 2,7% 
x  x Ube2n Ubiquitin-conjugating enzyme E2 N IPI00165854 17 98,4% 1 1 1 7,2% 
           
 x x - 10 kDa protein IPI00111076 10 87,9% 1 1 1 11,0% 
 x x - 18 kDa protein IPI00277450 18 99,7% 1 1 3 5,5% 
 x x 1300007C21Rik Gag protein IPI00224370 60 99,8% 2 2 5 6,3% 
 x x 
1300012G16Rik NOD-derived CD11c +ve 
dendritic cells cDNA, RIKEN full-length enriched 
library, clone:F630111F13 product:RDCR-0918-
3 protein homolog 
IPI00165730 66 100,0% 4 4 6 9,6% 
 x x 
2010106G01Rik Signal peptide peptidase-like 
2A IPI00121776 58 99,8% 2 2 2 6,1% 
 x x Acaca Acetyl-CoA carboxylase 1 IPI00474783 265 87,9% 1 1 1 0,7% 
 x x Acp2 Lysosomal acid phosphatase precursor IPI00154056 48 99,8% 2 2 2 4,3% 
 x x 
Anxa7 Adult male medulla oblongata cDNA, 
RIKEN full-length enriched library, 
clone:6330545A10 product:annexin A7 
IPI00461322 44 87,9% 1 1 2 2,4% 
 x x Anxa7 Annexin A7 IPI00114017 50 100,0% 2 2 2 5,2% 
 x x 
Ap2b1 Isoform 1 of AP-2 complex subunit beta-
1 IPI00119689 105 97,9% 1 1 1 1,4% 
 x x Arl8a ADP-ribosylation factor-like protein 8A IPI00124610 21 100,0% 4 4 7 24,2% 
 x x 
Arpc2 Actin-related protein 2/3 complex subunit 
2 IPI00661414 34 99,5% 1 1 2 4,7% 
 x x 
Arpc3 Actin-related protein 2/3 complex subunit 
3 IPI00124829 21 87,9% 1 2 3 7,3% 
 x x Arpm1 Actin-related protein M1 homolog IPI00226663 40 87,9% 1 1 2 6,0% 
 x x Arsb Isoform 1 of Arylsulfatase B precursor IPI00652358 60 100,0% 3 4 6 8,4% 
 x x 
Atp2a1 Sarcoplasmic/endoplasmic reticulum 
calcium ATPase 1 IPI00311654 109 99,8% 2 2 2 2,8% 
 x x Atp2a3 ATPase, Ca++ transporting, ubiquitous IPI00311200 114 87,9% 1 1 1 1,4% 
 x x 
Bard1 BRCA1-associated RING domain protein 
1 IPI00118250 84 87,9% 1 1 2 2,4% 
 x x BC006779 MKIAA1769 protein IPI00464131 182 87,9% 1 1 1 1,1% 
 x x BC031853 BC031853 protein IPI00395204 50 99,2% 1 1 1 1,9% 
 x x Bcap31 B-cell receptor-associated protein 31 IPI00230422 28 87,9% 1 1 1 6,9% 
 x x 
Calm2;Calm3;Calm1 12 days pregnant adult 
female placenta cDNA, RIKEN full-length 
enriched library, clone:I530005B05 
product:calmodulin 1, full insert sequence 
IPI00467841 22 99,8% 2 2 2 19,8% 
 x x Canx Calnexin precursor IPI00119618 67 100,0% 5 5 9 11,7% 
 x x 
Cdc42 Isoform 2 of Cell division control protein 
42 homolog precursor IPI00113849 21 99,9% 2 2 2 15,7% 
 x x Cpne1 Copine-1 IPI00224075 59 100,0% 5 5 7 10,5% 
 x x Creg1 Protein CREG1 precursor IPI00133103 24 100,0% 2 2 4 10,5% 
 x x 
Csf1r Macrophage colony-stimulating factor 1 
receptor precursor IPI00108003 109 99,8% 2 2 2 2,3% 
Supplement  
 
 x x 
Ctbs Isoform 2 of Di-N-acetylchitobiase 
precursor IPI00110868 35 87,9% 1 1 2 4,8% 
 x x Ctsl Cathepsin L precursor IPI00128154 38 100,0% 7 9 9 38,9% 
 x x Cyb5 Cytochrome b5 IPI00230113 15 87,9% 1 1 1 9,0% 
 x x Cyb5b Cytochrome b5 type B precursor IPI00315794 16 87,9% 1 1 1 8,9% 
 x x 
Dnajc11 Isoform 1 of DnaJ homolog subfamily 
C member 11 IPI00226466 63 87,9% 1 1 1 1,4% 
 x x Dpp7 Dipeptidyl-peptidase 2 precursor IPI00331550 56 100,0% 3 3 6 5,7% 
 x x Dsc3 Isoform 3A of Desmocollin-3 precursor IPI00113853 101 87,9% 1 1 1 2,5% 
 x x Eea1 Early endosome antigen 1 IPI00453776 161 100,0% 7 7 8 5,9% 
 x x 
EG667952;LOC671953 similar to Myosin light 
polypeptide 6 IPI00264053 22 99,4% 1 1 2 4,0% 
 x x 
Fcgr2b Fc receptor, IgG, low affinity IIb isoform 
1 IPI00129485 38 99,8% 2 2 2 7,7% 
 x x Fth1 Ferritin heavy chain IPI00230145 21 99,7% 1 1 1 8,2% 
 x x Ftl1 Ferritin light chain 1 IPI00315299 21 99,8% 2 2 2 11,5% 
 x x Gla Mammary gland RCB-0526 Jyg-MC IPI00123814 48 99,8% 2 2 4 5,2% 
 x x 
Gng2 Guanine nucleotide-binding protein 
G(I)/G(S)/G(O) gamma-2 subunit precursor IPI00230194 8 87,9% 1 1 1 22,5% 
 x x Gpsm3 Hypothetical protein NG1 IPI00130761 13 87,9% 1 1 1 16,1% 
 x x Gria4 Glutamate receptor 4 precursor IPI00131471 101 87,9% 1 1 1 2,2% 
 x x Gusb Beta-glucuronidase precursor IPI00309230 74 100,0% 3 4 5 5,4% 
 x x Hbxip hepatitis B virus x interacting protein IPI00132747 15 87,9% 1 1 4 13,8% 
 x x 
Hsd17b12 Isoform 1 of Estradiol 17-beta-
dehydrogenase 12 IPI00119219 35 99,8% 2 2 3 5,1% 
 x x 
Hspe1-rs1;EG628438;LOC636088 CPN10-like 
protein IPI00120045 11 99,8% 2 2 2 25,5% 
 x x Ifi30 interferon gamma inducible protein 30 IPI00113659 28 100,0% 3 3 7 19,4% 
 x x Ift172 intraflagellar transport 172 protein IPI00762129 198 87,9% 1 1 1 0,8% 
 x x Itga4 Integrin alpha-4 precursor IPI00121334 116 99,8% 2 2 2 2,9% 
 x x 
Lamp2 lysosomal membrane glycoprotein 2 
isoform 2 IPI00310109 46 87,9% 1 1 2 2,2% 
 x x Lgals1 Galectin-1 IPI00229517 15 87,9% 1 1 1 11,1% 
 x x 
Lgals3 Beta-galactoside-binding lectin 
(Fragment) IPI00120051 16 99,9% 1 1 2 10,8% 
 x x 
Lgals3bp Lectin, galactoside-binding, soluble, 3 
binding protein IPI00648096 15 87,9% 1 1 2 10,8% 
 x x Lgals9 Isoform Long of Galectin-9 IPI00114396 40 99,8% 2 2 2 7,4% 
 x x Lnpep Leucyl-cystinyl aminopeptidase IPI00223987 117 100,0% 2 2 3 2,3% 
 x x Lypla3 1-O-acylceramide synthase precursor IPI00124428 47 100,0% 5 5 8 14,1% 
 x x 
Man2a2 N-glycan processing alpha-
mannosidase IIx IPI00224294 131 87,9% 1 1 1 1,7% 
 x x 
Man2b2 Epididymis-specific alpha-
mannosidase precursor IPI00117842 116 87,9% 1 1 1 1,1% 
 x x Manba Beta-mannosidase precursor IPI00118011 101 87,9% 1 1 1 1,0% 
 x x Mbc2 Isoform 1 of Protein FAM62A IPI00128450 122 100,0% 4 4 5 5,4% 
 x x Mela Gag-Pol polyprotein IPI00108206 194 100,0% 4 4 6 1,9% 
 x x 
Msr1 Isoform II of Macrophage scavenger 
receptor types I and II IPI00124283 39 99,3% 1 1 1 3,1% 
 x x 
Myadm Myeloid-associated differentiation 
marker IPI00132938 35 87,9% 1 1 1 4,7% 
 x x Myl6b Myosin light polypeptide 6B IPI00261638 23 87,9% 1 1 1 6,3% 
 x x Nbeal2 mKIAA0540 protein IPI00421222 305 87,9% 1 1 1 0,9% 
 x x Npc2 Epididymal secretory protein E1 precursor IPI00129186 16 99,8% 2 2 3 18,8% 
 x x Nptn Isoform 1 of Neuroplastin precursor IPI00123831 31 87,9% 1 1 1 3,6% 
 x x Ppia Peptidyl-prolyl cis-trans isomerase A IPI00554989 18 99,8% 2 2 3 13,4% 
 x x Psen1 Isoform 1 of Presenilin-1 IPI00117124 53 99,7% 1 1 1 4,3% 
 x x Psen2 Isoform 1 of Presenilin-2 IPI00357545 50 87,9% 1 1 1 4,5% 
 x x Ptgs1 Prostaglandin G/H synthase 1 precursor IPI00128389 69 100,0% 3 3 3 7,3% 
 x x Rab11b Ras-related protein Rab-11B IPI00135869 24 87,9% 1 1 1 5,1% 
 x x Rab27a Ras-related protein Rab-27A IPI00112374 25 87,9% 1 1 1 5,0% 
 x x 
Rab31 Osteoclast-like cell cDNA, RIKEN full-
length enriched library, clone:I420001G12 
product:Similar to RAB31, member RAS 
oncogene family, full insert sequence 
IPI00222632 21 100,0% 3 4 5 23,1% 
Supplement  
 
 x x Rap1b Ras-related protein Rap-1b precursor IPI00407954 21 99,8% 2 2 3 15,2% 
 x x Rap2b Ras-related protein Rap-2b precursor IPI00138716 20 99,7% 1 1 1 6,0% 
 x x 
Rhog Rho-related GTP-binding protein RhoG 
precursor IPI00116558 21 87,9% 1 1 1 6,8% 
 x x 
Rpn1 Dolichyl-diphosphooligosaccharide--
protein glycosyltransferase 67 kDa subunit 
precursor 
IPI00309035 69 99,6% 1 1 1 2,8% 
 x x 
Rpn2 Dolichyl-diphosphooligosaccharide--
protein glycosyltransferase 63 kDa subunit 
precursor 
IPI00475154 69 99,8% 2 2 2 6,3% 
 x x Rtn4 Isoform 2 of Reticulon-4 IPI00270767 127 87,9% 1 1 3 1,1% 
 x x Scarb2 Lysosome membrane protein 2 IPI00127447 54 100,0% 4 4 5 8,4% 
 x x 
Sirpa Isoform 1 of Tyrosine-protein 
phosphatase non-receptor type substrate 1 
precursor 
IPI00129158 56 98,3% 1 1 1 3,3% 
 x x Slc25a5 ADP/ATP translocase 2 IPI00127841 33 87,9% 1 1 1 3,7% 
 x x Sqstm1 Isoform 1 of Sequestosome-1 IPI00133374 48 99,9% 2 2 2 8,1% 
 x x 
Ssr4 10 day old male pancreas cDNA, RIKEN 
full-length enriched library, clone:1810061C01 
product:signal sequence receptor, delta 
IPI00122346 19 87,9% 1 1 1 7,5% 
 x x Ssx2ip Afadin- and alpha-actinin-binding protein IPI00121490 71 87,9% 1 1 1 3,4% 
 x x Tagln2 MKIAA0120 protein (Fragment) IPI00117007 24 99,9% 2 2 2 12,0% 
 x x Tfrc Transferrin receptor protein 1 IPI00124700 86 100,0% 3 3 5 4,6% 
 x x Tlr13 Toll-like receptor 13 precursor IPI00342691 114 99,0% 1 1 1 1,0% 
 x x 
Tm9sf2 Transmembrane 9 superfamily protein 
member 2 precursor IPI00115787 75 87,9% 1 1 1 2,9% 
 x x 
Tmed10 Isoform 1 of Transmembrane emp24 
domain-containing protein 10 precursor IPI00466570 25 87,9% 1 1 1 4,1% 
 x x Tmem106a Transmembrane protein 106A IPI00121229 29 87,9% 1 1 2 6,9% 
 x x Tpp1 Tripeptidyl-peptidase 1 precursor IPI00130661 61 100,0% 3 3 5 6,2% 
 x x 
Uba52;LOC669193;LOC676687;LOC666586 
Uba52 protein IPI00138892 15 98,6% 1 1 3 7,0% 
 x x Utrn utrophin IPI00353420 393 87,9% 1 1 1 0,8% 
 x x Vamp4 Vesicle-associated membrane protein 4 IPI00118372 16 87,9% 1 1 2 13,5% 
 x x 
Vapb Vesicle-associated membrane protein-
associated protein B IPI00135655 27 99,7% 1 1 2 5,8% 
 x x 
Vps11 Vacuolar protein sorting-associated 
protein 11 homolog IPI00229777 108 99,8% 2 2 2 3,9% 
 x x Vps13c vacuolar protein sorting 13C isoform 7 IPI00473340 415 87,9% 1 1 1 0,4% 
 x x 
Vps35 Vacuolar protein sorting-associated 
protein 35 IPI00111181 92 87,9% 1 1 1 1,4% 
           
x   - 10 kDa protein IPI00272545 10 88,0% 1 1 1 9,8% 
x   - 12 kDa protein IPI00123164 12 88,0% 1 1 1 8,5% 
x   - 12 kDa protein IPI00761871 12 88,0% 1 1 1 20,4% 
x   - 15 kDa protein IPI00463248 15 88,0% 1 1 1 7,6% 
x   - 18 kDa protein IPI00116718 18 98,1% 1 1 1 9,7% 
x   - 18 kDa protein IPI00268802 18 99,8% 2 2 2 15,8% 
x   
- 2 cells egg cDNA, RIKEN full-length enriched 
library, clone:B020003N11 product:hypothetical 
protein, full insert sequence 
IPI00652026 16 88,0% 1 1 1 19,9% 
x   - 36 kDa protein IPI00753274 36 88,0% 1 1 1 6,4% 
x   - 37 kDa protein IPI00137389 37 88,0% 1 1 1 5,5% 
x   - 55 kDa protein IPI00761249 55 88,0% 1 1 1 2,9% 
x   - 70 kDa protein IPI00381231 70 88,0% 1 1 1 5,2% 
x   - Desmoglein4 IPI00828745 122 88,0% 1 1 1 1,0% 
x   - Hypothetical protein (Fragment) IPI00808130 46 88,0% 1 1 1 5,0% 
x   - M.musculus endogenous provirus env (Frag.) IPI00463556 35 99,8% 2 2 2 10,1% 
x   - Novel protein IPI00648985 49 88,0% 1 1 1 3,0% 
x   
- PKA phosphorylated calcium and CABYR-
binding protein IPI00828958 115 88,0% 1 1 1 2,2% 
x   - Pol protein IPI00380444 90 88,0% 1 1 1 2,2% 
x   - Rims1 protein IPI00755092 25 88,0% 1 1 1 10,6% 
x   0910001A06Rik Protein FAM49B IPI00122015 37 88,0% 1 1 1 5,6% 
x   1700016K13Rik similar to septin 10 isoform 1 IPI00122828 IPI00331497 48 88,0% 1 1 1 2,2% 
Supplement  
 
x   
1700120B06Rik Adult male testis cDNA, RIKEN 
full-length enriched library, clone:1700120B06 
product:hypothetical protein 
IPI00463280 33 88,0% 1 1 3 5,5% 
x   
2210010A19Rik 2 days pregnant adult female 
ovary cDNA, RIKEN full-length enriched library, 
clone:E330016A09 product:hypothetical 
Pyridoxal-dependent decarboxylase family 
containing protein, full insert sequence 
IPI00336503 87 88,0% 1 1 1 2,7% 
x   
2410017P07Rik Isoform 2 of Uncharacterized 
protein C6orf182 homolog IPI00112580 41 88,0% 1 1 1 4,8% 
x   
2410104I19Rik 16 days embryo heart cDNA, 
RIKEN full-length enriched library, 
clone:I920055G02 product:RNA-binding protein 
SiahBP homolog 
IPI00127174 59 88,0% 1 1 1 4,0% 
x   
2610019P18Rik 10 days embryo whole body 
cDNA, RIKEN full-length enriched library, 
clone:2610019P18 product:hypothetical protein 
IPI00224957 29 88,0% 1 1 1 6,0% 
x   
2610301F02Rik Adult male aorta and vein 
cDNA, RIKEN full-length enriched library, 
clone:A530084A08 product:RIKEN cDNA 
2610301F02 
IPI00222928 84 88,0% 1 1 1 2,8% 
x   
2900073G15Rik myosin light chain, regulatory 
B-like IPI00109044 20 99,8% 2 2 2 12,2% 
x   
4930471M23Rik Uncharacterized protein 
C2orf18 homolog precursor IPI00165834 41 88,0% 1 1 1 3,2% 
x   
4930556P03Rik RIKEN cDNA 4930556P03 
gene IPI00137809 32 88,0% 1 1 1 3,5% 
x   
4930570C03Rik 0 day neonate thymus cDNA, 
RIKEN full-length enriched library, 
clone:A430032I09 product:hypothetical protein 
IPI00111694 16 88,0% 1 1 2 8,2% 
x   
6030445D17Rik 13 days embryo male testis 
cDNA, RIKEN full-length enriched library, 
clone:6030445D17 product:hypothetical protein 
IPI00228686 16 88,0% 1 1 1 11,5% 
x   
9030411M15Rik;LOC629416 similar to 
CG8486-PA, isoform A IPI00670041 74 88,0% 1 1 1 1,7% 
x   
9130401M01Rik Uncharacterized protein 
C8orf76 homolog IPI00135489 42 88,0% 1 1 1 5,1% 
x   
9230020A06Rik hypothetical protein 
LOC619299 IPI00652070 22 88,0% 1 1 1 11,9% 
x   
9530053A07Rik Adult male urinary bladder 
cDNA, RIKEN full-length enriched library, 
clone:9530053A07 product:hypothetical von 
Willebrand factor type D domain/EGF-like 
domain/Trypsin Inhibitor-like cysteine rich 
domain containing protein 
IPI00227522 53 88,0% 1 1 1 4,4% 
x   9930023K05Rik 9930023K05Rik protein IPI00457712 11 88,0% 1 1 1 14,4% 
x   
A230046K03Rik hypothetical protein 
LOC319277 IPI00130714 146 88,0% 1 1 1 0,9% 
x   
Abcg3 ATP-binding cassette sub-family G 
member 3 IPI00120454 74 88,0% 1 1 1 1,2% 
x   
Aco2 Aconitate hydratase, mitochondrial 
precursor IPI00116074 85 100,0% 3 3 3 5,4% 
x   
Acsl6 acyl-CoA synthetase long-chain family 
member 6 isoform 1 IPI00123390 81 88,0% 1 1 1 1,7% 
x   Adss Adenylosuccinate synthetase isozyme 2 IPI00135969 50 88,0% 1 1 1 2,4% 
x   AI481877 Novel protein IPI00357650 168 88,0% 1 1 1 1,8% 
x   
Aldh2 Aldehyde dehydrogenase, mitochondrial 
precursor IPI00111218 57 99,4% 1 1 1 3,3% 
x   Aldoc Fructose-bisphosphate aldolase C IPI00119458 39 88,0% 1 1 1 4,4% 
x   
Alox5ap Arachidonate 5-lipoxygenase-
activating protein IPI00129296 18 88,0% 1 1 1 8,1% 
x   
Amfr Isoform 1 of Autocrine motility factor 
receptor IPI00319880 73 88,0% 1 1 1 2,3% 
x   
Ankrd10 Ankyrin repeat domain-containing 
protein 10 IPI00117242 44 88,0% 1 1 1 6,0% 
x   Anln Actin-binding protein anillin IPI00172197 123 88,0% 1 1 1 1,4% 
x   Anxa11 Annexin A11 IPI00124264 54 100,0% 4 4 5 11,1% 
x   Aof2 Lysine-specific histone demethylase 1 IPI00453837 93 88,0% 1 1 1 2,8% 
x   Ap1s3 AP-1 complex subunit sigma-3 IPI00380276 18 88,0% 1 1 1 11,7% 
Supplement  
 
x   Ap3b1 AP-3 complex subunit beta-1 IPI00130444 123 88,0% 1 1 1 1,5% 
x   Ap4b1 Ap4b1 protein IPI00468690 83 88,0% 1 1 1 4,2% 
x   Apob Apolipoprotein IPI00350772 418 88,0% 1 1 3 0,2% 
x   Appbp2 Amyloid protein-binding protein 2 IPI00119142 67 88,0% 1 1 1 2,7% 
x   Aprt Adenine phosphoribosyltransferase IPI00128491 20 99,8% 2 2 2 15,6% 
x   
Asxl3 similar to Putative Polycomb group 
protein ASXL1 IPI00225360 233 88,0% 1 1 1 1,1% 
x   
Atic Bifunctional purine biosynthesis protein 
PURH IPI00330303 64 99,2% 1 1 1 2,2% 
x   
Atp1b3 Sodium/potassium-transporting ATPase 
subunit beta-3 IPI00124221 32 99,8% 2 2 2 11,2% 
x   
Atp2c1 Calcium-transporting ATPase type 2C 
member 1 IPI00336323 100 88,0% 1 1 1 2,1% 
x   Atp8b4 ATPase, class I, type 8B, member 4 IPI00662513 135 88,0% 1 1 1 1,9% 
x   
BC023829 similar to family with sequence 
similarity 11, member A isoform 6 IPI00755522 41 88,0% 1 1 1 2,5% 
x   BC037393 CDNA sequence BC037393 IPI00131157 54 88,0% 1 1 1 5,3% 
x   
Bcl11b Isoform 1 of B-cell lymphoma/leukemia 
11B IPI00121608 95 99,2% 1 1 1 1,7% 
x   C3 Isoform Long of Complement C3 precursor IPI00323624 187 88,0% 1 1 1 0,7% 
x   
C330023M02Rik ES cells cDNA, RIKEN full-
length enriched library, clone:C330023M02 
product:WEAKLY SIMILAR TO DEC1 
PROTEIN homolog 
IPI00226576 112 88,0% 1 1 1 2,1% 
x   C6 Complement component 6 IPI00314270 87 88,0% 1 1 1 3,4% 
x   
Cad carbamoyl-phosphate synthetase 2, 
aspartate transcarbamylase, and 
dihydroorotase 
IPI00380280 243 99,8% 2 2 3 1,2% 
x   Capn8 Calpain 8 IPI00126630 79 88,0% 1 1 1 2,4% 
x   Capza2 F-actin capping protein subunit alpha-2 IPI00111265 33 99,8% 2 2 3 9,8% 
x   Cbx3 Chromobox protein homolog 3 IPI00129468 21 99,8% 2 2 2 14,8% 
x   
Ccnf Isoform Short of G2/mitotic-specific cyclin-
F IPI00128673 86 88,0% 1 1 1 1,3% 
x   Cct2 T-complex protein 1 subunit beta IPI00320217 57 100,0% 3 3 4 12,0% 
x   Cct7 T-complex protein 1 subunit eta IPI00331174 60 99,9% 2 2 2 4,2% 
x   Cdc37 Hsp90 co-chaperone Cdc37 IPI00117087 45 88,0% 1 1 1 5,5% 
x   Cdca8 Isoform 2 of Borealin IPI00221934 37 88,0% 1 1 1 4,9% 
x   Cdh19 cadherin 19, type 2 IPI00660475 87 88,0% 1 2 2 2,6% 
x   Cdk3 Isoform 1 of Cell division protein kinase 3 IPI00109650 IPI00109672 61 88,0% 1 1 1 1,5% 
x   
Cep350 centrosome-associated protein 350 
isoform 1 IPI00118304 346 88,0% 1 1 1 0,4% 
x   
Cic CDNA, RIKEN full-length enriched library, 
clone:M5C1067E09 product:capicua homolog 
(Drosophila), full insert sequence 
IPI00653910 258 88,0% 1 1 1 1,0% 
x   Clic1 Chloride intracellular channel protein 1 IPI00130344 27 88,0% 1 1 1 7,1% 
x   
Copg 8 days embryo whole body cDNA, RIKEN 
full-length enriched library, clone:5730412D09 
product:coatomer protein complex, subunit 
gamma 1, full insert sequence 
IPI00223437 99 88,0% 1 1 1 1,9% 
x   Cpne2 Copine-2 IPI00172189 61 88,0% 1 1 1 3,3% 
x   Cpne3 Copine-3 IPI00266752 60 99,8% 2 2 2 7,1% 
x   Cpne4 Copine-4 IPI00108980 62 88,0% 1 1 2 1,6% 
x   
Ctdp1 Isoform 1 of RNA polymerase II subunit 
A C-terminal domain phosphatase IPI00338904 105 88,0% 1 1 1 1,5% 
x   Ctsh Cathepsin H precursor IPI00118987 37 99,8% 2 2 4 8,4% 
x   Cyp4f15 Cytochrome P450 CYP4F15 IPI00117994 61 88,0% 1 1 1 3,9% 
x   D8Ertd587e hypothetical protein LOC52335 IPI00605902 73 88,0% 1 1 1 5,2% 
x   Dars Aspartyl-tRNA synthetase, cytoplasmic IPI00122743 57 99,8% 2 2 3 6,0% 
x   
Dcps Scavenger mRNA decapping enzyme 
DcpS IPI00459280 39 88,0% 1 1 1 3,3% 
x   Ddb1 DNA damage-binding protein 1 IPI00316740 127 99,8% 2 2 2 1,8% 
x   
Ddx39 Isoform 1 of ATP-dependent RNA 
helicase DDX39 IPI00123878 49 99,4% 1 1 1 2,3% 
x   
Dhx15 Putative pre-mRNA-splicing factor ATP-
dependent RNA helicase DHX15 IPI00128818 91 88,0% 1 1 3 1,5% 
Supplement  
 
x   
Dhx9 Isoform 1 of ATP-dependent RNA 
helicase A IPI00339468 150 99,9% 2 2 2 2,0% 
x   
Dld TIB-55 BB88 cDNA, RIKEN full-length 
enriched library, clone:I730035F24 
product:dihydrolipoamide dehydrogenase 
IPI00331564 55 99,8% 2 2 4 6,3% 
x   
Dlst Dihydrolipoyllysine-residue 
succinyltransferase component of 2- 
oxoglutarate dehydrogenase complex, 
mitochondrial precursor 
IPI00134809 49 88,0% 1 1 1 4,6% 
x   
Dmkn 18-day embryo whole body cDNA, 
RIKEN full-length enriched library, 
clone:1110014F24 product:hypothetical protein 
IPI00271738 11 88,0% 1 1 1 16,4% 
x   
Dnahc8 Isoform 1 of Ciliary dynein heavy chain 
8 IPI00172328 542 88,0% 1 1 1 0,6% 
x   
Dock7 Isoform 2 of Dedicator of cytokinesis 
protein 7 IPI00339428 241 88,0% 1 1 1 0,8% 
x   Dpysl2 Dihydropyrimidinase-related protein 2 IPI00114375 62 99,8% 2 2 2 4,0% 
x   Dscam Down syndrome cell adhesion molecule IPI00112204 222 88,0% 1 1 1 1,3% 
x   
E030049G20Rik Nck-associated protein 5 
isoform 2 IPI00463392 201 88,0% 1 1 1 0,8% 
x   Eda Isoform TAA of Ectodysplasin-A IPI00117049 42 88,0% 1 1 1 6,1% 
x   
Eef1d eukaryotic translation elongation factor 1 
delta isoform a IPI00118875 73 88,0% 1 1 1 3,6% 
x   Eef1g Elongation factor 1-gamma IPI00318841 50 99,8% 2 2 3 5,5% 
x   
Eftud2 116 kDa U5 small nuclear 
ribonucleoprotein component IPI00469260 109 88,0% 1 1 1 1,2% 
x   
EG236622 similar to SMT3 suppressor of mif 
two 3 homolog 2 isoform 3 IPI00108762 11 88,0% 1 1 1 12,8% 
x   
EG330948 similar to ribosomal protein S8 
isoform 1 IPI00274175 24 100,0% 4 4 6 19,2% 
x   EG434077;LOC669183 similar to B0507.2 IPI00408556 46 88,0% 1 1 1 3,9% 
x   EG546797 similar to 40S ribosomal protein S2 IPI00378671 31 88,0% 1 1 1 4,2% 
x   
EG619697 similar to putative pheromone 
receptor IPI00409025 98 88,0% 1 1 2 1,8% 
x   EG627889 similar to 60S ribosomal protein L6 IPI00282248 33 88,0% 1 1 2 3,1% 
x   EG631797 similar to otoferlin isoform a IPI00659709 211 88,0% 1 1 1 1,3% 
x   
EG632671 similar to putative pheromone 
receptor IPI00465475 96 88,0% 1 1 1 2,3% 
x   
EG667965 similar to pleiomorphic adenoma 
gene-like 1 IPI00755396 21 88,0% 1 1 1 7,5% 
x   
EG668389 similar to Ig heavy chain V region 
PJ14 precursor IPI00751105 30 88,0% 1 1 1 8,8% 
x   Egfl9 EGF-like-domain, multiple 9 IPI00321725 45 88,0% 1 1 1 4,7% 
x   
Eif3s10 Eukaryotic translation initiation factor 3 
subunit 10 IPI00129276 162 98,9% 1 1 2 0,8% 
x   
Eif3s4 Eukaryotic translation initiation factor 3 
subunit 4 IPI00622371 36 88,0% 1 1 2 5,0% 
x   
Eif3s7 eukaryotic translation initiation factor 3, 
subunit 7 IPI00115751 64 99,8% 2 2 3 4,4% 
x   
Eif3s8 Eukaryotic translation initiation factor 3 
subunit 8 IPI00321647 106 88,0% 1 1 1 1,1% 
x   Eif3s9 Eif3s9 protein IPI00229859 109 88,0% 1 1 2 1,3% 
x   
Eif4a3 Probable ATP-dependent RNA helicase 
DDX48 IPI00126716 47 88,0% 1 1 1 3,2% 
x   Eif4b Eukaryotic translation initiation factor 4B IPI00221581 69 88,0% 1 1 1 2,6% 
x   
Eif4g1 Isoform 1 of Eukaryotic translation 
initiation factor 4 gamma 1 IPI00421179 176 88,0% 1 1 1 1,2% 
x   Eno3 Beta-enolase IPI00228548 47 88,0% 1 1 1 6,9% 
x   
Epb4.1l5 CDNA, RIKEN full-length enriched 
library, clone:I530014H17 product:erythrocyte 
protein band 4.1-like 5, full insert sequence 
IPI00116447 58 88,0% 1 1 1 3,2% 
x   Eprs Bifunctional aminoacyl-tRNA synthetase IPI00339916 170 99,3% 1 1 1 1,1% 
x   Esr1 Estrogen receptor IPI00117980 67 88,0% 1 1 1 3,3% 
x   Fabp5 Fatty acid-binding protein, epidermal IPI00114162 15 100,0% 3 3 4 23,7% 
x   Fasn Fatty acid synthase IPI00113223 272 100,0% 2 2 2 1,0% 
x   Fbxo18 Isoform 1 of F-box only protein 18 IPI00322250 118 88,0% 1 1 1 2,2% 
x   Fbxo2 F-box only protein 2 IPI00153176 34 88,0% 1 1 1 6,7% 
Supplement  
 
x   Fdps Farnesyl pyrophosphate synthetase IPI00120457 41 99,8% 2 2 2 8,2% 
x   
Fh1 Isoform Mitochondrial of Fumarate 
hydratase, mitochondrial precursor IPI00129928 54 88,0% 1 1 1 2,8% 
x   Fkbp4 FK506-binding protein 4 IPI00230139 52 99,9% 1 1 1 2,0% 
x   Flot1 Flotillin-1 IPI00117181 47 88,0% 1 1 1 7,2% 
x   Fn1 Fibronectin precursor IPI00113539 272 98,9% 1 1 1 0,7% 
x   
Frap1;Angptl7 Isoform 1 of FKBP12-rapamycin 
complex-associated protein IPI00268673 289 88,0% 1 1 1 0,5% 
x   
G430095P16Rik NOD-derived CD11c +ve 
dendritic cells cDNA, RIKEN full-length enriched 
library, clone:F630221H03 product:hypothetical 
protein, full insert sequence 
IPI00653065 16 88,0% 1 1 1 12,8% 
x   G6pc Glucose-6-phosphatase IPI00119645 40 88,0% 1 1 1 5,0% 
x   
G6pdx Glucose-6-phosphate 1-dehydrogenase 
X IPI00228385 59 88,0% 1 1 1 1,6% 
x   Gadl1 glutamate decarboxylase-like 1 IPI00316617 63 88,0% 1 1 1 3,8% 
x   Gck Isoform 1 of Glucokinase IPI00130751 52 88,0% 1 1 1 2,6% 
x   
Gfpt2 Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] 2 IPI00278312 77 88,0% 1 1 1 2,3% 
x   
Gm1323 similar to protein expressed in 
prostate, ovary, testis, and placenta 8 isoform 2 IPI00379098 33 88,0% 1 1 1 4,2% 
x   Got1 Aspartate aminotransferase, cytoplasmic IPI00230204 46 88,0% 1 1 1 2,7% 
x   Gpi1 Glucose-6-phosphate isomerase IPI00228633 63 88,0% 1 1 3 2,0% 
x   
Gpnmb Transmembrane glycoprotein NMB 
precursor IPI00311808 64 100,0% 4 6 8 5,6% 
x   Gramd1a GRAM domain containing 1A IPI00124534 81 88,0% 1 1 1 2,4% 
x   Gsn Isoform 1 of Gelsolin precursor IPI00117167 86 100,0% 3 3 3 6,2% 
x   
H2-K1 H-2 class I histocompatibility antigen, K-
D alpha chain precursor IPI00110807 41 99,8% 2 2 2 6,3% 
x   Hc Complement C5 precursor IPI00330833 189 88,0% 1 1 1 0,8% 
x   
Hcls1 Hematopoietic lineage cell-specific 
protein IPI00117011 54 99,5% 1 1 1 2,7% 
x   Helz Helicase with zinc finger domain IPI00453654 220 88,0% 1 1 1 0,8% 
x   Hist1h1b Histone H1.5 IPI00230133 23 99,3% 1 1 1 4,9% 
x   Hist1h1e Histone H1.4 IPI00223714 22 88,0% 1 1 1 5,5% 
x   Hist1h2ba Histone H2B type 1-A IPI00111957 14 99,3% 1 1 1 8,7% 
x   
Hnrpa0 12 days embryo head cDNA, RIKEN 
full-length enriched library, clone:3010025E17 
product:Heterogeneous nuclear 
ribonucleoprotein A0 (hnRNP A0) homolog 
IPI00109813 31 88,0% 1 1 1 6,6% 
x   
Hnrpa3 Isoform 1 of Heterogeneous nuclear 
ribonucleoprotein A3 IPI00269661 40 97,6% 1 1 3 2,6% 
x   
Hnrpab Heterogeneous nuclear 
ribonucleoprotein A/B IPI00117288 31 100,0% 3 3 3 15,1% 
x   
Hnrpc Bone marrow macrophage cDNA, RIKEN 
full-length enriched library, clone:I830120C02 
product:heterogeneous nuclear 
ribonucleoprotein C, full insert sequence 
IPI00130343 37 88,0% 1 1 1 3,6% 
x   
Hnrpd Isoform 2 of Heterogeneous nuclear 
ribonucleoprotein D0 IPI00230086 36 88,0% 1 1 2 7,1% 
x   
Hnrpf Isoform 1 of Heterogeneous nuclear 
ribonucleoprotein F IPI00226073 46 99,8% 2 2 3 8,0% 
x   
Hnrph2 Heterogeneous nuclear 
ribonucleoprotein H' IPI00108143 49 99,8% 2 2 2 6,0% 
x   
Hnrpk Isoform 1 of Heterogeneous nuclear 
ribonucleoprotein K IPI00223253 51 100,0% 4 4 4 13,0% 
x   
Hnrpl Heterogeneous nuclear ribonucleoprotein 
L IPI00620362 64 100,0% 2 2 2 3,6% 
x   
Hnrpr Bone marrow macrophage cDNA, RIKEN 
full-length enriched library, clone:I830045N07 
product:heterogeneous nuclear 
ribonucleoprotein R, full insert sequence 
IPI00128441 71 88,0% 1 1 1 1,7% 
x   
Hsp110 Isoform HSP105-alpha of Heat-shock 
protein 105 kDa IPI00123802 96 100,0% 3 3 6 4,8% 
x   Hspbap1 Hspb associated protein 1 IPI00222501 54 88,0% 1 1 1 4,4% 
x   Ibrdc1 similar to IBR domain containing 1 IPI00381171 75 88,0% 1 1 1 2,2% 
x   
Idh1 0 day neonate lung cDNA, RIKEN full-
length enriched library, clone:E030024J03 IPI00135231 48 88,0% 1 1 1 3,1% 
Supplement  
 
product:isocitrate dehydrogenase 1 (NADP+), 
soluble, full insert sequence 
x   Ift74 Intraflagellar transport 74 homolog IPI00222584 69 88,0% 1 1 1 3,5% 
x   Igh-1a Igh-1a protein IPI00556788 52 88,0% 1 1 1 4,0% 
x   
Impdh2 Inosine-5'-monophosphate 
dehydrogenase 2 IPI00323971 56 88,0% 1 1 1 2,1% 
x   Irak3 Interleukin-1 receptor-associated kinase 3 IPI00420378 68 88,0% 1 1 1 2,6% 
x   
Itih4 Adult male liver cDNA, RIKEN full-length 
enriched library, clone:1300004A21 
product:inter alpha-trypsin inhibitor, heavy chain 
4, full insert sequence 
IPI00119818 100 88,0% 1 1 1 2,3% 
x   
Itpr2 Isoform 2 of Inositol 1,4,5-trisphosphate 
receptor type 2 IPI00222043 182 99,8% 2 2 2 2,4% 
x   Kin Antigenic determinant of rec-A protein IPI00169984 45 88,0% 1 1 1 4,1% 
x   Kpnb1 Importin beta-1 subunit IPI00323881 97 100,0% 3 4 5 4,8% 
x   Krt19 Keratin, type I cytoskeletal 19 IPI00112947 45 88,0% 1 1 1 1,7% 
x   Krt42 Type I keratin KA22 IPI00468696 50 88,0% 1 1 1 4,2% 
x   
LOC382492 similar to 40S ribosomal protein 
S17 IPI00381546 29 88,0% 1 1 1 10,1% 
x   
LOC433460 similar to Glyceraldehyde-3-
phosphate dehydrogenase IPI00758061 37 88,0% 1 1 1 8,1% 
x   LOC433546 similar to ribosomal protein L9 IPI00117610 22 88,0% 1 1 2 5,1% 
x   LOC545588 similar to ribosomal protein L35a IPI00115233 12 88,0% 1 1 2 8,2% 
x   LOC546179 similar to Spindlin-like protein 2 IPI00474748 27 88,0% 1 1 1 6,8% 
x   
LOC632266;EG545091 similar to 
Heterogeneous nuclear ribonucleoprotein A1 
(Helix-destabilizing protein) (Single-strand 
binding protein) (hnRNP core protein A1) (HDP-
1) (Topoisomerase-inhibitor suppressed) 
isoform 1 
IPI00129808 27 99,8% 2 2 2 12,3% 
x   
LOC633279 similar to palmitoyl-protein 
thioesterase-like protein IPI00669306 17 88,0% 1 1 1 10,4% 
x   
LOC635561;EG665395;LOC675444 similar to 
40S ribosomal protein S29 
IPI00132856 
IPI00625088 7 88,0% 1 1 1 14,3% 
x   LOC638429 similar to olfactory receptor Olr121 IPI00674425 10 88,0% 1 1 1 22,3% 
x   LOC654465 Beta-defensin 41 IPI00656305 9 88,0% 1 1 1 19,0% 
x   
LOC668899;LOC433476 similar to ribosomal 
protein L27a IPI00137687 17 99,8% 2 2 3 16,2% 
x   LOC670174;Ptges3 Prostaglandin E synthase 3 IPI00127989 19 99,9% 2 2 2 9,4% 
x   
LOC671726;EG666974 similar to Proteasome 
subunit alpha type 5 (Proteasome zeta chain) 
(Macropain zeta chain) (Multicatalytic 
endopeptidase complex zeta chain) isoform 1 
IPI00122562 26 100,0% 2 2 2 9,1% 
x   
LOC671929;Rps2;EG667279;LOC665951 40S 
ribosomal protein S2 IPI00318492 32 88,0% 1 1 1 3,7% 
x   
LOC672818;EG545121 similar to ribosomal 
protein S14 IPI00112407 16 88,0% 1 1 1 7,3% 
x   
LOC675192;LOC672281;EG668182 similar to 
60S ribosomal protein L13 IPI00134097 24 99,1% 1 1 1 5,3% 
x   
Lonrf2 LON peptidase N-terminal domain and 
ring finger 2 IPI00378496 58 88,0% 1 1 1 1,5% 
x   
Lrp8 Isoform 2 of Low-density lipoprotein 
receptor-related protein 8 precursor IPI00121600 96 88,0% 1 1 1 2,0% 
x   Lrpprc Leucine-rich PPR-motif containing IPI00420706 147 88,0% 1 1 1 0,8% 
x   Lrrc56 Leucine-rich repeat-containing protein 56 IPI00170019 60 88,0% 1 1 1 4,7% 
x   
Lrrn3 Leucine-rich repeat neuronal protein 3 
precursor IPI00314773 79 88,0% 1 1 1 3,0% 
x   
Ly6e 13 days embryo head cDNA, RIKEN full-
length enriched library, clone:3110052M08 
product:lymphocyte antigen 6 complex, locus E, 
full insert sequence 
IPI00110520 14 88,0% 1 1 1 10,5% 
x   
Macf1 microtubule-actin crosslinking factor 1 
isoform 2 IPI00663180 832 99,7% 1 1 1 0,2% 
x   Mad2l1bp MAD2L1-binding protein IPI00121481 31 88,0% 1 1 1 6,2% 
x   
Map3k7ip2 Mitogen-activated protein kinase 
kinase kinase 7-interacting protein 2 IPI00115639 76 88,0% 1 1 1 2,9% 
x   
March1 Isoform 3 of E3 ubiquitin-protein ligase 
MARCH1 IPI00421198 32 88,0% 1 1 1 4,9% 
Supplement  
 
x   
Mcm2 CRL-1722 L5178Y-R cDNA, RIKEN full-
length enriched library, clone:I730064M13 
product:minichromosome maintenance deficient 
2 mitotin (S. cerevisiae), full insert sequence 
IPI00323820 103 88,0% 1 1 1 1,2% 
x   
Mcm5 minichromosome maintenance deficient 
5, cell division cycle 46 IPI00309398 82 88,0% 1 1 2 1,8% 
x   Mdh1 Malate dehydrogenase, cytoplasmic IPI00336324 36 100,0% 4 4 7 14,1% 
x   Mfge8 Isoform 2 of Lactadherin precursor IPI00322712 47 100,0% 3 3 3 8,7% 
x   
Mitf Isoform H of Microphthalmia-associated 
transcription factor IPI00230197 57 88,0% 1 1 1 5,7% 
x   Mon1b;4930481F22Rik MON1 homolog b IPI00223080 60 88,0% 1 1 1 3,3% 
x   
Mphosph1 Isoform 1 of M-phase 
phosphoprotein 1 IPI00405665 203 88,0% 1 1 1 0,8% 
x   Mug1 Murinoglobulin-1 precursor IPI00123223 165 88,0% 1 1 1 0,5% 
x   
Mvp TIB-55 BB88 cDNA, RIKEN full-length 
enriched library, clone:I730057I21 
product:major vault protein, full insert sequence 
IPI00111258 97 88,0% 1 1 1 2,0% 
x   Mybbp1a Myb-binding protein 1A IPI00331361 152 88,0% 1 1 1 1,1% 
x   Myef2 Isoform 2 of Myelin expression factor 2 IPI00154084 62 99,5% 1 1 1 7,0% 
x   Myh11 Isoform 1 of Myosin-11 IPI00114894 227 98,2% 1 1 1 0,7% 
x   
Myl2 Myosin, light polypeptide 2, regulatory, 
cardiac, slow IPI00230438 19 88,0% 1 1 1 7,8% 
x   
Naca Nascent polypeptide-associated complex 
subunit alpha, muscle-specific form IPI00111831 221 99,8% 2 2 3 1,3% 
x   Nap1l1 Nucleosome assembly protein 1-like 1 IPI00123199 45 88,0% 1 1 2 3,1% 
x   
Nap1l4 Bone marrow stroma cell CRL-2028 
SR-4987 cDNA, RIKEN full-length enriched 
library, clone:G430136P17 product:nucleosome 
assembly protein 1-like 4, full insert sequence 
IPI00133977 47 88,0% 1 1 1 4,0% 
x   
Nars Activated spleen cDNA, RIKEN full-length 
enriched library, clone:F830225J05 
product:asparaginyl-tRNA synthetase, full insert 
sequence 
IPI00223415 64 88,0% 1 1 1 2,0% 
x   
Nasp nuclear autoantigenic sperm protein 
isoform 1 IPI00115987 49 88,0% 1 1 1 2,2% 
x   
Nasp nuclear autoantigenic sperm protein 
isoform 2 IPI00830976 84 88,0% 1 1 1 1,6% 
x   Neb similar to Nebulin IPI00755239 747 88,0% 1 1 1 0,0% 
x   Nolc1 Nolc1 protein IPI00453865 41 88,0% 1 1 1 3,0% 
x   Nudc Nuclear migration protein nudC IPI00132942 38 88,0% 1 1 1 3,6% 
x   Olfr1333 Olfactory receptor 1333 IPI00380564 36 88,0% 1 1 1 3,2% 
x   Olfr615 Olfactory receptor MOR19-2 IPI00127910 35 88,0% 1 1 1 6,7% 
x   Osbpl5 oxysterol-binding protein-like protein 5 IPI00624705 102 88,0% 1 1 1 3,0% 
x   Palmd Palmdelphin IPI00314152 63 88,0% 1 1 1 6,2% 
x   Pcbp1 Poly(rC)-binding protein 1 IPI00128904 37 88,0% 1 1 1 3,1% 
x   Pcna Proliferating cell nuclear antigen IPI00113870 29 100,0% 2 2 3 12,3% 
x   Pcnt pericentrin IPI00457623 331 88,0% 1 1 1 0,3% 
x   
Pet112l Probable glutamyl-tRNA(Gln) 
amidotransferase subunit B, mitochondrial 
precursor 
IPI00457976 62 88,0% 1 1 1 4,5% 
x   Pfkl Phosphofructokinase, liver, B-type IPI00387312 85 100,0% 3 3 3 6,3% 
x   
Phgdh;LOC673015 D-3-phosphoglycerate 
dehydrogenase IPI00225961 57 100,0% 5 6 9 13,3% 
x   
Picalm Isoform 1 of Phosphatidylinositol-binding 
clathrin assembly protein IPI00264501 72 88,0% 1 1 1 3,0% 
x   
Pik3r1 Phosphatidylinositol 3-kinase regulatory 
subunit alpha IPI00263878 83 88,0% 1 1 1 2,8% 
x   
Pip5k1b Isoform 1 of Phosphatidylinositol-4-
phosphate 5-kinase type-1 alpha IPI00331736 60 88,0% 1 1 1 2,9% 
x   Plk1 Serine/threonine-protein kinase PLK1 IPI00120767 68 88,0% 1 1 1 5,1% 
x   
Polr3a similar to polymerase (RNA) III (DNA 
directed) polypeptide A, 155kDa IPI00753896 156 88,0% 1 1 1 0,9% 
x   Ppfibp2 Ppfibp2 protein IPI00400017 101 88,0% 1 1 1 1,8% 
x   
Ppp2cb Serine/threonine-protein phosphatase 
2A catalytic subunit beta isoform IPI00111556 36 88,0% 1 1 1 3,6% 
x   
Ppp2r1a Serine/threonine-protein phosphatase 
2A 65 kDa regulatory subunit A alpha isoform IPI00310091 65 88,0% 1 1 1 1,9% 
Supplement  
 
x   
Ppp4r1 13 days embryo head cDNA, RIKEN 
full-length enriched library, clone:3110001J10 
product:protein phosphatase 4, regulatory 
subunit 1, full insert sequence 
IPI00461455 39 88,0% 1 1 1 4,2% 
x   Prdx4 Peroxiredoxin-4 IPI00116254 31 88,0% 1 1 1 2,9% 
x   
Prkcsh Isoform 1 of Glucosidase 2 subunit beta 
precursor IPI00115680 59 88,0% 1 1 1 1,9% 
x   
Prkdc Isoform 1 of DNA-dependent protein 
kinase catalytic subunit IPI00123886 471 97,7% 1 1 1 0,4% 
x   
Prmt1 Isoform 1 of Protein arginine N-
methyltransferase 1 IPI00120495 42 88,0% 1 1 1 4,3% 
x   Psat1 Phosphoserine aminotransferase IPI00115620 40 100,0% 3 3 3 8,9% 
x   Psma1 Proteasome subunit alpha type 1 IPI00283862 30 100,0% 2 2 2 10,3% 
x   Psma6 Proteasome subunit alpha type 6 IPI00131845 27 100,0% 3 3 4 16,7% 
x   Psma8 Proteasome subunit alpha type 7-like IPI00109122 28 88,0% 1 1 1 5,6% 
x   
Psmb1 Proteasome subunit beta type 1 
precursor IPI00113845 26 98,5% 1 1 2 5,8% 
x   
Psmb4 Proteasome subunit beta type 4 
precursor IPI00129512 29 88,0% 1 1 1 5,7% 
x   
Psmb5 proteasome (prosome, macropain) 
subunit, beta type 5 IPI00317902 29 88,0% 1 1 1 5,3% 
x   
Psmc2 Adult male testis cDNA, RIKEN full-
length enriched library, clone:4930525G09 
product:PROTEASOME (PROSOME, 
MACROPAIN) 26S SUBUNIT, ATPASE 2 
IPI00270326 53 88,0% 1 1 1 4,6% 
x   
Psmd11 26S proteasome non-ATPase 
regulatory subunit 11 IPI00222515 47 88,0% 1 1 1 3,1% 
x   Ptprs Ptprs protein IPI00230067 168 88,0% 1 1 1 0,9% 
x   
Ranbp1 Ran-specific GTPase-activating protein 
(Fragment) IPI00321978 24 99,8% 2 2 2 10,8% 
x   Rangap1 Ran GTPase-activating protein 1 IPI00467338 64 88,0% 1 1 1 2,0% 
x   Rars Arginyl-tRNA synthetase, cytoplasmic IPI00315488 76 100,0% 3 3 3 4,7% 
x   
Rbmx Heterogeneous nuclear ribonucleoprotein 
G IPI00124979 42 88,0% 1 1 1 3,3% 
x   Reln Isoform 1 of Reelin precursor IPI00121421 387 88,0% 1 1 1 0,3% 
x   
Rnf123 Isoform 2 of E3 ubiquitin-protein ligase 
RNF123 IPI00471406 149 88,0% 1 1 1 1,2% 
x   
Rnf207 3 days neonate thymus cDNA, RIKEN 
full-length enriched library, clone:A630086J06 
product:hypothetical Zn-finger, B-box/Zn-finger, 
RING containing protein, full insert sequence 
IPI00136356 71 88,0% 1 1 1 2,1% 
x   
RP23-331I21.14 similar to poly(A) binding 
protein, cytoplasmic 4 isoform 1 isoform 1 IPI00461269 73 88,0% 1 1 1 3,2% 
x   Rpl10 60S ribosomal protein L10 IPI00474637 25 88,0% 1 1 1 6,5% 
x   Rpl15 60S ribosomal protein L15 IPI00273803 24 88,0% 1 1 2 6,9% 
x   Rpl19 60S ribosomal protein L19 IPI00122426 23 88,0% 1 1 1 8,7% 
x   Rpl28 60S ribosomal protein L28 IPI00222547 16 88,0% 1 1 1 5,1% 
x   Rpl36 60S ribosomal protein L36 IPI00230679 12 97,8% 1 1 1 9,5% 
x   Rps14 40S ribosomal protein S14 IPI00322562 16 99,8% 2 2 2 20,5% 
x   Rps15a 40S ribosomal protein S15a IPI00230660 15 99,8% 2 2 2 12,3% 
x   Rps16 Rps16 protein IPI00469918 19 100,0% 1 1 2 6,4% 
x   Rps27l 40S ribosomal protein S27-like protein IPI00124709 9 88,0% 1 1 2 15,5% 
x   Rps7 40S ribosomal protein S7 IPI00136984 22 99,8% 2 2 3 10,3% 
x   Rpsa Ribosomal protein SA IPI00126010 33 88,0% 1 1 1 9,2% 
x   
Rrn3 RRN3 RNA polymerase I transcription 
factor homolog IPI00127454 75 88,0% 1 1 2 1,8% 
x   Ruvbl1 RuvB-like 1 IPI00133985 50 88,0% 1 1 1 2,4% 
x   Ruvbl2 RuvB-like 2 IPI00123557 51 88,0% 1 1 1 2,4% 
x   Sall2 Sal-like protein 2 IPI00134563 105 88,0% 1 1 1 3,0% 
x   
Sars ES cells cDNA, RIKEN full-length enriched 
library, clone:C330018O14 product:seryl-
aminoacyl-tRNA synthetase 1 
IPI00225307 61 99,8% 2 2 2 5,6% 
x   
Scye1 small inducible cytokine subfamily E, 
member 1 IPI00132194 35 88,0% 1 1 1 5,6% 
x   Sdro Retinol dehydrogenase similar protein IPI00170115 35 88,0% 1 1 1 8,0% 
x   Sept2 Septin-2 IPI00114945 42 100,0% 2 2 3 7,8% 
Supplement  
 
x   Sept6 Isoform V of Septin-6 IPI00226602 49 88,0% 1 1 1 2,6% 
x   Sept7 cell division cycle 10 homolog IPI00224626 51 99,8% 2 2 2 7,8% 
x   Sept9 Isoform 1 of Septin-9 IPI00457611 66 88,0% 1 1 1 1,5% 
x   Sesn2 Sestrin-2 IPI00115849 54 88,0% 1 1 1 5,0% 
x   Set;LOC671392 Isoform 1 of Protein SET IPI00111560 33 99,8% 2 3 6 8,3% 
x   Sez6l2 Seizure related 6 homolog like 2 IPI00128454 99 88,0% 1 1 1 2,7% 
x   
Sf3b2 Bone marrow macrophage cDNA, RIKEN 
full-length enriched library, clone:I830028H02 
product:splicing factor 3b, subunit 2 
IPI00349401 98 88,0% 1 1 1 1,6% 
x   Sf3b3 Isoform 1 of Splicing factor 3B subunit 3 IPI00122011 136 88,0% 1 1 1 0,9% 
x   Sfpq Splicing factor, proline- and glutamine-rich IPI00129430 75 99,8% 2 2 2 3,7% 
x   
Sfrs1 Isoform 1 of Splicing factor, 
arginine/serine-rich 1 IPI00420807 28 99,8% 2 2 3 8,9% 
x   Sfrs2 Splicing factor, arginine/serine-rich 2 IPI00121135 25 88,0% 1 1 1 3,6% 
x   Sfrs5 Splicing factor, arginine/serine-rich 5 IPI00314709 31 88,0% 1 1 1 8,5% 
x   
Sfrs7 Isoform 2 of Splicing factor, 
arginine/serine-rich 7 IPI00153743 27 99,9% 1 1 1 8,8% 
x   Sfrs9 Splicing factor, arginine/serine-rich 9 IPI00132340 26 88,0% 1 1 1 3,2% 
x   Slc22a1 LX1 IPI00331032 62 88,0% 1 1 1 4,3% 
x   
Slc24a6 Isoform 1 of 
Sodium/potassium/calcium exchanger 6 
precursor 
IPI00127134 64 88,0% 1 1 1 2,9% 
x   
Slc2a8 Solute carrier family 2, facilitated 
glucose transporter member 8 IPI00310367 52 88,0% 1 1 1 5,9% 
x   
Slc6a12 Solute carrier family 6 
(Neurotransmitter transporter, betaine/GABA), 
member 12 
IPI00466652 71 88,0% 1 1 1 2,1% 
x   Slit3 Slit homolog 3 protein precursor IPI00664551 168 88,0% 1 1 1 1,6% 
x   
Snrp70 Isoform 2 of U1 small nuclear 
ribonucleoprotein 70 kDa IPI00230541 20 88,0% 1 1 1 9,6% 
x   Snrpd3 Small nuclear ribonucleoprotein Sm D3 IPI00119224 14 99,8% 2 2 2 15,1% 
x   
Snrpf similar to Small nuclear ribonucleoprotein 
F IPI00666526 26 88,0% 1 1 1 4,6% 
x   Sorl1 Sortilin-related receptor precursor IPI00129831 247 88,0% 1 1 2 0,7% 
x   Spert Spermatid associated IPI00112593 48 88,0% 1 1 1 3,4% 
x   Spnb4 spectrin beta 4 IPI00270149 289 88,0% 1 1 1 0,5% 
x   Srm Spermidine synthase IPI00136912 34 99,8% 2 2 2 7,3% 
x   Ssb Lupus La protein homolog IPI00134300 48 88,0% 1 1 1 2,7% 
x   Ssty1 spermiogenesis gene IPI00756509 27 98,8% 1 1 1 3,8% 
x   St13 Hsc70-interacting protein IPI00116308 42 99,3% 1 1 1 2,7% 
x   Stip1 Stress-induced-phosphoprotein 1 IPI00121514 63 100,0% 3 3 5 7,6% 
x   
Stk39 STE20/SPS1-related proline-alanine-rich 
protein kinase IPI00622783 60 88,0% 1 1 1 5,6% 
x   
Strbp Isoform 1 of Spermatid perinuclear RNA-
binding protein IPI00128254 74 88,0% 1 1 1 2,4% 
x   Stx8 Syntaxin-8 IPI00136653 27 99,0% 1 1 1 7,6% 
x   
Stxbp5l Isoform 3 of Syntaxin-binding protein 5-
like IPI00309953 129 88,0% 1 1 1 1,5% 
x   Syngr1 Isoform 1A of Synaptogyrin-1 IPI00115763 26 88,0% 1 1 2 5,1% 
x   Taldo1 Transaldolase IPI00124692 37 100,0% 3 3 4 10,1% 
x   Tardbp TAR DNA-binding protein 43 IPI00121758 45 88,0% 1 1 2 2,9% 
x   Tcp1 T-complex protein 1 subunit alpha B IPI00459493 60 99,8% 2 2 3 4,5% 
x   Thoc1 THO complex subunit 1 IPI00153778 76 88,0% 1 1 1 3,8% 
x   Tle4 Bce-1 protein IPI00463249 12 88,0% 1 1 1 18,1% 
x   
Tmc4;Leng1 transmembrane channel-like gene 
family 4 IPI00387513 77 88,0% 1 1 1 1,2% 
x   Tmc5 Transmembrane channel-like protein 5 IPI00468700 88 88,0% 1 1 1 1,7% 
x   Tmem59 Transmembrane protein 59 precursor IPI00135648 36 88,0% 1 1 1 3,1% 
x   Tmem70 Transmembrane protein 70 IPI00467349 28 88,0% 1 1 1 6,7% 
x   
Tmie Transmembrane inner ear expressed 
protein precursor IPI00170169 17 88,0% 1 1 1 20,3% 
x   Tnxb Tenascin X IPI00130794 435 88,0% 1 1 1 0,3% 
x   Tpm3 Tropomyosin 3, gamma IPI00169707 33 100,0% 2 2 2 8,1% 
x   Tpm4 Tropomyosin alpha-4 chain IPI00421223 28 88,0% 1 1 1 6,1% 
x   Tpt1 Translationally-controlled tumor protein IPI00129685 19 88,0% 1 1 1 8,1% 
Supplement  
 
x   Tspan3 Tetraspanin-3 IPI00135517 28 88,0% 1 1 1 6,3% 
x   Tspan32 Isoform 4 of Tetraspanin-32 IPI00263117 19 88,0% 1 1 1 16,2% 
x   
Ttll1 Isoform 1 of Probable tubulin 
polyglutamylase IPI00126079 49 88,0% 1 1 1 3,8% 
x   Ttyh3 Tweety homolog 3 IPI00226563 58 88,0% 1 1 1 2,7% 
x   Tubb6 Tubulin beta-6 chain IPI00122928 50 88,0% 1 1 1 3,8% 
x   U2af2 Splicing factor U2AF 65 kDa subunit IPI00113746 53 88,0% 1 1 1 3,8% 
x   
Ube1x;Ube1y1 Ubiquitin-activating enzyme E1 
X IPI00123313 118 100,0% 4 4 5 6,0% 
x   Ush2a Isoform 1 of Usherin precursor IPI00720231 570 88,0% 1 1 2 0,4% 
x   
Usp47 Isoform 2 of Ubiquitin carboxyl-terminal 
hydrolase 47 IPI00420143 155 88,0% 1 1 1 1,6% 
x   
Vat1 Synaptic vesicle membrane protein VAT-1 
homolog IPI00126072 43 88,0% 1 1 1 2,2% 
x   
Vcan Isoform V0 of Versican core protein 
precursor IPI00121038 367 88,0% 1 1 1 0,7% 
x   
Vps13d similar to vacuolar protein sorting 13D 
isoform 2 isoform 5 IPI00649141 488 98,9% 1 1 1 0,3% 
x   
Vps26a Isoform 2 of Vacuolar protein sorting-
associated protein 26A IPI00329942 42 88,0% 1 1 1 4,7% 
x   
Xpnpep1 Bone marrow macrophage cDNA, 
RIKEN full-length enriched library, 
clone:G530009C13 product:X-prolyl 
aminopeptidase (aminopeptidase P) 1, soluble 
IPI00420231 75 88,0% 1 1 2 2,4% 
x   
Ywhab Isoform Long of 14-3-3 protein 
beta/alpha IPI00230682 28 99,9% 2 2 3 8,1% 
x   Ywhag 14-3-3 protein gamma IPI00230707 28 100,0% 2 2 2 13,4% 
x   Zfp353 zinc finger protein 353 IPI00121571 62 88,0% 1 1 1 4,2% 
x   Zfp385 zinc finger protein 385 IPI00135630 40 88,0% 1 1 1 5,2% 
x   Zfp410 Isoform 1 of Zinc finger protein 410 IPI00123438 52 88,0% 1 1 1 4,4% 
           
 x  
- 13 days embryo heart cDNA, RIKEN full-
length enriched library, clone:D330011K04 
product:hypothetical EGF-like domain, subtype 
2 containing protein, full insert sequence 
(Fragment) 
IPI00652223 14 87,9% 1 1 1 11,5% 
 x  - 195 kDa protein IPI00788398 195 87,9% 1 1 1 1,3% 
 x  - 25 kDa protein IPI00755602 25 87,9% 1 1 2 5,6% 
 x  - 39 kDa protein IPI00753041 39 87,9% 1 1 1 4,7% 
 x  - 9 kDa protein IPI00138204 9 87,9% 1 1 1 20,5% 
 x  - 95 kDa protein IPI00762641 95 87,9% 1 1 1 2,8% 
 x  - Gag protein IPI00466581 65 87,9% 1 1 1 2,7% 
 x  
0610031J06Rik Bone marrow macrophage 
cDNA, RIKEN full-length enriched library, 
clone:I830015H17 product:Kidney predominant 
protein (RIKEN cDNA 0610031J06 gene) 
IPI00459432 44 87,9% 1 1 1 5,0% 
 x  1700016L21Rik hypothetical protein LOC72208 IPI00807926 12 87,9% 1 1 1 16,2% 
 x  
1700106N22Rik NOD-derived CD11c +ve 
dendritic cells cDNA, RIKEN full-length enriched 
library, clone:F630211G03 product:hypothetical 
protein, full insert sequence 
IPI00378272 36 87,9% 1 1 1 9,9% 
 x  
2310047H23Rik RIKEN cDNA 2310047H23 
gene IPI00378224 38 99,6% 1 1 1 5,8% 
 x  
2410018C17Rik 6 days neonate head cDNA, 
RIKEN full-length enriched library, 
clone:5430419M09 product:hypothetical 
protein, full insert sequence 
IPI00759959 37 87,9% 1 1 1 9,2% 
 x  
2700008B19Rik hypothetical protein 
LOC217026 IPI00420246 129 87,9% 1 1 1 2,7% 
 x  
3110043A19Rik 13 days embryo head cDNA, 
RIKEN full-length enriched library, 
clone:3110043A19 product:hypothetical protein, 
full insert sequence 
IPI00110576 21 87,9% 1 1 1 9,0% 
 x  4921505C17Rik Pianissimo IPI00399440 192 87,9% 1 1 1 2,0% 
 x  
4930563M21Rik Adult male testis cDNA, 
RIKEN full-length enriched library, 
clone:4930563M21 product:hypothetical 
protein, full insert sequence 
IPI00229144 22 87,9% 1 1 1 11,2% 
